health humanity report scientist jan g shown working johnson johnsons molecule library stores million unique compounds scientists access library order compounds rd activities johnson johnson photo frederik beyens health humanity report approach diverse surgeon initiative participants ryan randle md michelle salazar md mhsc participate laparoscopic surgery handson labgri health year achievement evolution johnson johnson leading accountability innovation grounded humanity report met important global targets including belief science technology advance healthcare decade last century invested nearly billion championing global health equity pleased ranked rd integrated digital capabilities work access medicine index evaluates worlds largest pharmaceutical companies efforts already use data science drug distribute medicines low middleincome countries message chairman ceo discovery advanced three treatments also exceeded health humanity goal support multiple myeloma second common million frontline health workers tools training initiatives include johnson johnson center health worker blood cancer providing transformational care innovation committed million three years cancer patients message africa frontline first catalytic fund expand professional workforce community health workers ten african countries data science also applied rd ecosystem medical chairman ceo devices software robotics solutions helping healthcare empowering employees continued focus accelerating providers care patients greater precision efficiency diversity equity inclusion outcomes helps us meet following acquisition abiomed inc world leader changing needs communities serve proud heart recovery solutions integrating technology achieved health humanity goal reaching percent expanding leadership cardiovascular care racial ethnic diversity us management roles also global community track achieve gender parity women management positions technology also helping supply chain make leaps forward around world upskill employees launched jj learn productivity efficiency sustainability fact recognized world opportunity innovation johnson johnson dynamic development ecosystem ensure easy access learning world economic forum granted three new committed improving health people everywhere growth opportunities also enhanced mental health resources lighthouse designations manufacturing facilities employees families guided credo set values reflect accomplishments eye inspires employees different less exciting future track advance two global companies kenvuea new consumer health put needs wellbeing people companyand johnson johnsondedicated pharmaceutical serve first years motivated medtechthat uniquely positioned fastmoving us solve complex health challenges healthcare landscape spirit innovation report discover many insights johnson johnson creating longterm sustainable value improving health humanity purpose shared responsibility honored chairman ceo continue years come committed lead seize legacy opportunities humanity following credo values solid financial performance driven industry joaquin duato johnson johnson colleagues attending american society thank interest hematology annual meeting new orleans louisiana leading portfolio scientific technological innovations advancing environmental health secured deal reshaping many aspects healthcare environmental social source percent renewable electricity operations governance esg strategy underpins business performance brazil also joined collaboration pharmaceutical companies health humanity goals key performance support ingredient suppliers efforts decarbonize addition indicators progress frameworks guide decisions expanded pharmaceuticals us safe returns program joaquin duato direct positive contributions society economy switzerland plans add countries year also chairman board chief executive officer sustainable development also remind us much europe expanded singleuse device hospital recycling world program eight countries health independent directorsprovides robust leadership oversight operations risk officer executive committee member humanity report boards oversight times responsibilities overseen board type oversight new standing committees must evolve meet fiduciary responsibility board view compliance business obligations changing needs company example opportunity closely linkednot tensionwhen comes board formed special committee oversee strategy ethical compliant conduct basis separation consumer health business special successful business enabler opportunity committee remained active addressing esg matters strategic holistic way board johnson johnson realized connection long qa lead director johnson johnson embedded esg ago significantly integrated esg matters qa business operations board agenda example joined board committee johnson johnson longstanding commitment creating chairs overseeing risk sustainability topics engaging lead director longterm value stakeholders mitigate risk companys recent esg priority topics assessment results explore develop new business opportunities informed companys reporting disclosure responsibilities outlined companys credo set play significant role johnson johnsons next set business principles guided company years public goals boards understanding ofand perspective onenvironmental board decided realign committee responsibilities anne mulcahy lead director social governance matters relevance value enhanced expanded scope regulatory creation evolved significantly past several years johnson johnson board directors compliance sustainability committee action better taken many opportunities engage business positions board oversee certain esg matters alongside plays pivotal role ensuring board help guide esg considerations decision making across many compliance matters aspects companys activities example supported deeply engaged esg strategy formalization johnson johnsons esg strategy progress anne shares insights monitored progress esg strategyaligned health believe greatest opportunity johnson johnson create longterm value stakeholders response questions reflect current humanity goals plays integration global health equitya core esg key focus areain different business financial results always important measure interests key stakeholders processes example janssen companys pharmaceutical performance johnson johnson continue sustainable business actively addresses health inequities improving diverse longterm growth operating focus future changes johnson johnsons business recruitment clinical trials supporting next generation refusing compromise credo values core environment affected nature boards underrepresented diverse physicians advancing environmental responsibility board capitalize companys position oversight responsibilities health another esg priority jj medtech advancing strength leader healthcare guiding johnson johnson circularity partnering hospitals europe recycle metal address pressing concerns today preparing meet board helm dynamic organization plastic components singleuse surgical instruments challenges tomorrow investments rd data science constantly evaluating changing world affecting program currently active eight countries excited digital innovation central advancing companys companys business board must respond projects like underway esg strategy investments reflected strategies current emerging challenges also opportunities johnson johnsons business segments enterprise particularly true company navigated social taken many opportunities engage functions emerging fields drive value creation unrest conflict many parts world supply chain issues throughout company increased inflation interest rates extreme weather events business help guide esg considerations preparing successful separation decision making across many aspects im excited future johnson johnson especially consumer health business segment focus innovation enables company companys activities pursue purpose performance equal commitment johnson johnson long thrived changing environment transformational innovation science technology company years increasing regulation expected esg matters us fundamental companys strong financial performance independent lead director johnson johnson board countries around world role board powerful financial performance enables johnson directors work closely chairman board chief become compliance opportunity johnson sustain exceed investment lifesaving executive officer focuses companys trajectory highly regulated business johnson johnson relies lifeenhancing innovations benefiting millions patients longterm growth current board structurean independent robust compliance organization led chief technical consumers year lead director five standing committees comprised entirely year brief health humanity report champion global health equity empower employees advance environmental health million year brief patients treated janssen medicine ethnicracial diversity management positions within renewable electricity us achieving health humanity goal secured operations brazil starting direct power purchase agreement cumulative doses sirturo bedaquiline treatments multidrugresistant tuberculosis shipped employees responded credo survey cdp list favorability rate among participantsa testament leadership climate action valuesdriven culture fifth year row ranking access medicine index reflecting strategy enable access medicines technologies people low jj learn new multiyear middleincome countries collaborative initiative launched dynamic learning development million dicedigital health circular economy ecosystem empowers launched janssen cofunding nurses midwives community health workers employees continuous eu horizon europe program address digital supported skills tools growth opportunities reskilling health waste johnson johnson center health worker upskilling development innovation exceeding health humanity goal lead accountability billion responsibility innovation standards suppliers invested research employees completed health care development across compliance training highest updated expanded expectations supplier businesses completion number date diversity equity inclusion information security environmental responsibility funded part johnson johnson foundation registered charity company limited guarantee corporation operating companies across johnson johnson family companies foundation operates worldwide johnson johnson foundation united states founded johnson johnson foundation scotland founded health recognitions esg ratings humanity report improved maintained esg rater score notes ranked ranked top allstar pharmaceutical industry ranked access medicine index fortunes worlds list fortune worlds previous current featured index topthree performer score score admired companies list admired companies list sixth consecutive year th consecutive year ninth year row year brief recognized cdp list rating previous current leadership climate action fifth score score consecutive year innovative ranked climate companies drucker institutes top jj medtech selected bestmanaged companies previous current achieved cdps rating water risk one fast companys score score innovative companies water scored th percentile previous current pharmaceutical manufacturing sector score score fifth consecutive year six years row ecovadis sustainability assessment trendsetter status included seramount top named cpazicklin index inclusion index member included ftsegood index series corporate political disclosure diversity best practices previous current nd year scoring th percentile score score accountability sector previous b current b received iss esg good rating score score best employer th consecutive year diversity member forbes billion dollar roundtable ranked pharmaceuticals supplier diversity moodys analytics previous current biotechnology sector north america score score moodys analytics esg scorecard ranked sixth consecutive year p sr ce ov ri eous bbb c scu orr ent achieved msci esg rating gartner incs annual ranking named cdp top company supply chains supply chain leaderboard previous current received sustainalytics medium risk rating score score current iss esg score august update use johnson johnson msci esg research llc affiliates msci data use msci logos trademarks service marks index names herein constitute sponsorship endorsement recommendation promotion johnson johnson msci msci services data property msci information providers provided asis without warranty msci names logos trademarks service marks msciabout johnson johnson gri health humanity report purpose business blend heart science johnson johnson family companies company largest ingenuity profoundly change diversified healthcare products company headquartered new jersey us operating trajectory health humanity companies employ approximately employees virtually countries world engaged research development manufacture sale broad range products johnson johnson healthcare field work suppliers hundreds external values manufacturers support development manufacturing products worldwide driven credo set companys product portfolio includes thousands pharmaceutical medtech consumer values principles since health products address health wellness needs people every day challenged inspired us put needs wellbeing people serve first financial results millions sales business segment millions johnson johnson publicly owned corporation stock traded pharmaceutical medtech consumer health new york stock exchange nysejnj market price consecutive cardiovascular interventional solutions baby care r vd es tment per share years dividend metabolism retina orthopaedics oral care yearend close increases immunology surgery general advanced overthecounter medicines infectious diseases vision skin healthbeauty vaccines net womens health earnings neuroscience wound care oncology pulmonary hypertension total sales november company announced intention separate companys consumer health business new publicly traded company september kenvue announced name planned new consumer health company kenvue millions part johnson johnson reporting period health humanity report kenvue completed initial public offering shares common stock may th closing initial public offering includes dividend declared april company owns approximately total outstanding shares kenvue common stock company remains track complete separation subject market conditions abiomed headcount included total employee number due yearend acquisition timing human resources information system integration processes esg governance gri health humanity report companys dedication integrating esg business strategies starts highest levels leadership board overall accountability esg risk management oversight effective esg governance requires management engagement board priority topics matrix level oversight boards esg risk management approach designed effectively govern manage esg risks opportunities integral companys core business strategy significant esg risks reviewed evaluated board committees part ongoing risk oversight esg governance company improved esg governance matters following ways w e announced evolved esg strategy focused championing global health equity empowering employees advancing environmental health leading accountability innovation foundational efforts enterprise governance council companys primary governance body esg matters updated esg knowledge module made available employees help understand esg management approach including esg strategy w e held fifth investor relations esg webcast june update shareholders esg performance progress health humanity goals webcast included interview members johnson johnson board directors chief financial officer w e continued improve disclosures esg topics including enhancing tax policy position disaster relief position employee development also expanded disclosures additional metrics greater transparency esg priorities johnson johnson use materiality assessment call priority topics assessment pta identify prioritize strategically address relevant esg topics significant impact society business since conducted pta every two three years last pta conducted double materiality focus examined esg priority topics two standpoints impact topic johnson johnsons business results impact johnson johnsons business people environment society general priority topics matrix presents esg priorities health esg strategy stakeholder engagement humanity report esg strategy grounded credo values informed companys purpose deep longstanding relationships cultivate stakeholders vital business change trajectory health humanity views external stakeholders set success esg strategy johnson johnson interacts numerous stakeholder groups esg strategy deliberate manner focusing efforts areas well positioned global national local levels including membership participation broad range achieve greatest impact championing global health equity empowering employees advocacy organizations industry associations advancing environmental health leading accountability innovation foundational targeted engagement activities included efforts esg approach designed effectively govern manage risks including esg risks also enabling us identify opportunities accurately reflect business strategy promoting health legislation us us maternal mortality rate continues exceed rate sustained focused approach promotes resiliency drives growth better positioning us continue highincome countries including increase us medicaid vital investing future enhancing longterm value business role play improving maternal health outcomes nearly half births financed medicaid esg governance strongly supported state efforts advance legislation extend medicaid postpartum coverage months new mothers helping address disproportionate maternal mortality outcomes disadvantaged communities johnson johnson also joined healthcare organizations advocating dr lorna breen health care provider protection act hr first ever federal legislation us directed protecting mental health countrys healthcare workforce facilitate reduction prevention suicide burnout mental behavioral health conditions among hcps act became law march health worker burnout reached crisis point covid pandemic acute mental health needs risk factors among hcps brought sharp focus early days health workers experienced severe work trauma burnout exhaustion tragic death suicide emergency room physician dr lorna breen april underscored urgent need provide better support services health workers july senator tim kaine dva introduced bill protect mental health healthcare workforce developed alongside dr lorna breen heroes foundation support johnson johnson bill would eventually become dr lorna breen healthcare provider protection act scroll esg focus areas learn information help stakeholders understand managing risk relevant esg topics embedding sustainability decision making critical component esg governance please see esg strategy esg resources hoyert dl maternal mortality rates united states cdc national health center statistics httpswwwcdcgovnchsdatahestatmaternalmortalitymaternalmortalityrateshtm health supporting healthcare policy making europe founding strengthening healthcare industry asia johnson engaging industry esg continued engage humanity report knowledge partner sponsor policies healthy europe johnson led healthcare industry presence pharmaceutical industry ensure expertise coalition strengthened partnership development asia pacific economic cooperation apec leaders week industry reflected esg metrics related disclosures numerous publications policy dialogues coalition three bangkok thailand healthcare company speaking relevant sector working part areas economy wellbeing covering covid pandemic event apec critical highly influential forum driving biopharma sustainability roundtable bsrt network response health systems resilience valuebased healthcare improvements healthcare policy innovation access across supports sustainability biotech pharmaceutical industry eu beating cancer policies digitalization health contributing large diverse region world leaders week johnson johnson participates biopharma investor esg expertise emerging data governance european health first inperson apec gathering since significant communications initiative supports development data space ai policies environmental health supporting opportunity global delegation engage heads state decisionuseful communications sectors important revision ambient air directive government leaders apec countries industry esg issues bsrt released biopharma investor esg academia shared johnson johnsons perspective key communications guidance result collaboration among esg governance janssen leading industry voice shaping eu healthcare challenges importance advancing quality leading pharmaceutical companies including johnson johnson pharmaceutical strategy championing patient access health data health financing innovation supply chain well investor groups medicines strong ip rights shone light resilience improve healthcare outcomes changes eu legislation would diminish ip rights critical element underpinning medical innovation europe janssen participating global convenings advance healthcare provides evidence data help stakeholders appreciate systems leaders across johnson johnson participated need strong ip protections develop new treatments several key events meetings un general leading pharmaceutical company always address unmet medical needs also advocate agile assembly engagement emphasized importance seeking respond positively investor information regulatory framework allow fast adoption innovative advancing equitable access care investing health workers needs well stakeholders new medicines supported use realworld evidence innovation eradicate pandemic epidemic diseases value opportunity collaborate peer digital health technology data sharing activities pandemic response companies define disclosure guidance specific included direct dialogue european policymakers sector believe helps elevate also global health leaders stakeholders gathered stakeholders along yearlong media engagement adding esg awareness sets benchmark investor geneva switzerland th annual world health assembly voice public debate expectations industry wha representation country delegations wha provides important opportunity partners across sectors engage build strengthen relationships accelerate action pressing health challenges facing world global monica neufang healthcare leader johnson johnson active convenor vice president enterprise esg program office every asset start working actually contributor events wha providing critical johnson johnson member biopharma investor makes finish line ip allows us generate esg communications initiative working group private sector lens bringing greater awareness unique return value bring patients labtolastmile approach advancing equitable access care society therapy available thats engaging stakeholders report many internal stakeholders engagement covered key issues including vaccination return actually reinvest developing new across johnson johnsons global teams provided input eradicate disease ebola fighting infectious diseases like advanced lifesaving breakthrough therapies report chairman board ceo disclosure tb supporting frontline health workers also wha committee disclosure subcommittee reviewed johnson johnson announced new global surgery initiative report outline metrics disclosure committee reviewed joined discussions importance investing sustainable full report entire executive committee reviewed dirk de smaele surgical systems advance equitable access care approved health humanity report shared global head vice president regulatory compliance sustainability committee therapeutics development supply janssen board directors full board prior publication learn importance ip pharmaceutical innovation disclosure subcommittee comprises corporate secretary leaders controllers office treasury investor relations departments disclosure committee comprises chief financial officer general counsel corporate secretary head litigation plus leaders controllers office investor relations global audit assurance departmentshealth humanity goals health humanity report ambitious set health humanity goals align esg focus areas foundation goal key performance indicator target status accountability innovation hold publicly accountable creating sustainable society measure track performance goals progress assured employees third party health humanity goals support un sdgs women women management positions management scorecard ataglance ethnicracial ethnicracial diversity management positions exceeded exceeded target progress progressing slowly expected diversity us achieved met target plans place meet target management track expected meet target track progressing expectedcurrently risk meeting target blackafrican black african american employees americans growth management positions us goal key performance indicator target status management health humanity goals global health equity healthiest johnson johnson leaders managers leaders identified assets johnson johnson global workforce score achieving annual healthiest workforce score global access public health janssen infectious diseases vaccines managers plans rd pipeline global access plans place girls participated virtual inperson women access hiv two activities led employees partnership lai access program place two rls countries stemd treatment countries nonprofit partners access cumulative patients receiving access bedaquiline environmental health tuberculosis tb molecule branded generic globally treatment end renewable renewable electricity globally electricity stringent regulatory authority approval new tb drug new tb developing regimen reduces treatment length least drug carbon absolute reduction greenhouse gas tb treatment effective safe current recommended treatment regimen neutrality ghg emissions scope carbon operations credits vs baseline access complete clinical study demonstrate health complete schizophrenia economic social value using paliperidone palmitate clinical scope emissions absolute reduction greenhouse gas ghg treatment lai treat schizophrenia rwanda study reductions emissions scope upstream vs baseline support frontline nurses midwives community health workers accountability innovation health workers reached globally supplier r oe bd su tec te r ib cu fr id se tun l aof pf r fi odst uu cla dre op na ai tr e du r geries based surgeries reported pu ros gta ri mability suppliers included one three tiers sull p pliers p v cr pav l ae v bn li c iv tc ie ei n se c r deere maa ot ine n e sp tsl rsa f eb r p aak cn ci dn eec lel mu rad ic tin e p dg r ed pp ro oac r ceu edm sn se e fn ot bd ema eer rg ga eon nniz c ta yht ei uo sn ea l c plr ae ya bt oe k g inil cvo leb ura ss il ts nu ap np dli er enp te en rd p rw isi eth ndie tr ie rm sl ul pn pd li ed ri v se pr es ne uppliers social billion licensure submission covid vaccine partnerships vaccination adoption endorsed platform least two countries two good supplier partnerships monitoring countries platform see health humanity goals scorecard full results healthcare three bestpractice healthcare women insights three women published report gri health humanity report johnson johnsons health humanity report details esg progress performance reviewed conjunction disclosures esg policies positions data annual report cover period january norges bank investment management basel institute employee retention turnover december unless otherwise indicated governances measuring effectiveness anticorruption employee engagement credo survey results select metrics published june reporting matters specific programmes reporting framework adding disclosures financial performance company subsidiaries set indicators employee safety found annual report un global compact ungc see annual communication ethics compliance inquiries complaints recorded credo integrity line category progress report covers johnson johnsons worldwide operations across three business segments pharmaceutical medtech ethics compliance compliancerelated allegations materiality approach content report guided report investigated triage committee consumer health select metrics report segment pta helps us identify prioritize esg topics level data contract manufacturers excluded scope matter stakeholders company please see product quality indicators report unless otherwise noted references report priority topics assessment details latest update tax contributions johnson johnson company us refer priority topics johnson johnson consolidated subsidiaries unless global audit assurance organization reviewed select otherwise stated indicated context monetary references independent review assurance erm certification data accuracy completeness validity financial data dollars refer us dollars usd verification services erm cvs conducted independent review general information business report assurance following information data report previously audited disclosure annual report report also covers activities johnson johnson foundation registered charity company limited progress health humanity goals acquisitions ehs data recently acquired companies guarantee foundation separate legal entity associated data presented health humanity goals except employee road safety data site iso ohsas johnson johnson family companies funded solely scorecard see erm cvss health humanity goals certification data included report two years johnson johnson family companies foundation assurance acquisition unless otherwise noted approach allows operates worldwide johnson johnson foundation united select global ghg emissions inventory percentage new acquisitions adjust ehs management reporting systems johnson johnson standards states founded johnson johnson foundation scotland electricity use generated renewable energy sources nox founded details foundation activities found sox emissions combustion sources select water road safety data integrated first year acquisition johnson johnson foundation united states annual management data see ghg air emissions electricity available two years acquisition latest report johnson johnson foundation scotland water data assurance scope ghg emissions iso ohsas certification data integrated three years directors report reported using wbcsdwri ghg protocol corporate acquisition accounting reporting standard updated report prepared accordance global january abiomed acquired late december reflected reporting initiative gri standards see esg disclosure index pricewaterhousecoopers llp pwc performed limited assurance financial data included health humanity report gri content index also disclose performance certain data following categories see pwcs report due timing acquisition nature human additional esg standards frameworks see esg disclosure resources information system abiomed data included independent accountants managements assertion index including health humanity report see johnson johnson sustainability accounting standards board sasb giving annual report information abiomed relevant standards hcbp hcms cghp diversity equity inclusion select metrics dates details recent acquisitions found task force climaterelated financial disclosures environmental health safety ehs compliance note acquisitions divestitures tcfd building responses cdp climate certifications annual report change questionnaire johnson johnsons consumer health segment kenvue operated part johnson johnson materiality used report pta process different definitions used context filings us securities exchange commission health divestitures except injury statistics violations cautionary note regarding forwardlooking statements separation new consumer health companys humanity report fines ehs data divested companies excluded report contains forwardlooking statements defined ability succeed standalone publicly traded company reporting year private securities litigation reform act regarding risks related ongoing impact covid global among things future operating financial performance pandemic including continued supply chain disruptions november company announced intention product development market position business strategy impacts business list descriptions separate companys consumer health business new anticipated separation companys consumer health risks uncertainties factors found johnson publicly traded company september kenvue business reader cautioned rely forward johnsons annual report fiscal year ended announced name planned new consumer health looking statements statements based current january including sections captioned cautionary company kenvue part johnson johnson expectations future events underlying assumptions prove note regarding forwardlooking statements item reporting period health humanity report inaccurate known unknown risks uncertainties materialize risk factors johnson johnsons subsequent quarterly kenvue completed initial public offering shares actual results could vary materially expectations reports form q filings securities common stock may closing initial projections johnson johnson risks uncertainties include exchange commission copies filings available online public offering company owns approximately limited economic factors interest rate wwwsecgov wwwjnjcom request johnson total outstanding shares kenvue common stock company currency exchange rate fluctuations competition including johnson forwardlooking statement made report report remains track complete separation subject technological advances new products patents attained speaks date report johnson johnson market conditions competitors challenges inherent new product research undertake update forwardlooking statement result development including uncertainty clinical success new information future events developments future reporting years starting health obtaining regulatory approvals uncertainty commercial success humanity report kenvue data included restated thirdparty trademarks used herein trademarks new existing products challenges patents impact respective owners restatements use change threshold apply patent expirations ability company successfully significant changes data information restated unless execute strategic plans impact business combinations otherwise noted several potential reasons may lead divestitures manufacturing difficulties delays internally restatement either prior periods baseline data eg within supply chain product efficacy safety concerns significant change newly published measures new acquisitions resulting product recalls regulatory action significant adverse divestitures data errors improvements data collection litigation government action including related product liability methodology time depending circumstances claims changes applicable laws regulations including tax evaluated using threshold appropriate disclosures laws supply chain due diligence regulation greenhouse gas included report data disclosed prior emission related reporting global healthcare reforms years noted reported relevant tables throughout trends toward healthcare cost containment changes behavior report spending patterns purchasers healthcare products services financial instability international economies legal contact us welcome queries feedback systems sovereign risk increased scrutiny healthcare report please contact johnson johnson enterprise industry government agencies companys ability satisfy esg program office wwcorporategovernanceitsjnjcom necessary conditions consummate separation companys consumer health business timely basis please visit reporting hub archive annual companys ability successfully separate companys health humanity reports consumer health business realize anticipated benefits health humanity report global health equity healthcare workers bomu hospital kenya teach members maasai community obstetric fistula johnson johnson foundation continued support healthcare workers fistula foundation photo credit bomu hospitalaccess gri jj sasb hcbpa sasb hcbpa health humanity report across johnson johnson continue build legacy years blending innovation scientific excellence caring people tackle todays toughest health johnson johnsons current cumulative challenges help deliver improved health everywhere accomplishments recognized atmi include core mission commitment advance global seek enhance access innovative nd largest rd courses access health equity become reality people need medicines vaccines medical technologies everywhere priority pipeline medicine sirturo access affordable lifesaving lifeenhancing treatments especially populations resourcelimited settings share projects addressing bedaquiline treat every corner world need even acute due progress making medicines technologies available diseases hiv tb multidrugresistant tb covid pandemic severely disrupted essential health help combat specific diseases hiv tb ebola certain dengue rd delivered since largest overall rd pipeline services shortened life expectancy exacerbated inequities ntds pandemics epidemics section report people scope atmi access basic health services projects vaccinated ebola vaccine regimen two billion people worldwide unable access essential taking lead access medicine access medicines healthcare services plans place digital public progress advancing access innovating novel medicines good designation eligible latestage access medicine central global health equity strategy recognized access medicine foundation projects projects achieved vxnaid embedded health humanity goals across access medicine index atmi johnson total vaccination several explicit commitments progress johnson ranked second rising third monitoring platform centers global commitments described report summarized initiatives health discovery health humanity goals scorecard addressing health systems support research strengthening rd address critical health million patients treated globally capacity building challenges including tb janssen medicine noted meeting good position among top three companies amr dengue practice standards worldwide atmi sixth consecutive year note patients treated represents estimated number people phase reflects decades commitment enhancing initiatives globally treated janssen medicine clinical study completed including patients reached vermox mebendazole access medicines strengthening healthcare evaluated dengue addressing supply chain donation program total excludes people vaccinated systems also testament colleagues specific antiviral treatment manufacturing johnson johnson covid vaccine reported partners around world endeavor every day prophylactic use capacity building enable millions people almost lower noted meeting good separately estimated number patients treated middleincome countries benefit innovative billion doses practice standards converting quantities janssen medicines courses therapy medicines technologies medicine vermox total patient days therapy per year converting mebendazole treat million numbers people based average utilization per patient children infected invested help intestinal worms donated establish billion patients taking multiple janssen products may counted jennifer taubert since amr action fund multiple patients total methodologies may vary product executive vice president worldwide chairman type given nature product available data pharmaceuticals johnson johnson estimated number patients treated may revised time gain new information patient usage experience restatements underlying data sources changes product portfolios united nations department economic social affairs sustainable development goal ensure healthy lives promote wellbeing ages httpssdgsunorggoalsgoal accessed february big pharma access medicine foundation rdbased pharma companies httpsaccesstomedicinefoundationorgsectorsandresearchbigpharma accessed february health making progress design apply janssen access relating pricing medicines rd investments healthevoices community reaches vast digital humanity report pricing principles across entire pharmaceutical portfolio patient support programs notable details include network advocates across nearly health planning access early research phase work conditions collective reach million patients billion paid rebates discounts fees systematically asset development thoroughly caregivers healthcare professionals understand disease characteristics patient burden disease average net price decline janssen medicines product characteristics access planning consider declining sixth year row health system characteristics access affordability applying advocating inclusive access variety approaches including valuebased pricing equity signatory business social responsibility based tiered pricing access initiatives tailored bsr guiding principles access healthcare healthevoices diversity equity accessibility inclusion access disease product work stakeholders enable engage broadly across industry improve access deai task force shapes healthequityfocused programming patient access medicines across wide variety health system patients around world collaborated patient advocates johnson johnson audiences characteristics country ability willingness pay member bsrs working group develop access supported close followers social media healthcare ladder healthevoices support deai task janssen along global public health organization deploys force published instagram live series transgender labtolastmile approach fight diseases hiv tb access treatment last mile part johnson health advocacy allyship generated educational social ebola driving targeted innovation initiatives overcome johnsons commitment advancing equitable access media campaigns around awareness events throughout barriers deliver access medicines strengthen health medicines funded innovative pilot study infectious year including juneteenth pride hispanic heritage month systems support frontline health workers diseases institute uganda assess impact medical issued public statements support aapi lgbtqia drones increasing access improving community disease communities following violence us management pilot study used small unmanned aircraft participated discussions health equity johnson medicine prequalification world health deliver hiv treatments people kalangala islands johnson leaders ongoing deai task force activities organization designed ensure result pilot project researchers able quantify add vital momentum driving equitable change healthcare medicines supplied procurement agencies meet effectiveness medical drones hiv drug delivery help sustaining trust patient communities johnson acceptable standards quality safety efficacy inform future efforts scale drone technology solve last johnson teams resulting stronger patient voice across broad mile delivery challenges uganda elsewhere range healthcare interventions eight johnson johnson products received prequalified listed status supporting patient advocacy community healthevoices leadership conference convened nearly leading online patient advocates three days places life experience johnson johnson johnson johnson learning sharing debating topics impacts diversity backgrounds find healthevoices products addressing products ebola culture health bridging change healthcare space great reminder everyone chronic hiv intestinal vaccine regimen culturally inclusive marketing muchawaited event health issue comes ethnic background worms first inperson conference since covid region country socioeconomic situation list prequalified list prequalified pandemic eighth annual healthevoices conference health condition comes unique symptoms medicinal products vaccines since inception healthevoices designed challenges treatments everyone chooses online patient advocates offering safe space deliver embrace diversity inevitably create authentic content pressing issues impacting patients accepting environment tackle difficult issues advancing access us equitable access strategies approximately johnson johnson leaders attended important lmics also higherincome countries conference demonstrating keen commitment home vulnerable underresourced populations understanding patient needs empowering patient advocates well focus access us published influence communicate patients howard chang seventh annual janssen us transparency report sharing updates improve patient experience psoriasis advocate former healthevoices conference advisor medicinesfinished pharmaceutical products httpsextranetwhointpqwebcontentprequalifiedlistsmedicines twodose ebola vaccine regimen comprising zabdeno adzebov bavarian nordics mvabea mvabnfilo figures according janssen internal financial accountingadvancing public health gri jj health humanity report decades johnson johnson remained steadfast commitment leadership public health health equity strategy reflects longheld belief creating societal value goes hand hand generating longterm business value champion health equity initiatives maximize value reach business areas advancing public health greatest impact alongside increasing access medicines ambitions advance public health include believe strongly power strategic partnerships excited collaborate collaborations address crosscutting healthcare issues advance health equity enhance patient care advancing global surgery capabilities provide even greater support nurses developing new solutions enhance access quality mental healthcare delivering innovation better eye health sam hazen promoting initiatives eliminate health inequities chief executive officer hca healthcare people color supporting frontline health workers also joined several private sector organizations pledging funding support end critical diseases helping communities need strengthen health systems part global funds seventh replenishment conference global fund international gph organization mission develop relevant innovations organization established defeat hiv tb malaria ensure save lives cure patients prevent disease make healthier safer equitable future new global available affordable accessible worlds fund contribution form partnership skoll vulnerable underresourced populations health foundation jointly provide million anchor investment humanity goals underpin mission empower us fund accelerate professionalization community health target efforts deliver improved health outcomes workers see also section frontline healthcare communities johnson johnson convenes collaborations across multiple dimensions advance public health whether address global diseases disproportionate impact strengthen healthcare systems example joined hca healthcare leading healthcare provider us address key industry issues improving health equity enhancing nursing support improving patient outcomes specifically collaboration encompasses development program early stage lung cancer detection black community initiatives improve cardiovascular health education training resources elevate family member patient caraes support nurses ndera neuropsychiatric hospital stands outside home kigali rwanda credit swanson devex global surgery health humanity report johnson johnson jj medtech business segment helping transform example trialed new surgical instruments freedom fistula hospital sierra leone collaboration dr future medical intervention tackling worlds pressing healthcare rachel pope associate professor urology institute university challenges across several surgical fields hospitals cleveland medical center progressed trials instruments advances surgical technology transformed medical care capabilities together collaborators aim address kenya new cases obstetric fistula highincome countries yet quality surgical care remains healthcare inequities expand patient access improve outcomes recorded year part ongoing program seek feedback surgeons inform future innovation help scale largely reach people living lowincome countries reduce health system costs commitment changing global surgery many billion people access quality surgical trajectory surgical care encompassed health surgical capacity countrywide reach even women suffering careclosing gap critically important advance global humanity goals made strong progress far obstetric fistula health equity accelerating access surgery th world health johnson johnson one first companies partner million surgical procedures undertaken worldwide assembly may launched global surgery initiative dr catherine hamlin addis ababa fistula hospital year occur poorest countries goal advancing entire continuum surgical ethiopia beginning donation third worlds population lives carefrom prevention treatment rehabilitationacross sutures fistula surgeries two significant areas unmet need obstetric fistula long bone fracture announced beginning pilot programs two areas kenya malawi working government academic ngos strengthen surgical systems combining jj medtechs global core capabilities strengths expertise johnson johnson global local collaborators aim accelerate access streamlining ethicon depuy synthes supply chains reducing costs better equipping surgeons surgical technologies orthopaedics including health systems meet needs patients communities including advanced joint reconstruction digital solutions trauma spine sports serve robotics robotics obstetric fistula repair surgeries supported interventional johnson johnson johnson johnsons suture donation program two years solutions vision specialty surgery specialist eye healthcare neurovascular care heart including improving surgical instruments obstetric fistula repair rhythm disorders ear nose advanced intraocular surgery obstetric fistula serious childbirth complication throat treatment contact lenses preventable improved practices treatable access breast reconstruction surgical care johnson johnson helps improve care developing providing access improved surgical instruments fistula scissors bladder sounds suturecatheter organizers improvements aim provide highquality instrumentation increase patient comfort maximize surgeon visibility johnson johnson committed elevating standard improve safety patient surgeon work care surgery bringing insights scale new technologies expert collaborators help train surgeons frontline health elizabeth yearold woman kenya received fistula surgery gynocare meet needs people communities limited womens fistula hospital flagship facility fistula foundation treatment workers effective use instruments surgical capacity around world deploy global surgery network keyna johnson johnson supports donated surgical products photo credit roshni lodhia lancet global surgery evidence solutions achieving health welfare economic development wwwthelancetcomjournalslancetarticlepiisxfulltext accessed february ibid unfpa kenya fistula camp tackles covid related backlog cases restore dignity women httpskenyaunfpaorgennewsfistulacamptacklescovidrelatedbacklogcasesrestoredignitywomen accessed february health collaborations reduce burden obstetric fistula along improving access care long bone fracture left untreated humanity report johnson johnson foundation supported long bone fractures crack break tibia another long obstetric fistula procedures donated surgical products bone result longterm disability johnson johnson fistula foundation treatment network together direct relief working malawi help train surgeons novel tools delivered sutures new instruments nine hospitals techniques strengthen supply chains improve sustainable kenya fistula treatment network working access surgical trauma care people need improved instruments supported training surgeons supported johnson johnson foundation launched able perform safe obstetric fistula repairs long bone fracture pilot program malawi introducing women kenya novel devices strengthening supply chains training districtlevel providers complete procedures elevating operating room women year suffer processes better patient care team experience aim global surgery obstetric fistula scale initiative lmics building experience malawi also continued support ongoing obstetric fistula education surgeons nearly year collaboration mercy ships largest nongovernmental fleet hospital delivery products implants instrument sets queen elizabeth hospital malawi photo precious kamange ships world support helped hundreds surgeons operating room specialists receive advanced training collaborating design essential skills training provide hygiene kits surgical products health humanity goals progress reducing burden participants orthopaedic clinical officers training dowa obstetric fistula conduct practice exercise colleague photo katrin drner supported delivery obstetric fistula repair surgeries cumulative total since beginning new surgical instruments piloted sierra leone expanded kenya increase patient comfort maximize surgeon visibility improve safety patient surgeon continued support healthcare workers fistula foundation obstetric fistula httpswwwwhointnewsroomfactsinpicturesdetailfactsonobstetricfistula accessed february mental healthcare health humanity report mental illness continues one greatest unmet needs healthcare intensified covid pandemic addition protracted conflict growing social inequities around world threaten exacerbate mental healthcare hardships challenging availability resources address nowhere truer vulnerable communities several improving access quality mental healthcare rwanda parts world people mental fiveyear collaboration rwanda ministry health starting disorders live lmics many receive care due achieved major progress creating framework mental healthcare lack treatment options trained mental health workers quality accessible mental healthcare country including associated stigma among reasons supporting training community health workers general practitioner nurses signs levels public expenditure mental health low global symptoms mental illness including unique median government health expenditure phonebased training program particularly meager lmics conducting first national mental health survey rwanda last half century developed several innovative one extensive nationwide surveys completed treatments conditions impacting brain central nervous subsaharan africa date published system building legacy expanded access open access peerreviewed bmc public health journal mental healthcare innovation research programs making available secondgeneration antipsychotics including empower frontline health workers better manage mental illness oral risperidone paliperidone palmitate longacting injectables pplai clinical study evaluating treatment realworld healthcare settings health humanity goals continued clinical study assess treatment caspar study team representing schizophrenia paliperidone palmitate rwandan healthcare johnson johnson tours laboratories university teaching settings caspar designed assess impact pplai hospital butare one patients schizophrenia realworld healthcare settings participating sites caspar study photo carla decotellimendes end patients screened nearly patients moved treatment phase study also includes progress access clinical research training local principal investigators schizophrenia treatment five study sites rwanda well site visits johnson caspar study assessing treatment schizophrenia johnson research team caspar represents important step paliperidone palmitate lai rwandan healthcare forward generating evidence could inform adoption settings achieved patients screened nearly pplai treatment option schizophrenia patients moved treatment phase clinical research trainings site investigators rwanda ongoing world mental health report transforming mental health httpswwwwhointpublicationsiitem accessed february mental health atlas httpswwwwhointpublicationsi item accessed february vision health humanity report according world health organization sight dominant five senses plays advancing eye health digital innovation asia pacific johnson johnson vision signed memorandum crucial role every facet lives unmet needs eye health continue affect people understanding agency science technology world especially vulnerable underresourced populations research astar jointly establish eye health digital innovation consortium singapore hosted astars institute high performance computing consortium focuses worldwide billion people visually impaired improving vision digital world adults spending advancing eye health research asia pacific region joint billion forced live preventable time digital devices postpandemic world investment sgd million organizations treatable conditions get care need hours per day according estimatesthe strain eye channeled consortium course three years johnson johnson vision part jj medtech health noticeable eyes locked screen long periods first kind region consortium initially bold ambition change trajectory eye health worldwide people blink less destabilizing effect tear film focus following deliver innovation enables eye care professionals causing dryness discomfort following feedback eye care vision improving eye healthcare delivery eye care professionals create better outcomes patients throughout lives professionals patients weve worked help meet needs patients singapore beyond collaborate expand access quality eye care communities digitally intensive lifestyles increased education greatest need launch new contact lens acuvue oasys max day help optimizing collaboration private public sector enhance eye healthcare delivery reduce light scatter block uva uvb rays developing new technological processes support enterprises cataracts one leading causes preventable blindness directly involved primary eye healthcare delivery worldwide impacting almost million people globally prevalence distance vision impairment low things important ability seeing better lowlight conditions presbyopia simple middleincome regions estimated four times higher see world around us know healthy terms agerelated condition reduces ability near highincome regions sight lifelong journey thats johnson vision projected affect billion people globally johnson vision working meet patient needs provide relief many people whose quality life throughout lives areas reduced presbyopia johnson johnson vision introduced greatest impact delivering innovation nextgeneration presbyopiacorrecting intraocular lens pciol treat childhood myopia leveraging cuttingedge tecnis symfony optiblue iol us select countries science bring forward best solutions eye care high prevalence eye disorders among emea using highperformance technology eye surgery every stage aims help singapores population cause concern care professionals offer patients full range highquality support eye care professionals worldwide enable open innovation publicprivate partnerships continuous vision lighting conditions millions patients see better pave way us leverage strengths different half worlds population projected myopic parties develop solutions address complex nearly one billion people expected healthcare challenge peter menziuso high myopia company group chairman johnson johnson vision professor tan sze wee assistant chief executive enterprise astar world report vision httpswwwwhointpublicationsiitem accessed february covid screen time spikes hours per day according eyesafe nielsen estimates published https eyesafecomcovidscreentimespiketooverhoursperday accessed february blindness vision impairment httpswwwwhointennewsroomfactsheetsdetailblindnessandvisualimpairment accessed february grzybowski ruamviboonsuk v pharmacological treatment presbyopia j clin med httpsdoiorgjcm accessed february world report vision httpswwwwhointpublicationsi item accessed february blindness vision impairment httpswwwwhointennewsroomfactsheetsdetailblindnessandvisualimpairment accessed february health slowing myopia progression children myopia sometimes prioritizing eyes south america johnson johnson vision humanity report called nearsightedness chronic progressive disease led meaningful campaign advance access eye care lead sightthreatening complications time children people living remote areas several countries including diagnosed myopia greater risk argentina brazil chile colombia mexico led awareness developing high myopia later life among first industry campaigns using different media channels raise awareness recognize importance myopia management following worked closely nonprofits throughout region encourage decades research develop scientifically proven solutions people show eye tests receive necessary treatment johnson johnson vision launched acuvue abiliti address prevalence progression myopia children abiliti designed fit seamlessly lifestyle parents children launched abiliti day abiliti overnight people reached canada hong kong singapore also received fda vision approval lens parameter expansion abiliti overnight extend reach patients us developments patients parts world enjoy better vision throughout lifetimes bringing critical eye care children sight kids sfk eye examinations founded johnson johnson vision lions clubs two students nairobi kenya path brighter future thanks vision screenings sight kids photo lions club international foundation international foundation administered free volunteer directed vision screenings million children five countries including india kenya philippines thailand us today sfk celebrates years bringing critical eye care children underresourced communities largestknown eye surgeries program kind world healthy sight critical childs academic performance selfesteem overall wellbeing us sfk expanded beyond south florida region helping vision sight kids second location teaming louisiana lions eye make meaningful impact carry celebrating world sight day johnson johnson vision foundation provide free statewide eye care louisianas youth future studies career selected world sight day share vision good impact vision screening event tours mobile screening unit review additional examples helping change marked new activity trajectory eye health operating environmentally sustainable manner dr freddy simon ophthalmologist kerala india learn social responsibility johnson johnson vision race health equity gri health humanity report heart johnson johnsons commitment health equity desire create world johnson johnson awarded winners health equity innovation challenge designed empower communities color skin determine access care quality care health accelerate solutions stimulating innovation entrepreneurship outcomes launched race health equity orthe million enterprise social impact challenge called local entrepreneurs wide initiative focused closing racial health gap us chicago detroit los angeles new orleans new york philadelphia deliver locally inspired innovative approaches advance health equity engaging credible community leaders johnson johnson orthe initiative focuses eradicating racial people color us face higher incidences understood local health challenges independent selection social injustice public health threat eliminating health death rates conditions heart disease stroke committee chose winners applicants inequities people color us committed closing cancer diabetes covid winners included community organizations provide services racial health gap investing culturally competent community including free healthcare underresourced neighborhoods care models create healthy outcomes people color improving birth maternal health outcomes black families race health equity community health capacity building providing youth educators communities programs end committed million designed support mental wellness equity winner advance orthe programs following areas three programs helped expand access affordable community awarded seed funding pool million centric care along mentorship renowned entrepreneurs public health experts access jlabs ecosystem following community health workers alabama mississippi north carolina community inclusive challenge many organizations continued positively south carolina tennessee benefited health worker health capacity research impact communities actively expanding network collaborative grant contributed establishing building representative alongside management skills training executive directors clinical trials expanding access leaders communitybased healthcare organizations working community engagement education affordable community increasing access partnership many organizations aim help build trust centric care clinical trials underresourced communities health systems backed three innovative programs continued orthe umbrella investments diverse site selection community health patient recruitment commitment supporting hcps researchers helping people informed options prioritize centers community well incorporating healthcare treatment health cant wait educational health workers equity endtoend effort resource hub created jj medtech inspire people care model therapy device end us hcps researchers get information need pursue care confidence innovations design provided development support help create especially experience covid pandemic equitable healthcare systems caused many americans delay healthcare treatment also launched new initiative support climate resilience community culturally jj medtechs signature equity program community healthcare clinics us serve people engagement competent care identifying communities across us help deliver limited access care communities vulnerable impacts education impact forming partnerships communitybased increasing racial climate change collaboration americares organizations offering johnson johnson resources empowering patients ethnic diversity harvard th chan school public healths center climate expertise help meet community healthcare needs jj end users healthcare talent pipeline health global environment harvard chan cchange tools resources workforce medtech janssen helped provide free health education aim bolster operational resilience clinics well communitybased promoting equitable access health screenings thousands community members resilience healthcare workers help inimize disruptions services point care experience events atlanta chicago columbia south carolina los health increase bipoc patients healthcare caused extreme weather events goal support angeles plan expand populations around health literacy medical clinics across us world us department health human services office minority health profile blackafrican americans httpswwwminorityhealthhhsgovomhbrowseaspxlvllvlid accessed february health save legs change lives multiyear initiative janssen humanity report address hidden threat peripheral artery disease pad related amputation black americans pad four times higher risk amputation white americans janssen collaborated leading professional associations including american college cardiology well healthcare systems community organizations raise awareness padrelated issues facilitate equitable access treatment janssen continued share pad information widely implemented thousands free screenings advanced research help overcome padrelated health inequities johnson johnson vision first major eye health additionally expanded pioneering climate company sign promise initiative created health equity fellowship created medical race health equity nonprofit black eyecare perspective increase equity society consortium climate health national representation optometry mirror black people medical association support physicians color become us population leaders climate health equity education advocacy policy solutions increased contribution second class culturally competent care fellows supported physicians across us representing diverse specialties advocacy experiences cultural backgrounds line goal promote better care people color interests climate health enhancing leadership addressing unconscious bias healthcare colaunched cross capabilities medical professionals caring patients sector partnership initiative unconscious bias disparities planet healthcare call action continuing medical education program core program targets hcps communities color assists enact changes daily practice inclusive research representative improve patient care outcomes additionally maintained clinical trials sponsorship alliance inclusion medicine scholarship program scholarship mentorship commitment launched advance multiple initiatives enhance diversity national medical fellowships nmf alliance healthcare across several dimensions include johnson inclusion medicine aim welcomed johnson rd outreach community representatives two cohorts underrepresented medical students total advocates one example research includes initiative program committed million scholarship janssen communityfocused campaign designed create funding across cohorts support johnson johnson awareness engagement within black brown communities nmf welcomed inaugural cohort underrepresented elevate discussion around clinical trials campaign helps medical students selected second cohort second build trustbased relationships communities provide clinical thirdyear medical school scholars aim scholars paired trial information hosts educational website provide johnson johnson mentor provide guidance insight underrepresented patients greater access information young scholars embark medical career journey resources clinical trial research learn race health equity national heart lung blood institute facts peripheral artery disease pad african americans httpswwwnhlbinihgovfilesdocspublicheartpad extfactsheetaapdf accessed february frontline healthcare communities gri jj gri health humanity report line commitment advancing public health invest extensively raising quality strengthening communitybased health systems center helped establish community health worker think tank led health wellbeing communities live work south africas national department health address critical gaps facing community health worker policy implementation communitylevel service delivery nigeria center johnson johnsons global community impact gci organization center advanced several initiatives including collaborated widely internally externally help create funding johnson johnson foundation corporation roadmap partnership opportunities strengthen nursing supporting community health workers across africa operating companies across johnson johnson family midwifery workforce nigeria emphasis mental professionalized workforce community health workers companiesdrives communitygiving initiatives around health oncology maternal newborn health also engage daily communities key responding world aligned esg strategy health humanity center launched basecamp health system transformation disease outbreaks making gains longstanding global goals well driving orthe initiative gci specifically school system change pilot program nurture system health priorities including universal health coverage africa advances initiatives front line healthcare ambitious change practitioners build community health system capacity frontline first catalytic fund affcf launched public goal across europe subsaharan africa support community health workers african countries frontline healthcare communities million commitment johnson johnson foundation harnessing power data support frontline health workers million commitment skoll foundation making trusted datadriven decisions center supported health humanity goals investments matched global fund fight aids tb several thousand hours pro bono data science services malaria affcf help accelerate progress improve subsaharan africa leveraged data sets millions health healthcare delivered community level well ensure encounters generated community health women make large proportion community health workers improve data quality inform best practices workers properly paid work fund aims triple center collaborating datakind communitybased number salaried community health workers subsaharan organizations champion data collection practices enable progress supporting frontline africa expanding coverage million people health systems stakeholders make healthcare delivery decisions health workers backed trusted data reached nurses midwives helping health workers manage stress support health workers community health workers supporting managing stress exacerbated covid pandemic frontline health workers cumulative total resilience collaborative centers global learning health workers cornerstone care training community launched grew members empowering integrating community health opensource resources including spanish portuguese supporting frontline health workers workers existing health systems possible hindi translations accessed extend care reduce burden disease organizations countries assisting raising awareness believe solve challenges facing frontline millions people investment african ways implement evaluate evidencebased programs health workers improve healthcare everyone frontline first catalytic fund builds improved health worker resilience wellbeing johnson johnson center health worker innovation years supporting health workers especially center established tasked guiding resourcelimited settings million commitment support frontline health workers goal supporting one million nurses midwives community health workers although exceeded one million lauren moore goal well advance plan continue work vice president global community impact center provide critically needed support community johnson johnson health workers health supporting supply chain training health workers africa healthcare systems work work together support humanity report johnson johnson provided funding empower school health nurses advancing better healthcare goal develop free online supply chain training curriculum aims work likeminded partners attract strengthen thriving help frontline health workers understand role supply innovative diverse nursing workforce empowered advance working jjiv team allowed us improve chain delivery essential medicines treatments empower health equity transform healthcare support empower thoughtfulness create business school health delivered training east central nurses advocacy scholarships clinical leadership impact outcomes inextricably linked bigger southern african college nursing ecumenical education events teach hone healthcare innovation skill business impact achieve pharmaceutical network successful pilot botswana sets mental health resources kenya curriculum currently rolled three work includes advocating fundamental value additional countries nigeria rwanda south africa nursing profession catalyzing workplace culture farouk meralli enhancing hcp education around world jj medtech environment nurses thrive strengthening diversity founder ceo swiperx partnered advances surgery industry associations nursing bring greater awareness extraordinary impact provide million hcps online webinars across nurses healthcare key activities programs range topics specialties example dei series including tv social media advertising storytelling see progress made new investments frontline healthcare communities webinars dedicated discussing workplace challenges podcast notes nursing working approximately half million fund best practices resilient resident series webinars spark interest profession among diverse prospective committed companies across five continents since joining targeted leading surgeons early career overall suite nursing students new series called future nursing portfolio companies reached million patients directly webinar series attracted hcps countries across supported hcps events also support events like nursehackhealth support supporting field fueled belief potential ethicon reignited partnership nurseled innovation healthcare working collaboration marketbased solutions address health equity issues jjiv society black academic sonsiel microsoft launched first pitchathon provided funding early stage health impact entrepreneurs surgeons expanding diverse elevate foster nurseled ideas redesigning healthy work develop ideas various external partnerships surgeons initiative dsi program environment workforce thrive nearly nurseled programs jjiv also provided funding rock healths focused equipping promising interdisciplinary health systems applied pitchathon equitable investments initiative research publish minority surgical residents selected finalists representing transformative power calltoaction report greater investment underrepresented fellowship attainment faculty nurseled innovation three teams awarded entrepreneurs us additionally jjiv helped fund appointment dsi supported grant funding bring solutions life development iris investment tool global impact clinical technical training investing network assist investors identify support mentorship surgical residents continue help wilson aloubia md msc accelerating health equity entrepreneurship enterprises combating racial health disparities ladonna kearse md realize potential future practice laparoscopic skills surgical training lab johnson johnson impact ventures jjiv million impact milestone year jjiv first return surgical fellows faculty leaders diverse surgeon initiative investment patients know best personal health record fund within johnson johnson foundation invests dsi participants prior cohorts company helping give patients control healthcare companies entrepreneurs innovative business completed subspecialty fellowships obtained faculty medical information models improve health equity access affordable positions following next five years careers quality care underresourced patients around world financial returns portfolio companies reinvested enabling championing nurses expansion funds impact jjiv also leverages johnson johnsons network experience expertise healthcare johnson johnson proudly championed nursing provide resources support guidance portfolio companies profession century innovative mindsets invaluable insights handson experience nurses make health giving enterprise across johnson johnson enterprise level ihps approved product donations partners offering increased humanity report operating companies countries visibility alignment well streamlined automated largest diversified healthcare products company world donate funds products regional local causes approvals system innovative technology improving johnson johnson essential part fabric society aligned credo purpose specific needs local speed product donations across geographies communities around globe care deeply communities including disaster relief donations examples support communities struck disaster wellbeing communities use reach share discretion local johnson johnson leaders globally amount humanitarian crises include resources communities around world hundreds millions dollars year collaborations partnerships forge healthier war ukraine contributed million overall equitable future patient assistance us support independent initiatives relief efforts including cash product donations compliance donating medicines funding johnson johnson current international sanctions donations included patient assistance foundation inc jjpaf independent giving millions humanitarian support refugees combined million nonprofit helps eligible patients without insurance coverage international rescue committee international federation scroll chart information receive prescription products donated johnson johnson red cross red crescent well products valued operating companies million including medical devices essential medicines consumer health products firstaid frontline healthcare communities femininehygiene products disaster preparedness relief hurricanes fiona continue work trusted partners including americares ian partnered heart heart international catholic medical mission board americares gulf coast map international medshare international health partners community foundation front lines care coordinating product donations address immediate supporting programs help communities recover rebuild needs restore health become resilient immediate aftermath major disasters services areas affected provide essential pharmaceutical medtech consumer health hurricane ian central products well monetary donations support florida hurricane fiona heart heart internationals disaster response puerto rico team provided free healthcare services products contributed cash contributed volcano tonga worked unicef address chart includes enterprise giving including disaster relief value million million needs children caregivers following eruption products donated janssen jjpaf significant increase underwater volcano hunga tonga hunga haapai giving attributed product donations jjpaf value johnson funding provided johnson products readiness blanketed majority tonga volcanic ash affecting nearly community giving categorized three channels provided communities immediate mid tongas population displacing people impacted natural longterm response including children foundation johnson johnson foundation registered disasters around natural disasters world flooding kentucky joined americares charitable organization funded solely johnson aftermath devastating flooding struck southeastern johnson family companies foundation operates worldwide kentucky help restore health services three clinics johnson johnson foundation united states founded support people displaced homes johnson johnson foundation scotland founded building year collaboration johnson johnson independent entities support regionspecific global international health partners ihp debuted shared global earthquake indonesia following earthquake struck partnerships initiatives employee volunteering disaster donation platform harnesses best practices scale help west java indonesia displacing people response activities specific initiatives supported foundation communities crisis recover rebuild regain resilience provided together project hope communitymanaged mentioned report include center health worker disasters technology behind unified global system latrines water tanks two villages offering access clean innovation johnson johnson impact ventures product donation extended johnson johnsons water sanitation facilities pandemics epidemics gri sasb hcbpa health humanity report united nations sustainable development goal urges us work toward ensuring healthy lives promoting wellbeing ages specific target end epidemics including hiv health humanity goals tuberculosis neglected tropical diseases vaccine protection treatments pandemic epidemic diseases critical achieving goal worldwide providing access progressing development effective transformational impact public health expanding use progress global access plans treatments vaccines combat worlds deadliest vaccination monitoring platform vxnaid one health diseases long global public health priority johnson humanity goals crucial step advancing largescale c ontinued evaluation development access plans relevant pipeline assets including dengue johnson important part global health equity strategy immunization protect people save lives around world amassed century experience advancing pecific internal milestones set progress novel treatment regimens vaccines facilitating access achieved address multiple diseases including hiv tb covid ebola enabling access vaccination dengue well addressing growing threat amr monitoring platform pandemics epidemics progress preventive viral developed vxnaid vaccineagnostic digital platform vaccine capabilities supports adherent vaccine administration framework emonstrated supply capabilities access pathways clinical studies campaigns vxnaid digital tool johnson johnson covid vaccine including integrates innovative technologies improve patient tracing shipping million covid vaccines us johnson johnson credo inspires data management communication implement impactful captured processes internally future documentation us responsible communities live vaccination campaigns resourcelimited settings playbook work world community well internal external pandemic preparedness activities core tenet approach global health security platform deployed largescale continue across several potential threats aim stop spread lifethreatening diseases ebola vaccination campaigncalled umurinziin collaboration potential wipe entire communities government rwanda umurinzi first large left unchecked never determined use case platform fully vaccinated progress vaccination advance plans safeguard people rwandans ebola johnson johnson ebola monitoring platform threat pandemics epidemics vaccine regimen comprising zabdeno adzebov p latform implemented solidarity trial bavarian nordics mvabea mvabnfilo vaccines covid vaccines continued including expansion new countries vxnaid optimized based umurinzi campaign vanessa broadhurst secondgeneration platform shared opensource chieved external endorsement designation executive vice president global corporate affairs digital public good dpg digital public goods johnson johnson code enabling global open access platform alliance addition digital public goods registry vaccination program ptimized platform shared opensource code enabling globalopen access platform vxnaid granted digital public good designation approach envisions creating robust health ecosystem advance vaccination program digital public goods alliance added availability affordability needed medicines vaccines digital public goods registry c ompleted registered trademark filing platform facilitating access including worlds vulnerable name vxnaid populations efficacious management vaccine administration especially combat urgent outbreaks disease ebola health vxnaid adopted use solidarity following inaugural jj satellite center global health developing effective responses rapidly evolving global humanity report trial vaccines stv international multivaccine clinical trial discovery launch london school hygiene health environment blue knight offers physical residency evaluate efficacy safety covid vaccines use tropical medicine aimed developing next generation select jlabs locations well virtual engagement option platform stv program acknowledged drug regimens needed treat forms tb opened two portfolio companies eligible receive access jlabs public statement vxnaid deployed satellite centers resources programming along dedicated mentorship stv program expanded countries johnson johnson barda south africa satellite center global health discovery vxnaid shared opensource code enabling holistic drug discovery development hd centre blue knight expanded portfolio companies include global open access vaccination program university cape town focuses outpacing rising threat companies end female led amr minority led firsttime entrepreneurs singapore satellite center global health discovery learn vxnaid practice dukenus singapore focuses catalyzing investment bolstering discovery flaviviruses investing research needed collaboration across healthcare sectors larger life science ecosystem critical forging safer pandemics epidemics johnson johnson committed addressing dual gap healthier future innovation today impact innovation health equity establishment approach potential solutions future jj centers global health discovery joining forces academic institutions leveraging regional networks growing scope centers provide longterm opportunities support rachel rath talent discovery sciences hopefully speed director barda alliance johnson johnson discovery novel mechanisms tackle expanding emerging innovation jlabs challenges global health last year worked expand connections strengthen potential global impact growing portfolio dr anil koul amarnath sharma launch jj satellite center advancing innovation collaboration following ways global disease discovery dukenus campus singapore critical invest locally led innovation held second blue knight symposium bringing people advance breakthrough science globally jj learn global health discovery centers together virtually person newly opened jlabs centers global health discovery latest washington dc blue knight hub symposium facilitated chapter efforts advance solutions growing global conversation health threats areas research collaboration combat health security threats innovators investors needed partners thought leaders blue knight collaboration made progress discover accelerate portfolio companies raised million secured nextgeneration solutions contingent funding end year blue knight future pandemics emerging william n hait md phd joint initiative created jlabs biomedical infectious diseases executive vice president chief external innovation medical officer johnson johnson advanced research development authority barda part known unknown health administration strategic preparedness response threats us department health human services dedicated people countries melinda richter global head jlabs gary disbrow barda director join anticipating potential health security threats aim registered event blue knight symposium statement solidarity trial vaccines httpswwwwhointnewsitemwhostatementonsolidaritytrialvaccines health launched first blue knight quickfire challenge covid vaccine humanity report inviting innovators across globe submit potentially groundbreaking ideas technologies aim enhance acting urgency onset covid johnson johnson preparedness toward future known unknown infectious galvanized resources help halt pandemic developing disease threats four awardees selected take easytodeploy vaccine obtaining regulatory authorizations potential health security solutions next level building supply chain capabilities engaging partners around world support health systems healthcare providers involved combating covid beginning identified enhanced reach influence blue knight new impactful ways optimize clinical trials reach diverse community participation several events communities ensure appropriate representation congresses including bipartisan commission biodefense populations research meeting banding together partnerships biodefense meeting examined ways incentivize manage partnerships johnson johnson covid vaccine federal government industry academia received multiple regulatory authorizations emergency use waivers ngos drive technology innovation improve biological import permits many countries worldwide including intelligence current future threats three blue knight countries africa companies presented nextgeneration preparedness pandemics epidemics solutions meeting first time early stage companies invited speak commission showcasing power publicprivate partnerships accelerate scientific million technological advancements johnson johnson delivered million covid vaccines launchtodate shipped lmics selected blue knight company information related covid vaccine generated immediate increase scientific see annual report credibility exposure potential partners investors would taken us much longer small company brian wiley strategic advisor ena respiratory bipartisan commission biodefense meeting hiv health humanity report johnson johnson committed fighting hiv decades together helping advance science enable access collaborate improve lives around world health humanity goals determined effort make hiv history though significant advances prevention since fda approved label update product giving hcps beginning global epidemic million people acquired hiv people living hiv us option start alone underscoring high unmet need new options monthly everytwomonth injectable treatment without need progress access hiv treatment thats must continue drive inequalities access hiv oral leadin phase additionally fda approved registration approval received botswana treatment making hiv treatment easier effective cabenuva cabotegravir rilpivirine adolescents medicines regulatory authority marking first rls available everyone years age older first lai hiv regimen made approval codeveloped hiv lai regimen janssens available eligible adolescents reducing daily pill burden rilpivirine la viiv healthcares cabotegravir la treatment offered six days per year adhering treatment c linical studies ongoing demonstrate safety regimens difficult adolescents may skip hiv medicine efficacy hiv lai regimen adults adolescents doses hide hivpositive status others across multiple countries subsaharan africa hiv remain focused helping transform hiv regulatory approvals studies resourcelimited settings terminal illness manageable condition enabling hiv lai regimen approved botswana affected virus enjoy productive lives also conducting andor supporting four key additional medicines regulatory authority marking first approval best science passion dedication scientists clinical studies demonstrate safety efficacy randomized codeveloped hiv lai regimen resourcelimited country extensive collaborations enabled us controlled trials well feasibility acceptability continue seek regulatory approvals additional rls make significant progress implementation research hiv lai regimen adults including regulatory submissions south africa adolescents across four subsaharan african countries kenya thailand south africa uganda zimbabwe four studies different stages enrolling total participants brian woodfall md vice president global head development cabotegravir rilpivirine efficacy safety study cares infectious diseases vaccines janssen rd study hiv infected virologically suppressed adults longeracting treatment regimen could longacting treatment adolescents lata study hiv potentially gamechanging young people hiv infected virologically suppressed adolescents new expanded us regulatory approvals hiv treatment particularly since pill based fruitful collaboration viiv healthcare helped deliver acceptability feasibility longacting injectable art new meaningful treatment option worlds first complete adolescents afinaty study longacting injectable lai hiv treatment regimen lai regimen kati vandermeulen hiv infected virologically includes two arv drugs one developed janssen rilpivirine senior director compound development team suppressed adolescents viiv healthcare cabotegravir regimen also known leader infectious diseases vaccines janssen rd cabenuva cabotegravir rilpivirine us improving hiv control monthly everytwomonths versions hiv lai treatment africa longacting regimen adults approved health authorities europe antiretrovirals impala study switzerland canada additionally oncemonthly version hiv infected adults approved health authority australia history suboptimal adherence participants unaids global hiv aids statistics fact sheet httpswwwunaidsorgenresourcesfactsheet accessed february hivinfo nihgov hiv children adolescents httpshivinfonihgovunderstandinghivfact sheetshivandchildrenandadolescents accessed february health combating pediatric hiv addition fda approval hiv prevention women girls dapivirine vaginal ring learning hiv vaccine trials january together humanity report hiv lai regimen adolescents work expand improved recommended additional prevention consortium global partners discontinued mosaico solutions children living hiv ongoing combination choice women part combination prevention largescale efficacy study americas europe aimed tablet containing product prezista darunavir fixeddose approaches received approval south african test safety efficacy specific composition combination ritonavir mg received prequalification health products regulatory authority use women aged investigational hiv vaccine regimen among men sex helping meet treatment needs secondline older help reduce risk contracting hiv several men transgender individuals studys independent data treatment adults children johnson johnson approvals africa received additional safety monitoring board determined regimen specific policy since enforce patents owns applications currently pending effective preventing hiv infection compared placebo among controls prezista darunavir subsaharan africa least study participants vaccinerelated safety issues identified developed countries expanded geographical scope policy pediatric products used lmics effects gender inequalities womens children accounted people living hiv risks especially hiv aidsrelated deaths disappointed study outcome pronounced subsaharan serves underscore unique challenges africa women johnson johnson cofounder new horizons faced global scientific community accounted new collaborative aims improve treatment care year search hiv vaccine hopeful hiv infections hiv children young adults hiv countries across region learning mosaico may provide important data drug donation capacity building johnson ongoing fight hiv remain committed johnson collaboration elizabeth glaser pediatric aids mother daughter wait tested hiv clinic kihihi seeking innovative solutions hiv uganda photo new horizons collaborative foundation renewed commitment initiative pledging extend darunavir donation program continue enrolling dapivirine ring longacting hiv prevention method new pediatric young adult hiv patients least designed specifically women developed penny heaton md also important step toward meeting commitments international partnership microbicides exclusive global therapeutic area head infectious help tackle challenge pediatric hiv part rome license janssen use arv compound diseases vaccines janssen rd paediatric hiv tb action plan owned population council flexible silicone ring discreet children enrolled treatment program subsaharan easy use minimal side effects needs replaced african countries learn progress helping make hiv history monthly initial approvals pilot implementation dapivirine ring south africa important step decades long fight hiv particularly adolescent girls young women subsaharan africa three times likely acquire hiv male counterparts johnson johnson founding member menstar coalition helped million men living hiv subsaharan africa get treatment becoming virally suppressed child waits tested hiv clinic kihihi uganda photo new horizons collaborative unaids dangerous inequalities world aids day report httpswwwunaidsorgsitesdefaultfilesmediaassetdangerousinequalitiesenpdf accessed february funded primarily johnson johnson foundation registered charity company limited guarantee foundation separate legal entity johnson johnson family companies foundation operates worldwide johnson johnson foundation united states founded johnson johnson foundation scotland founded unaids dangerous inequalities world aids day report httpswwwunaidsorgsitesdefaultfilesmediaassetdangerousinequalitiesenpdf accessed february ibidtuberculosis health humanity report challenge end tuberculosis tb remains priority healthcare especially resourcelimited settings johnson johnson continue meet challenge lab last mile health driven year tb initiative two decades experience fight tb global healthcare company johnson johnson committed utilizing unique strengths including decades experience research development three years since start covid pandemic deep understanding insights behavior world still fighting regain progress made health humanity goals change help end tb pandemic combating tb first time several years increase people falling ill tb deaths continue increase year year howard reid global head global public health social impact globally estimated number deaths tb increased johnson johnson reversing years decline progress access million people died tb including tuberculosis tb treatment people hiv milestones fight tb n patients received access bedaquiline tuberculosis potentially averting million new mdrtb infections rising amr missing millions undiagnosed people december marked years since accelerated approval continue challenges made great strides help f rom patients received access sirturo bedaquiline fda johnson johnson bedaquiline potentially averting million new reignite global fight tb collaborations received approval sirturo bedaquiline mdrtb infections continue commitment patients reinvest first tb medicine novel mechanism action development new treatments advocate behalf years since bedaquiline recommended people affected tb core component alloral treatment regimens progress developing tb treatment mdrtb available countries representing learn tb johnson johnsons work c ontinued clinical development novel collaborative global tb burden asset including dosing completed phase study help end tb p rogress also made consortia groups including unitetb pantb using bedaquiline key without treatment death rate tb high component several studies currently recommended treatments four sixmonth course antitb drugs people cured mother receiving treatment tb three children gqeberha south africa global tuberculosis report factsheet httpswwwwhointpublicationsmitemglobaltuberculosisreportfactsheet accessed february ibid ibid health reached milestone studies help underscore importance humanity report courses sirturo bedaquiline multidrugresistant bedaquiline helping solve one todays greatest global health tuberculosis mdrtb medicine delivered cumulatively challenges reinforce confidence effectiveness countries including highburden tb countries treatment adults adolescents children today medicine become backbone whorecommended alloral treatment regimens milestone represents critical part year initiative nearly drtb patients pantb collaboration help end tb work continues johnson johnson allow us explore medicines potential continuing collaborate across sectors enable access help transform tb treatment patients need medicine mdrtb patients around world focus maintaining longterm effectiveness face expanding access pediatric formulation bedaquiline rising antimicrobial resistance part rome action plan safeguarding longterm effectiveness careful stewardship beyond medicine also continuing support global efforts help find ruxandra draghiaakli md phd missing millions people undiagnosed tb advance global head global public health rd innovative rd develop next generation tb treatments janssen rd since bedaquiline registered countries medicine specifically developed still large global gap estimated number treatment mdrtb advancing availability countries tuberculosis people fell ill tb number people newly greatest need diagnosed million people diagnosed scientist conducting tb research groote schuur research centre south africa disease officially reported national authorities mdrtb patients globally enrolled oral million collaborating advance tb drug regimens bedaquilinecontaining regimens project accelerate new treatments tuberculosis addition pantb membership several research new scientific data generated support safety pantb collaboration announced execution joint collaborations consortia ongoing include efficacy bedaquiline stream stage clinical trial development agreement jda supporting progression two following tb initiatives part innovative worlds largest clinical trial mdrtb conducted investigational tb combination treatment regimens phase medicines initiative imi medical research council clinical trials unit university clinical development collaboration evaluate whether unitetb global consortium collaborators college london sponsored vital strategies inc nearly novel regimens combine registered products new countries launched aims advance antitb science participants enrolled eight countries three continents chemical entities effectively treat forms active pulmonary enable progression new safe affordable treatment trial found bedaquilinecontaining regimens ninemonth tb using substantially shorter treatment durations existing solutions tb patients worldwide first year oral regimen sixmonth regimen eight weeks second drug regimens goal identifying regimen suitable project sponsor chosen first phase clinical line injectable superior efficacy compared ninemonth phase development trials innovative clinical trial designs developed injectablecontaining regimen fewer cases hearing loss project shortlisted first trial sites africa asia europe fills important gap evidence shortened regimens recognizing single organization produces full range south america mdrtb drugs needed respond tb pantb collaboration brings together philanthropic nonprofit privatesector organizations eratb eratb initiative integrates additionally study patients mdrtb accelerate development novel shorter drug regimens treat organizations eu us sixyear period sites south africa showed treatment bedaquiline forms tb alongside johnson johnsons bedaquiline four starting develop least two new containing regimen associated better survival additional antimicrobial agents evaluated new jda combination regimens treatmentshortening potential effectiveness compared nonbedaquilinecontaining regimens ready phase clinical evaluation patients mdrtb upon review data reconciliation processes change needed correct annual number courses sirturo bedaquiline shipped years resulted reduction total cumulative shipments goodall rl meredith sk nunn aj et al evaluation two short standardised regimens treatment rifampicinresistant tuberculosis stream stage openlabel multicentre randomised noninferiority trial lancet httpswwwthelancetcomjournalslancetarticlepiisfulltext accessed february bmc bedaquiline safety efficacy utilization emergence resistance following treatment multidrugresistant tuberculosis patients south africa retrospective cohort analysis httpsbmcinfectdisbiomedcentralcomarticlessx accessed february global tuberculosis report factsheet httpswwwwhointpublicationsmitem globaltuberculosisreportfactsheet accessed february health respiritb international research consortium eight highrisk populations streamlining tb case reporting southeast asia johnson johnson launched tb warriors humanity report european academic biotechnology organizations imi tracking mechanisms additionally collaborated launch initiative collaboration national tb programs respiritb aims develop new efficient combination youth volunteer patientfinding initiative sichuan indonesia philippines thailand vietnam educate youth drug regimen cure mdrtb focus shortening zhejiang provinces supported public awareness campaigns tb fun entertaining way using social media mobile treatment duration minimizing likelihood resistance focused tb including im great doctor tb special games philippines also collaborated beijing tv philippine tuberculosis society inc launch youth community eupearl strategic consortia public private casefinding initiative awareness care sectors shape future clinical trials developing specific investigational research platform frameworks trials south africa building pediatric drtb collaboration aquity innovations south africa johnson johnson ready operate disease areas still facing high unmet need foundation scotland aquity collaborated epcon gph organization jointly leads working group tb launch initiative improve healthseeking behavior among group presented new approach designing proud work key partners china youth conduct new insight study better understand adaptive platform trial tb drive impact tb based successful barriers care children youth outcome program extend key elements integrated models achieved engaging youth build tbfree future project places continue help enable tbfree china world tb day johnson johnson came together global community progress series initiatives every individual every organization potential tuberculosis highburden countries aimed helping empower generation make impact fight tb youth end tb initiatives advance global efforts help jenny zheng power multisector partnerships coming together find missing millions people living undiagnosed tb president xian janssen numbers uniting one common cause part johnson johnsons year initiative help drive help turn tide devastating disease progress toward ending disease aligned target un sdg india collaboration national tb elimination wide collaboration initiatives aimed engage program india launched youthfocused digitalfirst young people drive healthseeking behavior build community campaign called change badlaav change hindi sarthak ranade awareness improve active case finding reduce stigma social media chatbots initiative aims area managing director south east asia enhance early diagnosis tb goal encouraging create youth changemakers tb encourage health india janssen people tb seek care treatment need seeking behavior increase awareness disease build youth engagement participation support examples activations world tb day include indian governments vision tbfree india additionally engagement ending workplace tb initiative china celebrated conclusion threeyear sponsorship johnson johnson mtv staying multisectoral collaboration colaunched collaboration chinese government tb china alive foundation expanded success mtv nishedh continued initiative grew one highburden tb countries role assist youthfocused edutainment campaign india launching multinational companies pledging address tb chinese government addressing tb challenge across new season november part initiative workforce country build evidence support policy suggestions foundation developed episode drama series focused technical solutions national health commission lives young people india touched tb storylines learn progress helping end tb china improve diagnosis rates project effort raise awareness around disease reduce stigma carried across population million three promote early detection symptoms prefectures ganzhou linfen yulin involved training healthcare providers improving access molecular tests learn bethechangefortb india ebola health humanity report past three decades ebola outbreaks become larger frequent last recognizing africanled pandemic preparedness decade alone two deadliest outbreaks record west africa democratic republic johnson johnson supported government rwanda congo underscored urgent need innovation protect communities risk partners advance unprecedented movement drive unified rwandan initiative national ebola immunization umurinzi largescale vaccination effort ebola significant growing health threat recently additionally whos strategic advisory group experts prevent ebola along rwandan border democratic ranked africa centres disease control prevention recommended proactive use ebola vaccine regimen republic congo shared insights umurinzi among pathogens highestrisk trajectory epidemic nonoutbreak settings protect risk like healthcare symposium nd annual international conference public potential alone three outbreaksone uganda workers frontline workers recommendation health africa rwanda umurinzi campaign vaccinated caused rarer sudan ebolavirus countries additional tool deploy national pandemic people ebola vaccine regimen approved vaccine treatment outbreaks cause prevention strategies protect critical health security provides valuable experience used help prevent significant economic disruption illness loss life infrastructure countries living threat disease respond quickly threat pandemic particularly dangerous healthcare workers others working front lines december people worldwide ingabo study established part umurinzi received first dose ebola vaccine regimen evaluate vaccine healthy pregnant women continued zaire ebola virus species highest mortality including fully vaccinated enrollment patients completed rate fully vaccinated end year johnson additional data safety immunogenicity ebola johnsons first pregnancy vaccine trial positive results ebola vaccine regimen published new england journal johnson johnson vision protect people risk would offer ebola prevention option pregnant women medicine data generated phase clinical trial ebola preventing outbreaks begin part vision halt spread ebola partnership research ebola vaccinations prevac accelerated development vaccine regimen response evaluated ebola vaccine regimen among others may johnson johnson ebola vaccine regimen outbreak west africa help stop spread participants across trial sites guinea liberia mali granted temporary use authorization democratic republic outbreakadjacent areas today johnson johnsons twodose sierra leone results add growing body scientific congo support planned prophylactic deployment ebola vaccine regimen comprising zabdeno adzebov literature demonstrate johnson johnson ebola vaccine vaccine regimen help prevent future outbreaks johnson bavarian nordics mvabea mvabnfilo indicated regimen favorable safety profile well tolerated induces johnson collaborating ministry health hygiene active immunization disease caused ebola virus zaire robust immune response zaire ebola virus species prevention democratic republic congo acting ebolavirus species individuals year age building adults children aged years national institute biomedical research launch earlier approval european commission new ebola prevention program mbandaka parts prequalification quateur province program launched early aims regimen received new strengthen local capacity expanded capabilities prevent regulatory marketing ebola outbreaks respond swiftly outbreaks occur authorizations cte believe proactive use ebola johnson johnson donating ebola vaccine regimens divoire ghana vaccine global health community help working closely support capacity development rwanda sierra protect vulnerable communities living leone uganda early threat disease learn progress preventing spread ebola continued approvals key enabling access vaccine regimen people ruxandra draghiaakli md phd communities live global head global public health rd scientist works lab formulations ebola treatments leiden netherlands threat ebola janssen rd kadanali karagoz g overview ebola virus disease north clin istanb apr httpswwwncbinlmnihgovpmcarticlespmc new england journal medicine randomized trial vaccines zaire ebola virus disease dec httpswwwnejmorgdoifullnejmoa accessed february neglected tropical diseases health humanity report neglected tropical diseases ntds cause significant illness disability death especially centre drug design discovery belgium developed denguespecific antiviral compound novel mechanism among children worlds poorest vulnerable communities action could potentially protect treat dengue serotypes dengue eradication elimination feasible due existing animal reservoirs limitations current protective renewed commitment fight ntds joining since vermox mebendazole program donated measures multiple strains serotypes circulating global community including governments foundations nonprofit billion doses treating million patients toolbox combat dengue needs grow antivirals could organizations pharmaceutical companies endorse annually countries million doses vital new tool helping slow outbreaks limit kigali declaration neglected tropical diseases together vermox chewable donated alone epidemic levels cases recommitting longestablished efforts control eliminate ntds set debilitating diseases put risk health upon proofofconcept nonhuman primate model innovation combat flavivirus billion people around world especially vulnerable following results firstinhuman phase doubleblind underresourced committed following also invited scientists across apac oceania study showed compound safe well tolerated onating million doses annually vermox regions take part global health discovery quickfire progressed phase clinical studies evaluate mebendazole medicine treat intestinal worms challenge flavivirus infections challenge aimed attract antiviral compound prevention treatment dengue one potentially groundbreaking ideas treat control prevent study human challenge study conducted collaboration flavivirus disease innovators best potential solution johns hopkins university university vermont nih dvancing novel rd programs discover new medicines receive grant funding total pool access conducted collaboration singapores dukenus needed beat dengue leprosy jlabs apac community including dedicated workstation medical school also home johnson johnsons third neglected tropical diseases one year jlabs shanghai mentorship satellite center global health discovery apac launched ntds prioritized roadmap johnson johnson experts june satellite center aims catalyze investment johnson johnson research medicines support bolster rd infrastructure flaviviruses builds johnson treatment prevention three highprevalence ntds johnsons decadelong legacy ongoing collaboration dengue soiltransmitted helminthiasis sth also known treating leprosy dukenus public health research intestinal worms leprosy preliminary data janssens phase proofofconcept study show promising results bedaquiline treatment donating billion doses vermox mebendazole leprosy shared results st international leprosy years johnson johnson congress noting compound bedaquiline appears establishment satellite center duke forefront global efforts generally well tolerated dosed monotherapy nus builds upon strong track record flavivirus beat ntds donating period eight weeks leprosy study population consisting research benchtobedside innovations billion doses vermox mebendazole multibacillary leprosy patients advanced form leprosy facilitate antiviral drug discovery prevention treatment intestinal worms followed months whorecommended leprosy treatment treatment flavivirusassociated diseases field partners regimen preliminary data mark important milestone affecting communities southeast asia beyond countries bolstered johnson johnsons pledge advance research development development new chewable formulation vermox programs generate evidence needed explore innovative mebendazole easily administered children treatment options tackle leprosy young year age supporting training community health professor patrick casey workers enabling better data management supporting senior vice dean research dukenus progressing dengue treatment research medical school development new diagnostics tireless collaborative efforts countless children need given opportunity janssens dengue compound discovery program started recover play learn thrive collaboration ku leuven rega institute learn progress addressing ntds httpsunitingtocombatntdsorgenthekigalideclarationthedeclaration accessed february ending neglect attain sustainable development goals road map neglected tropical diseases httpsappswhoint irisrestbitstreamsretrieve accessed february antimicrobial resistance health humanity report antimicrobial resistance amr already crisis made even concerning covid johnson johnson one top three companies leading way addressing complex health challenge pandemic microorganisms develop resistance medicines millions people relied upon amr assessed independent access medicine years common diseases becoming difficult impossible cure spread infections foundation third amr benchmark published harder control largest diversified healthcare products company invasive expec disease ied sepsis caused purpose profoundly change trajectory health humanity nine prevalent serotypes expec adults aged years must come together advance investment care deeply reversing development amr rising amr older multicenter eventdriven vaccine efficacy study africanled innovation protect health ranked among significant health threats facing featuring groupsequential design includes communities world critical local world left uncontrolled could turn routine infections adults aged years older one additional risk researchers opportunity investigate surgical procedures lifeordeath situations factors invasive disease challenges impact communities without help counter amr threat johnson johnson committed leave communities collaboration investing advancing critical science well providing foster talent provide tools access antibiotics safeguarding longterm effectiveness opportunity needed create innovative solutions meet public health needs part efforts janssen public health antibiotics backbone modern medicine leading pursuit novel vaccines therapeutics tackle century increasing resistance range drugresistant infections including drtb e coli threatens render ineffective innovation specifically decades investment helping end tb critical antimicrobial resistance new antibiotic drug discovery must outpace rising kelly chibale phd contributor efforts outpace amr threat multi extremedrug resistant pathogens founder director hd declared amr one top global public health threats facing humanity annually million deaths attributable amr million deaths associated amr anil koul phd sharing data accelerate amr research vice president discovery partnerships pleased commit participating groundbreaking data global public health rd janssen rd sharing initiative increase understanding amr launched johnson johnson also founding member amr action nonprofit vivli amr register makes possible fund amr industry alliance focused creating biopharmaceutical companies share susceptibility data sustainable ecosystem investment innovation tackle dedicating resources amr science expanded infectioncausing pathogens first time ever one online amr threat amr action fund made first jj centers global health discovery jj centers platform marking critical step combating growing global investments two companies adaptive phage therapeutics launch johnson johnson satellite center global health health threat amr active participation leading venatorx pharmaceuticals promising deliver innovations discovery holistic drug discovery development hd pharmaceutical biotech enterprises including johnson change treatment landscape drugresistant infections centre university cape town south africa satellite johnson researchers able use amr register advance amr action funds goal bringing two center working drive new solutions address present four new antibiotics market within decade million rising threat amr specific focus multidrugresistant translate masses amr surveillance data meaningful action commitment fund helping advance toward goal gramnegative bacteria mdrgnb teams janssen saves lives preserves antibiotics future generations hd leverage combined global institutional regional advancing expec vaccine expec one leading strengths bolster early stage science innovation learn progress outpacing amr pathogens amr crisis last year initiated phase talent development needed tackle amr research new embrace study evaluate efficacy safety immunogenicity satellite center build johnson johnsons decades work single injection investigational vaccine prevent accelerating innovationfrom labtolastmile healthcare outpace threat amr antimicrobial resistance httpswwwwhointnewsroomfactsheetsdetailantimicrobialresistance accessed february ihme lancet estimated million people died antibioticresistant bacterial infections deaths hivaids malaria httpswwwhealthdataorgnewsreleaselancetestimatedmillionpeoplediedantibioticresistantbacterialinfections accessed february healthcare innovation gri jj jj health humanity report innovation essential part fabric johnson johnson years thanks incredible efforts tens thousands scientists researchers engineers designers clinicians pioneered multiple breakthroughs profoundly change trajectory health humanity advance innovation johnson johnson across many channels outlined position innovation rd investment millions new science facility bay area strengthens rd capabilities transforms discover develop deliver innovative medicines faster efficiently integrating drug discovery data science digital health aim accelerate growth bestinclass portfolio deliver better health outcomes people worldwide stacy feld site head san francisco bay campus regional head chairman ceo joaquin duato janssen rd employees opening johnson johnson innovation west north america san francisco bay campus photo orange photography healthcare innovation opened latest stateoftheart janssen rd facility doubling rd presence san francisco bay throughout world also expanded jj centers area located one worlds established global hubs global health discovery advance healthcare science targeting innovation campus bridges key scientific technological pressing challenges global health regions greatest need capabilities colocating janssen rd johnson johnson launched two satellite centersone south africa company thrive without innovation innovation integrating company bay areas address threat amr one singapore focus johnson johnson stating obvious innovation ecosystem strengthen increase collaborations dengue flaviviruses rd investment billion past innovators accelerate growth year walking talk investment learn global health discovery centers dual benefit patients globally gain access innovation across johnson johnson innovation well janssen rd advanced treatments johnson johnson continues billion leading impact healthcare marketscurrently brands platforms generate invested rd past five years deliver billion revenue annually investment innovation healthcare innovation advance purpose continues key element success improve lives joseph j wolk executive vice president chief financial officer johnson johnson pharmaceutical rd health humanity report pharmaceutical rd organization advances purpose change trajectory health advances treating leukemia also achieved two significant approvals imbruvica ibrutinib humanity pursuing breakthroughs across wide range therapeutic areas biological pathways applying expertise small molecules monoclonal antibodies cell gene therapies eu marketing authorization granted expanded use imbruvica ibrutinib fixedduration combination rna therapeutics regimen adults previously untreated chronic lymphocytic leukemia marks firstever approval imbruvica fixedduration regimen patients form cancer delivered numerous recent achievements across several agent anticd monoclonal antibody carvykti fda approval imbruvica ibrutinib granted therapeutic areas chimeric antigen receptor tcell cart therapy works first treatment children chronic graft harnessing patients immune system tcells attack versushost disease cgvhd lifethreatening complication cancer cells occur stem cell bone marrow transplant newly transplanted donor cells attack transplant recipients learn stories real patients treated body transplant sometimes used treat children carvykti caregivers following innovations led johnson hemoglobin problems sickle cell anemia thalassemia johnsons pharmaceutical teams many years children suffering leukemia deeply honored recently joined talented eu fda approvals tecvayli teclistamab novel firstinclass tcell redirecting bispecific antibody activates pharmaceutical rd team pharmaceutical innovation additionally johnson johnson innovation entered new bodys immune system fight cancer granted critical component global progress healthcare collaborations advance research specialist oncology fields treatment patients relapsedrefractory multiple myeloma johnson johnsons significant investments milestones marked significant developments heavily seeking new cancer treatments janssen oncology enable us discover develop transformational hangzhou dac biotechnology discovery clinical stage pretreated patients limited treatment options today medicines improve human health patients biotechnology company formed research collaboration serve around world license agreement aim discover develop novel pharmaceutical rd antibody drug conjugate candidates five targets using dac biotechnologys expertise innovative platform john reed md phd combined janssen oncologys proprietary antibodies given heterogeneity disease multiple executive vice president research collaboration focus prostate cancer hematologic myeloma incredibly challenging treat pharmaceuticals rd malignancies solid tumor targeted therapy help maximize nonetheless dedication janssen impact early stage research meet significant unmet working cure disease enabled need cancerrelated healthcare challenges conceptualization execution rich rd program oncology enabled significant step forward entire optimizing car cell treatment janssen biotech formed multiple myeloma community research collaboration serotiny gene cell therapy line strategy address unique cellular targets development company leverage serotinys multiprotein immunotherapy treatment regimens deep expertise domain discovery platform janssens antibody development multiple myeloma realized breakthrough developments cell therapy expertise create nextgeneration carbased multiple myeloma therapies addressing high unmet yusri elsayed md mhsc phd cell therapies collaboration potential advance need profoundly impact lives patients living vice president hematologic malignancies scientific innovation develop nextgeneration cellular therapies form cancer disease area leader janssen rd improved therapeutic function enhanced clinical benefit eu fda approval carvykti ciltacabtagene autoleucel could positively impact lives patients families granted treatment adults relapsed fda breakthrough therapy designation granted refractory multiple myeloma four prior lines talquetamab firstinclass bispecific antibody treatment therapy including proteasome inhibitor immunomodulatory heavily pretreated patients living multiple myeloma health immunology building legacy leadership immunology innovation myasthenia gravis mg highly debilitating rare humanity report janssen investigating targeted treatment nipocalimab autoantibody disease currently cure seek redefine standard care people living address underlying cause antibodydriven disease difficult diagnose investigating immunemediated diseases focusing unmet patient need nipocalimab investigated maternal fetal diseases rare nipocalimab address range serious autoantibodymediated actionable science two key products autoimmune diseases prevalent rheumatologic diseases unmet need diseases including mg results phase study community stelara ustekinumab tremfya guselkumab high cases therapy currently available nipocalimab patients generalized myasthenia gravis gmg made progress showed rapid robust sustained clinical response placebo phase trial adults phase study children stelara received fda approval treatment pediatric neuroscience underway patients aged six years older active psoriatic arthritis psa janssen intends reconceptualize diagnosis treatment tremfya celebrated fiveyear milestone approval nervous system disorders aim reduce burden cardiovascular metabolism retina treatment moderate severe psoriasis disability experienced patients worldwide researchers janssen published comprehensive analysis demonstrating janssen pioneering multiple approaches neuroscience cardiovascular metabolism retina therapeutic area covers tremfya ranked highest among approved therapies skin reduce disability caused serious neuropsychiatric common causes death cardiovascular clearance treatment psa neurodegenerative central nervous system autoantibody disease many lifethreatening conditions diseases extending scientific advances precision medicine significantly impact overall health including chronic kidney disease advanced critical research immunemediated inflammatory retinal diseases diseases imid crohns disease ulcerative colitis uc alzheimers disease ad leading way revolutionize psa progressed work studying oral cytokine inhibitors ad differentiated tau portfolio employs latest announced results phase axiomatic new form treatment people living imids phase advancements precision medicine data science digital secondary stroke prevention study milvexian novel oral b trial treatment moderate severe plaque psoriasis health use unique biomarkers speed earlier diagnosis drug anitcoagulant enrolled patients whats investigational novel combination therapy development decision making primary ischemic stroke early stroke recurrence ischemic guselkumab il golimumab tnf also showed promising stroke remains significant risk despite advances secondary pharmaceutical rd results treatment uc biomarker team developed evaluating blood test prevention data axiomaticsecondary stroke predict central amyloid positivity tau statusindicators prevention study showed approximate relative risk adwith high accuracy also developing novel digital reduction recurrent symptomatic ischemic strokes biomarkers collaboration leading technology firms favorable safety profile three arms study compared example together kielements piloting speech placebo suggests milvexian potential improve biomarker technology using ai machine learning identify pathway approach could potentially outcomes stroke patients clinical practice results abnormalities speech patterns may predictive treat multiple diseases rare prevalent one along findings axiomatictkr study set stage early disease mechanism really exciting bring comprehensive phase program therapy patients quicker efficiently depression neuroscience team leading charge excited potential nipocalimab also received encouraging results phase serious forms depression mental health condition bring relief patients suffering study evaluating investigational gene therapy botaretigene places heavy burden society affecting millions patients devastating diseases sparoparvovec treatment xlinked retinitis pigmentosa worldwide launched first new mechanism decades xlrp rare condition causes progressive vision loss starting spravato esketamine ciii nasal spray use conjunction childhood night blindness leading legal blindness oral antidepressant march adults treatment middle age using gene therapy approaches also advancing katie abouzahr md resistant depression august depressive symptoms candidate therapeutics common ocular diseases including vice president portfolio development leader adults major depressive disorder mdd acute suicidal geographic atrophy autoantibody janssen rd ideation behavior addition janssen advancing drug candidates novel mechanisms action depression including aticaprant seltorexant altogether efforts aim provide patients potential options combating depression medtech innovation health humanity report century harnessed power technology breakthrough innovation elevate new standards care surgery orthopaedics heart rhythm disorders eye health neurovascular care fields help save improve lives create future healthcare solutions smarter less invasive personalized period expansion innovation jj medtech delivered depuy synthes specializes orthopaedics solutions help heal ethicon continued advance nextgeneration treatment option significant product launches past two years restore movement millions patients china working lung tumors minimize impact surgery patients bringing advanced medical technologies people around johnson johnsons printing group depuy synthes allow speedier recovery ethicons solution world bringing chinese market highly personalized dprinted transbronchial microwave ablation using neuwave flex cranial implant made thermoplastic polymer execution microwave ablation system guided monarch platform enables availability critical implants much lower ethicons clinical trial patients lung tumors power cost shorter lead times implants manufactured study aims demonstrate safety effectiveness traditionally help ensure every surgery safe precise innovative approach december milestone jj medtech nurtured connection time efficient production cranial implants achieved first patient successfully treated part healthcare professionals latest technologies running depuy synthes suzhou manufacturing plant power study improve save lives rd forefront toward close december completed acquisition patient care uniquely positioned catalyst abiomed inc world leader heart recovery solutions drive scale progress creator worlds first totally implantable artificial heart abiomed brings rich history innovation cardiovascular care complements existing leadership diagnosis ahmet tezel treatment cardiac arrhythmias biosense webster medtech innovation company group chairman global head electrophysiology business medtech innovation rd johnson johnson advancing treatment stroke collaborate physicians academics invest scientific research advance treatment new patientcentered innovation across wide range ischemic hemorrhagic stroke stroke leading cause innovative surgical technologies solutions patients death million people worldwide affected stroke annually hcps seek continuous improvement deliver better patient cerenovus jj medtech company launched outcomes safety efficiency reliability examples emboguard balloon guide catheter part cerenovus include dprinted cranial plate sample produced johnson johnsons stroke solutions suite technologies emboguard designed printing group optimize removal blood clots controlling blood flow locally part jj medtechs depuy synthes velys digital surgery thrombectomy procedures balloon guide catheters platform cuptimize hipspine analysis latest surgical jj medtechs ethicon franchise received fda clearance shown increase ability restore blood flow one planning feature velys hip navigation simple xray urology procedures using monarch endoscopic robotic pass reduce procedure time reduce odds clot fragments based digital tool uses patient specific data help surgeons platform monarch first multispecialty breaking causing new ischemic events assess dislocation risk identify patients abnormal pelvic flexible robotic solution use bronchoscopy urology tilt may require unique cup placement dual mobility design stroke cerebrovascular accident httpswwwemrowhointhealthtopicsstrokecerebrovascularaccidentindexhtml accessed april jj medtech cerenovus launches emboguard balloon guide catheter use treatment acute ischemic stroke httpswwwjnjmedtechcomenusnewseventscerenovuslaunchesemboguardballoonguidecatheterusetreatmentacuteischemic health preventing treating atrial fibrillation afib advanced april biosense webster announced first patients biosense webster built largest online patient community humanity report solutions address afib new products research enrolled admire clinical trial us evaluate global get smart afib campaign us alone awareness efforts inform help patients including safety effectiveness companys investigational participants effort dedicated europe biosense webster launched first radiofrequency pulsed field ablation pfa platform principal components educating patients caregivers healthcare providers afib balloon ablation catheter heliostar enable physicians varipulse catheter trupulse generator signs symptoms treatment options including catheter ablation treatment afib pfa represents new approach europe advance safe effective efficient treatment treating afib utilizing controlled electric fieldinstead solutions patients suffering afib europe catheter thermal energyto ablate treat cardiac tissue could ablation recommended firstline treatment option exciting advance physicians patients may octaray mapping catheter launched mapping cardiac variety benefits biosense webster working bring arrhythmias including afib assist physicians capturing versatile portfolio pfa solutionscomplementary starlight action longterm education project precise information catheter ablation procedures rf catheter portfolioto address various ablation strategies enhanced clarity speed cardiovascular cerebrovascular health treatment afib aims pull strengths parties popularize jj medtech company biosense webster progressed research afibrelated knowledge advocate healthy afib patient behaviors north america help inform lifestyle entire population ways support afib prevention treatment physicians patients biosense websters afib pulsecheck survey splines electrodes increased among adults diagnosed afib revealed despite fears surface area coverage improved signal quality anxiety afib patients delayed seeking treatment sun zhiwei octaray mapping catheter allows better many ended emergency room due afib chairman beijing bethune charitable foundation understand anatomy conduction properties insights provide clues best promote afib behavior chamber interest change especially among highrisk patients china biosense webster supported new starlight afib public awareness campaign help popularize knowledge dr amit thosani prevention treatment afib top cause death medtech innovation director cardiac electrophysiology elderly cardiovascular diseases becoming major health allegheny health network threat chinese people afib frequent cardiac arrhythmia estimated million people worldwide suffer condition us million people europe hindricks g potpara dagres n et al esc guidelines diagnosis management atrial fibrillation developed collaboration european association cardiothoracic surgery eacts euro heart j feb https pubmedncbinlmnihgov accessed february lippi g sanchisgomar cervallin g global epidemiology atrial fibrillation increasing epidemic public health challenge int j stroke feb httpspubmedncbinlmnih gov accessed february data science digital health health humanity report johnson johnson view innovation data science digital health critical engine clinical trials subsequently deployed screening patients across clinical sites marks important advancement longterm business success foundation positive contribution sustainable development medicine data science demonstrating potential equitable inclusive society rapid optimized care patients need early detection pulmonary hypertension ph fda granted breakthrough device designation aienhanced across sectors combine innovative technologies data science projects spanning top development portfolio assets pulmonary hypertension early detection algorithm developed leading science deliver care groundbreaking new ways driving transformational innovation impact patients collaboration janssen anumana health technology vast diverse portfolio digitally powered treatments company mayo clinic algorithm precise non solutions aim keep people well every age stage life invasive screening tool could help address unmet need earlier diagnosis patients ph may otherwise go unnoticed disease advanced point limiting treatment efficacy downloadable physician digital johnson johnson continually evolving device accessed via cloud algorithm accessible shape future healthcare unlocking innovate stretch boundaries whats broadscale use early detection ph approved power people technology insights possible combining latest data science doctors use scalpels stethoscopes use digital health deep expertise science engaging patients remotely study immunemediated skin conditions launched remote immunodermatology connected data automation ai robotics change develop gamechanging solutions tackle observational study capture images patients lives digital build agile toughest health challengesall goal patients living immunemediated skin diseases support adaptive efficient sustainable processes across improving patient outcomes changing development ai algorithms needed creating objective business apply tech good trajectory healthcare measures disease severity diverse skin types study advance health wellbeing people around patients used smartphone capture photos skin world time creating unique data set volume required najat khan phd detailed analysis currently severity immunemediated skin data science digital health chief data science officer global head conditions measured doctors using naked eye strategy operations janssen rd jim swanson may lead high variability severity assessment digitally executive vice president chief information officer enabled remote study generating new ways assessing johnson johnson application data science digital health immunemediated skin conditions enabling improved treatment pharmaceutical rd programs helping transform solutions future moreover offering ability assess innovate examples among many ways ai ml skin conditions remotely technology helping reduce data science digital health data science methods leveraged include burden patients otherwise would required take time pharmaceutical rd work family visit doctors office clinical center bladder cancer trial recruitment janssen established one example johnson johnson leveraging collaboration paige global leader clinical ai applications potential data science digital health revolutionize digital tools help improve clinical trial diversity reducing pathology deploy firstofitskind aipowered biomarker healthcare immense largest diversified healthcare burden participation clinical studies test developed janssen screen presence certain products company johnson johnson using data science alterations fibroblast growth factor receptor fgfr genes digital health reimagine discovery development patients advanced urothelial cancer also known medicines advance mission bringing transformative bladder cancer goal provide physicians insights treatments vaccines patients around world help tailor patients treatment plans facilitate clinical trial methods fundamentally shaping way think work recruitment biomarker test validated janssen solve problems across rd portfolio health enabling healthcare selfmanagement developed empowering teams digital innovation humanity report diseaseagnostic digital health platform initiated first clinical study utilizing platform collaboration large diverse organization applying digital tools across university nairobi uon local tech company savannah many dimensions work digital health processes healthcare new place worlds map global health institute platform called mycarehub invest sharing work progress internally encouraging times crisis industry demonstrated tested young people living hiv kenya learning reapplication successful ideas creating unify world common purpose integrated clinical sites managed uon awareness latest technologies among teams brought together best minds science kenyan health system developed educate empower johnson johnsons data science council published internal engineering supply chain public health meet provide remote support patients manage data science business impact report showcasing evolving needs patients health systems health linking medical records secure digital compelling examples teams rd commercial supply around world wont stop jj vehicle facilitating engagement hcp connections chain enterprise functions working make promise medtech continue deliver innovation patients janssen made mycarehub available via potential data science reality advance modern connected digitallyenabled nonexclusive royaltyfree license uon experience representative health system patient also held annual janssen rd data science digital health gained help guide development platform center symposium bringing together colleagues two lay foundation potential future implementation across days discussion presentations janssen rd using regions data science digital health transformational force medicine patients data science digital health projects ashley mcevoy showcased symposium speakers delivering medical technology intelligence executive vice president worldwide chairman medtech johnson johnson including experts across industry startups academia well future medical technology smarter less invasive johnson johnson executives shared insights personalized digital technology helping enable future delivering data intelligence personalized patient outcomes improving efficiency accuracy knee surgery depuy synthes uses ml rightsize total knee arthroplasty tka focused precision efficiency operating room total hip arthroplasty tha implants creating deploying accelerated innovation across industry advanced analytics mldriven predictions tka tha procedures using direct data science practices impacting medtech industry want employees fluent language customer electronic medical records depuy synthes tailor data science digital health connected devices robotics software solutions generate data science achieve goal list required components meet need specific valuable connected data medtech embracing personalized learning development opportunities surgery rather delivering possible standard sizes power data science transform way help deliver support upskilling critical capabilities makes surgery coordination efficient accurate personalized healthcare better patient outcomes well needed effective increasingly way run business automating imaging improved eye disease diagnosis digital world improving afib treatment due complexity afib using customdesigned ml aidriven device johnson myriad decentralized data cardiac electrophysiologists johnson vision automated processing meibomian gland manufacturers struggle generate consistent results mg imaging leading better understanding patients mg peter fasolo phd across patients operators biosense webster introduced disease mgs produce meibum oily substance prevents executive vice president chief human cartonet first cloudbased data management system evaporation eyes tear film necessary full eye health resources officer johnson johnson potential improve procedure efficiency outcomes connecting new device johnson johnson visions using deep learning algorithm cartonet evaluates patterns lipiscan imager enables consistent evaluation patients mg enabling physicians assess performance easily disease based realworld outcomes enabling better diagnosis cartonet compatible carto biosense websters medical intervention mapping system integrates electrophysiology mapping ablation catheters innovation collaboration health humanity report johnson johnson innovation accelerates early stage innovation strategic partnership seoul innovation quickfire challenge september seoul innovation quickfire challenge awardees sirnagen therapeutics connecting best science technology entrepreneurs global resources portrai recognized seoul international biomedical expertise take worlds toughest healthcare challenges aim improve health conference help advance science companies received everyone everywhere krw grant funding two years residency seoul bio hub access johnson johnson innovations apac ecosystem mentorship experts across johnson johnson connect potential collaborators worldleading resources new quickfire challenges launched aim support advance transformation science four challenges completed technology across spectrum pharmaceutical medical devices consumer healthcare similarly collaborate advancing health equity quickfire challenge received widely across many groups partnerships consortia research submissions focused enabling inclusive clinical trial design agreements accelerate progress ways company equitable clinical decision making implementing community achieve alone based early diagnostics education patients providers advance health equity three awardees received grant funding total pool access global jlabs network mentorship experts across johnson johnson quickfire challenge awardees included prepare future johnson johnson womenled teams teams led people color promoting diversity healthcare startups feel efforts require new ideas new generation four quickfire challenges launched specifically johnson johnson innovation ecosystem empowering entrepreneurs deployment new tools health equity focused grant funding total pool healthcare startups embrace dei early stages scientific inquiry generate aggregate analyze million awarded teams companys lifewhen creating identity research data develop insights test hypotheses could focus approach culture end introduced inform development new ways prevent maternalfetal immune disorders quickfire challenge johnson johnson innovation health equity assessment intercept cure disease innovating health equity sought improve immunemediated tool heat johnson johnson innovation innovation collaboration pregnancy outcomes mothers children bipoc collaborating companies voluntary survey designed help early communities challenge awarded total grant stage innovators benchmark health equity maturity william n hait md phd funding two promising organizations aim advance health considering health disparities company leadership executive vice president chief external innovation equity addressing unmet medical needs pregnancy care potential healthcare solutions delivery selfassessment medical officer johnson johnson paired johnson johnson innovation health equity vets quickfire challenge lung cancer physical elearning module raise awareness help establish baseline trauma reflected commitment keeping veterans healthy understanding completion elearning module also activating health innovators entrepreneurs jlabs advancing healthcare innovation benefit military available public quickfire challenges effective way advance research community challenge sought ideas directly address practical innovation address range unmet medical needs unique healthcare needs military community including lung also introduced johnson johnson innovation board fellows quickfire challenge crowdsourcing platform committed cancer physical trauma made grants totaling program oneyear multifaceted education executive coaching identifying cultivating potential health solutions change six awardees three focusing lung cancer three offering mentorship program help strengthen diverse candidacy trajectory healthcare solutions address physical trauma potential board leadership positions june inaugural class five johnson johnson innovation board fellows began many quickfire challenges champion health equity seeking oneyear program board fellows paired jjdc mentors identify potential solutions serve historically underresourced help understand developmental opportunities communities reaching wide range diverse scientists achieve full potential potential board directors researchers innovators around world diversity equity inclusion clinical trials health humanity report johnson johnson made diversity equity inclusion clinical trials priority help create janssen oncology provided million grant stand cancer nonprofit organization supporting cancer research transformational therapies work patients support development innovative approaches removing barriers clinical trial participation patients racial ethnic backgrounds well patients medically important step journey achieving health equity deict team completed clinical trial diversity plan resourced communities ensuring everyone opportunity participate clinical across janssens therapeutic areas includes supporting local research right markets metrics reporting dashboard help guide progress approach also aligns anticipated fda initiatives underrepresented populations face variety barriers expand action disclosure clinical trial diversity within impact clinical trial enrollment including fear mistrust lack janssen different research teams demonstrate commitment awareness logistical challenges structured processes one leading funders cancer research stand area example janssen immunology dei working examine advance dei clinical trials including multiple cancer believes critical ensure group formulated specific dei strategy made progress partnerships enhancing awareness building trust among lack diverse representation cancer clinical trials hiring racially ethnically diverse leaders janssen rd underresourced underrepresented communities hope addressed national imperative enhancing culturally relevant training hosting speaker events change trajectory health disparities clinical research turn away need fresh ideas help innovate racial ethnic disparities healthcare engaging redesign cancer clinical research enterprise innovation partnerships promote inclusive research according fda clinical trial participants include communities long left new molecular entities therapeutic biologics approved janssen one first organizations proactively submit white black african american diversity plan fda oncology trial well ahead asian hispanic regulatory bodys new guidance initiatives expand action russell chew disclosure clinical trial diversity fdas commitment janssen diversity equity inclusion clinical president ceo stand cancer prioritizing diversity clinical research potential better trials deict team created template embed diversity connect regulatory approaches industrys broader health clinical trial process template relevant janssen janssen oncology provided grant million american equity goals help janssen deliver mission therapeutic areas covers dimensions diversity including race cancer society fund navigating patients across care create future disease thing past ethnicity gender sexual orientation socioeconomic factors treatment continuum program janssens contribution support using template insights janssens research includes improving representation cancer clinical trials janssen collaboration health systems three years enhancing dei clinical trials initiative equitable representation clinical trials oncology supports enhancing clinical research capabilities oncology patient experience addressing barriers strengthened africa collaboration african access initiative enrollment underrepresented marginalized communities aai publicprivate partnership driven bio ventures research includes meets communities global health nonprofit accelerates rd povertyrelated accelerating diversity medtech research jj medtech educational materials connects patients current trials diseases africa addresses disparity representation taking steps improve meaningful representation clinical partners advocacy groups understand communities africans cancer clinical trials janssen oncologys support studies leading better products better outcomes needs build trust safety clinical trials healthcare aai began initial assessment access cancer developed policy position diversity research clinical system overall research includes connected care hospitals five african countries patient education trials us outlining call policies reduce barriers million people messages importance diverse community awareness programs well training programs participation also continue support diversifying representation clinical research website cohosted hcps cancer diagnosis treatment investigations via equitable research studies everyone multilingual events participation community events diverse trials act introduced us house senate mobile health vans provides expanded legal authority companies diversify clinical trials founding sponsor medtech learn research includes color jj medtech helps advance representation persons color medtech industry drug trials snapshots report httpswwwfdagovmediadownload accessed february consumer health gri jj health humanity report announced intention separate johnson johnsons consumer health business supporting smoking cessation nicorette brought first nicotine replacement therapy market years ago create new publicly traded company would take place leader andbacked years research innovation intersection healthcare consumer goods remains committed eradicating smoking johnson johnson consumer health continued support smoking cessation joining launch event tobacco cessation new company named kenvue committed helping alongside preparation establish kenvue standalone consortium consortium publicprivate coalition support consumers realize extraordinary power everyday care company johnson johnson consumer health advanced whos work tobacco cessation worldwide participation kenvue combining power science meaningful human mission improve total health allfor individuals every age consortium builds nicorettes previous support insights digitalfirst capabilities empowers one billion stage life communities planet supported whos access initiative quit tobacco delivered positive people live healthier lives every day kenvues portfolio iconic million investment healthy lives mission aims results terms smokers quit completely nicorette brands built moments uniquely matter consumers fight preventable diseases impactful education donated million worth nicorette patches drives positive health outcomes around world partnerships starting smoking cessation skin cancer help people quit smoking prevention thibaut mongon formerly worldwide chairman consumer worlds billion tobacco users access health johnson johnson serves chief executive officer enhance product transparency help consumers make tools help quit successfully kenvue remain track complete separation informed choices personal health products subject market conditions advocating menstrual dignity stayfree joined improve sustainability products operations unicef another year promote education menstrual using recycled materials making packaging easier recycle name kenvue inspired two powerful ideas ken hygiene address menstrual poverty brazil reuse powering operations renewable electricity meaning knowledge vue referencing sight rich knowledge human needs deep consumer insights progress advancing healthy lives mission included million people directly affected menstrual kenvue deliver meaningful personal health solutions poverty brazil lowincome women know promoting skin cancer awareness neutrogenas sun menstrual poverty inschool program brought skin cancer prevention awareness students across us throughout access menstrual hygiene public health issue well following release neutrogena studios awardwinning human rights issue according un many women especially featurelength documentary film sun elevate lowincome regions live menstrual poverty means awareness understanding sun safety skin cancer lack basic access buy hygiene products often lack consumer health skin types colors schools participated access water sanitation stayfree joined unicef inschool education program two years feedback another year address menstrual poverty brazil inschool program amongst school students surveyed stayfree donated two sanitation pads menstrual students said change sun safety habits result hygiene kits distributed unicef teenagers brazil watching film supported educational outreach widely across country also india stayfree continued period campaign globally million cases skin cancers normalize topic menstruation india leveraging daughters diagnosed skin cancerassociated day second year occasion destigmatize first period deaths reported experience especially many households menstruation still considered taboo educating involving family kenvue planned new johnson johnson consumer health company members support announces purpose realize extraordinary power everyday care ultraviolet radiation httpswwwwhointnewsroomfactsheetsdetailultravioletradiation accessed february directorgeneral approves tobacco cessation consortium httpswwwwhointnewsitem tobaccocessationconsortium accessed february according research commissioned stayfree partnership kyra institute mosaiclab un women towards gender equality sanitation access httpswww unwomenorgendigitallibrarypublicationstowardsgenderequalitythroughsanitationaccess accessed february health expanding product transparency consumers johnson alignment target eliminate polystyrene jars collaborating greater impact johnson johnson consumer humanity report johnson consumer health expanded product transparency black plastic bottles global portfolio ceased health collaborates industry peers ngos suppliers dashboard across several leading consumer health brands sourcing packaging components resin material advance sustainability transparency objectives helping empower consumers make informed choices addition improved sustainability several products partnerships collaborations included personal care products use rely transparency packaging including dashboard consumers launched includes product animalfree safety assessment afsa collaboration listerine ogx introduced innovative product formats forum brings collective voice nonprofit industry specific information ingredients science sustainability including mouthwash concentrates shampoo bars leaders together support education advocacy help meet consumer needs expanded product reduce need packaging eliminate need animal testing cosmetics transparency dashboard across several consumer health brands tailoring information needs consumers aveeno neutrogena johnsons baby le petit ecobeautyscore consortium industryled collaboration marseillais launched reuse refill solutions reduce brandbybrand basis johnsons baby also unveiled companies associations help consumers plastic use compared existing packaging dashboard leading global markets outside us namely understand environmental impact cosmetic personal brazil canada uk ob introduced organic tampons made certified care products launch environmental scoring organic cotton plastic free top string system cosmetic products help inform consumer improving packaging sustainability advancing healthy purchasing decisions lives mission taking important steps reduce environmental carefree launched organic cotton topsheet liners impact personal care product packaging using less virgin certified organic cotton topsheet companies organizations across packaging value chain part digital watermarks initiative holygrail plastic increasing use recycled materials improving several brands portfolio also increased use pcr plan assess whether pioneering digital watermarking recyclability reusability packaging efforts plastic packaging materials forest stewardship council fsc technology enable better sorting higherquality recycling align consumer health packaging targets support certified paperboard rates packaging eu participation signatory ellen macarthur foundations new plastics economy global commitment additionally advance circular economy packaging sustainability continued collaboration several organizations including consumer goods forums plastics waste coalition action closed loop infrastructure fund consumer health sustainable packaging targets astar institute materials research engineering circular materials lab helping develop new global industry design rules eliminate reduce total sustainable packaging expand recycling infrastructure polystyrene jars black annual use plastic bottles global virgin plastics packaging north america research circular flexible film packaging solutions consumer health portfolio weight respectively compared achieved use combination recyclable reusable recycled plastic plastic compostable plastic packaging reductions packaging reuse models learn consumer health advances use sustainable manufacturing environmental health certified postconsumer recycled pcr paper pulp based packaging learn progress signatory ellen macarthur foundations new plastics economy global commitment health humanity report employees employees tiffani h renee e collaborate tampa global services siteemployee attraction development gri sasb hcbpa sasb hcbpa health humanity report employees johnson johnson around world continue energized purpose employee attraction blend heart science ingenuity profoundly change trajectory health humanity recruitment efforts include outreach wide range every single one employees make differenceand approximately channels partners encourage diverse representation individuals corners globethat adds huge impact top qualified candidates employee referrals generated significant proportion hiring efforts demonstrating employee confidence johnson johnson attractive workplace areas progress related employee attraction attracting developing retaining inspiring best people global workforce region development included globally crucial aspects johnson johnsons business employee attraction development promote culture respect inclusion excellence inspiring people return work career break reignite inspired credo talent every individual johnson johnsons global career reentry program offers johnson johnson leveraged ensure company experienced professionals taken break communities environment us individuals career two years opportunity return thrive grow workforce specialized onboarding networking development activities addition ambition support women returning stemd professions reignite genderinclusive program officially expanded focus include returning professionals outside stemd roles anticipating developing critical capabilities across johnson johnson help accelerate asia pacific europe middle east africa since inception reignite enabled professionals business outcomes today futureproof latin america north america countries across four regions return johnson organization tomorrow effectively johnson workplace continue careers must create meaningful personalized learning meaningful roles experiences help shape highly capable leaders empower employees chart individualized career new employee hires region paths feed purpose im like lot women school gates im highly peter fasolo phd skilled educated didnt know break executive vice president chief human back workplace didnt self resources officer johnson johnson confidence either sense hidden workforce reignite provided support structures needed help adjust returning workplace direct global workforce included approximately participating program found slotted back individuals includes approximately new work environment like never left hires across different regions women empowering felt relevant hadnt asia pacific europe middle east africa lost skills latin america north america abiomed headcount excluded global employee data well employee deirelated disclosures values rounded barbara mccarthy nearest tenth due rounding numbers presented add site pmo manager johnson johnson vision precisely totals provided percentages may precisely reflect absolute figures health hiring military veterans alongside appreciation valued advancing leadership development developed leadership also completed significant people leader assessment humanity report service appreciate unique skills experience military skills every level career stage ondemand content time people leaders receiving report veterans military spouses bring business engage innovative personalized modules across suite providing valuable feedback people leadership skills government bodies veteran support organizations expand leadership development programs many thousands support ongoing development empower hiring pathways military veterans offer veteran employees levels help organization deliver critical objectives development programs support transitioning civilian life work made strong progress employer choice military community e nhanced expanded hiring development opportunities sales leadership programs johnson johnsons learning development employee attraction development military veteran leadership development program launched numbers maintained retention across cohorts totaling veterans million h ired veterans department defense skillbridge total spend employee employees us program provides transitioning military service members learning development puerto rico participated civilian work experience final six months service tuition reimbursement part program johnson johnson offers internships program skillbridge participants completed first full learning hours programs annual cycle hiring skillbridge interns johnson johnson new leaders participated became johnson johnson fulltime employees jj learn hosts employees spent enterprise leader approximately average hours employees completed r eaffirmed commitment veteran military spouse hiring learning programs training development program yearend performance veteran jobs mission coalition brings together available employees reviews hundreds leading companies actively hire veterans managers moved across functions voluntary turnover rate learning development country business segment lines building continue invest heavily wide variety learning embracing learning mindsetboth diversity experiences development programs help employees realize career teamswe better able anticipate goals building capable resilient workforce develop critical capabilities needed future examples follow accelerate business outcomes futureproof delivering new learning ecosystem launched jj learn organization also providing rewarding career career progression movement opportunities allow employees realize includes upward promotion global learning development platform integrates lateral transfer excludes curricula multiple learning organizations across pursue unique purpose aspirations employees rd organizations enterprise including leadership development programs human performance institute programs become single source learning development needs leveraging sandra humbles latest technology including ai jj learn delivers streamlined chief learning officer johnson johnson learning experience easy access navigate enables every employee incorporate learning daily practices creating career path right jj learn includes learning programs facilitates matching mentors learn people development resources holistic career review development planning tools position employee development health building digital capabilities support everexpanding use compensation benefits humanity report digital technologies data science almost every aspect work every function business heavily investing compensation framework consistent worldwide building broad digital capabilities workforce focus includes set core principles guide compensation efforts provide common learning experience across decisions recognizing important contributions johnson johnson launched digital upskilling channel employees deliver mission ways align supported digital missions learning activations values committed pay equity including gender comprising various learning formats synchronous ethnicracial group pay equity asynchronous learning quizzes articles around one specific periodically analyze pay across functions assess digital capability provide teams effective experiential market competitiveness eliminate unconscious bias learning opportunity supported innovative approach employee attraction development barriers full pay equity across enterprise playbook local activation digital missions additionally invested significantly targeted salary increases johnson johnson employees continued access italk several countries enhance competitive pay position digital education series developed technology division also influenced inflationary pressures part teach digital topics italk videos available employees analysis year used new framework monitor inflation highlight areas alignment addition increased investment employees across total health portfolio address rising rates mental health concerns ongoing uncertainties consequences covid pandemic digital acumen continues critical capability believe investment employees across spectrum johnson johnson enabling teams reimagine compensation benefits helps make johnson johnson transform business models accelerate outcomes attractive employer resilient business futureproof organization additionally completed annual living wage assessment aim ensuring employees globally receive pay competitive local markets sufficient support michael ehret phd sustainable standard living families head global talent development johnson johnson see section human rights enhancing hybrid working continued implement hybrid working model jj flex globally capturing energy inperson interactions remote flexibility supply chain flexibility offerings onsite employees established combine locally relevant practices globally consistent hybrid working framework site new approach used example remotely onboard thousands supply chain team members also completed portion total required training assignments online diversity equity inclusion gri health humanity report diversity equity inclusion advances culture belonging open hearts minds combine unleash potential brilliant mix people working everywhere johnson johnson today well join us future take strategic approach driving dei johnson johnson dei fundamentally embedded human resources strategies see also section race health equity orthe ways based mission vision dei strategy designed health humanity goals helping eradicate racial social injustice public following health threat eliminating health inequities people color us build workforce reflects diversity diversity equity inclusion health humanity goals communities accelerate global culture inclusion every individual belongs dei numbers transform talent business processes achieve equitable access outcomes progress women management vice presidents directors drive innovation growth within business management positions globally held women globally women managers us serve diverse markets around world identify ethnic racially diverse progress ethnicracial diversity dei mission dei vision management employees make diversity equity management positions us held ethnic latin america women highest rate women us workforce change world inclusion racially diverse employees across four regions identifies ethnic work every day racially diverse progress blackafrican americans management workforce chieved growth black african management age employees engaged positions black african american employees employee resource overstate positive impact diverse representing management positions us groups ergs voices bring organizational culture community society large challenges remain must continue create inclusive environment fourth annual dei impact review shares insights employees embrace individual cultural evolution dei strategy wide range stories differences drive innovation progress throughout advance dei across four pillars strategy within three business segments wanda hope chief diversity equity inclusion officer johnson johnson health among areas progress advancing equitable access outcomes womens representation executive committee increased one five humanity report dei women following leadership restructure testifying strong pipeline women partnered multiple initiatives orthe senior levels company commitment realizing opportunities women teams business leaders address mental diverse workforce key roles also appointed first female general counsel companys history health inequities diverse communities strengthened development next generation johnson johnson leaders supported efforts advance inclusive rd rise ascend development programs diversity clinical trials provided gender representation opportunities hcps including women orthopaedic surgeons surgical residents fuc llc ce yle cr la et ie nd hve et der ea pn r th miri en ng w ofi dh eo fu er n fi sers color skillbridge program skillbridge facilitated robust duallanguage campaign janssen research includes initiative diversity equity inclusion interns becoming johnson johnson hispanic heritage month better fulltime employees communicate importance participating removed barriers access expanding clinical trials hispaniclatino community diverse slates broadening hiring criteria removing bias job postings innovation growth culture inclusion advanced supplier diversity though procurement teams helping achieve delivered conscious inclusion training significant increase diverse supplier spend vice presidents directors across women fulltime women women women johnson johnson supported brand teams deliver brand employees management positions executive positions new hires innovation awareness campaigns e mpowered ergs engaging nearly address needs diverse communities colleagues around world across skin care eye care oral health harnessing passions employees smoking cessation brands educate connect create space belonging partnered diverse communities ethnicracial diversity us multiple innovation quickfire challenges led expanded exploring diversity jlabs global immersive educational series build greater cultural knowledge expanded care pride initiative globally products brazil canada understanding among employees white germany japan uk delivered interactive dei glossary asian evolving resource commonly used dei recently filed us federal employer blackafrican american terms ensure understand use information report eeo publicly available hispaniclatino language representative inclusive note federal reporting requirements require johnson johnson employees patients specific employee categorization differs consumers communities way measure diversity progress declined answer reflected health humanity report therefore directly comparable values rounded nearest tenth due rounding numbers presented add precisely totals provided percentages may precisely reflect absolute figures employee engagement gri health humanity report across johnson johnson employees find inspiration purpose change trajectory women stem health provide platforms tools resources across enterprise help everyone aim encourage girls consider science technology contribute effectively engineering mathematics manufacturing design stemd studies career opportunities knowledge advancing gender equality technical professions strengthen encourage open inclusive communications society also build stronger pipeline diverse talent everyone feels welcome offer ideas suggestions underresourced stemdrelated professions critical improve outcomes patients consumers advancing innovation healthcare credo survey demonstrate care communities planet participation rate among key results eligible employees connecting employees one platforms use employee engagement track employee sentiment feeling connected health humanity goals colleagues values biennial credo survey administered countries made available languages past two years people around globe agreed favorability rate faced overcome many social economic challenges statement ensures reflects including relating covid pandemic face first responsibility fulfilling credo challenges employees maintained confidence commitments patients doctors progress women stemd nurses mothers credo values demonstrating stronger support recognition employees fathers others e ngaged girls way uphold values positively impact society use products events stemdorg activities total services girls engaged following analysis detailed results communicated employees developed plans address main areas opportunity identified employees feedback enterprise level within individual teams health humanity goals include specific target reach million girls stemd activities alternate years conduct global voice survey agreed agreed led johnson johnson employees partnership serves indicator employee satisfaction measures statement acts statement provides nonprofit organizations encourage employees play important aspects culture employee engagement responsibly inclusive work active role engaging advance women science inclusion development health wellness collaboration communities environment execution innovation compliance risk live work employee considered johnson johnson employee world community individual recognizing employees addition several awards honors well volunteers directly engaged stemd activities approximately girls programs recognize contributions employees across different functions regions maintain global women science technology engineering mathematics peer recognition platform inspire reaches global manufacturing design wistemd initiative supports youth workforce countries hundreds thousands undergraduates scholars professionals active recognition moments celebrated meaningful contributions since wistemd youth pillar seek spark purposeled behaviors among employees enchantment stemd young women girls around globe creative problemsolving play health wistemd undergraduate program collaborated engaging employees healthy communities bridge employment engages employees mentors help humanity report nearly universities delivering events reaching secondary school students improve academic performance university students via variety activities johnson johnsons gci organization drives talent elevate career aspirations extension program pathway social media campaigns also launched wistemd camp good strategy inspire employees help create healthy success helps students succeed thrive higher education weeklong pilot program europe give students opportunity communities across globe talent good offers wide providing additional support fulltime paid summer internships explore postsecondary options stemd fields initiative variety engagement opportunities employees inviting johnson johnson internships plan extend expanded wistemd take part preferred level participation focus area program apac latin america regions interest talent good programs include skillsbased one young world engages employees support frontline health volunteering opportunities conducted partnership nonprofit leaders various projects provide guidance mentorship wistemd scholars program selected six community partners programs range shortterm building young leadership capacity across globe change outstanding female researchers receive support drive volunteering local communities mediumterm programs trajectory health important research program active since connect employees nonprofits wherever capacity selecting early midcareer women faculty researchers building activities fully immersive engagements several talent healthy communities creates greater engagement employee engagement completed postdoctoral studies making key months support nonprofit skills competencies awareness employees partners stemd discoveries receive grant local community hybrid pro bono program addressing three years mentorship received quarterly giving initiatives engage employees support critical capacitybuilding needs community applications highly qualified nominees around local communities also encourage employees wistemd engages employees globally inspire young girls world applicants coming outside volunteer communities companywide days women enter stemd fields us selected wistemd scholars advancing caring pivotal global innovations across diverse fields aim global pro bono engages employees pairs selected significantly improve healthcare outcomes partner organizations working front lines health support build organizational capacity johnson johnsons wistemd scholars program provided outstanding female global secondment program enables empowers selected talent healthy communities program researchers million grant funding advance johnson johnson employees support partner organizations allowed use professional skill set help pivotal healthcare innovations front lines health raise public health standards community within project also learned communities around globe sharing knowledge skills effectively manage project work passions four sixmonth time frame multiple groups people quite challenging yet rewarding dr ange therese akono pro bono health equity utilizes skills talents awardee johnson johnson employees build capacity usbased working bone tissue community health centers supporting communities color regenerative engineering denivea williams program part race health equity commitment focus discovering senior manager acquisitions divestitures value see section race health equity excellence service lead johnson johnson nanostructured bone scaffolds help restore quality life patients many talent good programs build longstanding require maxillofacial collaborations johnson johnson maintained bone repairs several years organizations wide reach within communities help create meaningful volunteering opportunities johnson johnson employees maximize impact deliver tangible social benefit collaborations included health engaging employees healthy planet humanity report johnson johnson employees passionate environmental talent good engagement employee engagement healthy planet sustainability seek make impact engage inspire numbers numbers provide opportunities employees learn collaborate dedicated environmental sustainability programs bridge employment talent healthy learning ideasharing platforms wesustain communities healthyplanet environmental sustainability training active wesustain teams actions completed countries healthyplanet users employees volunteered protect environment employees water nourishes better world simon years old china one hours mentoring countries volunteered several winning original pieces employee engagement annual worldwide childrens energy coloring art contest employee training environmental sustainability students worldwide contest th year open built online selfpaced training module called sustainability community partners young relatives johnson johnson job demonstrate every johnson johnson employee employees opportunity contribute sustainability solutions work follows engage future generation one young world broader foundational sustainability training module launched play role reducing global secondment new training depicts real employee examples carbon emissions program guides employees build action plan based employees role function interest optional sustainability training collaborated modules strong employees around world employees wesustain environmental sustainability employee volunteered engagement program wesustain mobilizes passionate employees external scholars improve environmental health locations live projects addressing work sell products brought wesustain front lines healthcare ngo partners mentoring students community together first global wesustain summit continuously providing opportunities employees globally joined virtual live event hear internal employees learn build personal external speakers connect share ideas professional sustainability capabilities decisions pro bono sustainable future global pro bono made today help protect environment health equity healthyplanet healthyplanet platform health future generations launched challenged employees calculate employees employees environmental sustainability impact offering personal carbon regions volunteered volunteered calculator ideas reduce footprint throughout year deb gorhan employees completed actions topics ranging director sustainability culture engagement ngo partners reducing energy lessening food waste eliminating johnson johnson ngo partners singleuse plastics incentives like charitable donations drove employees take double actions taken previous year impact metrics healthyplanet illustrated employeeled savings including reduced paper use reduced trash lower energy see section women stem details wistemd activity consumption lower water use employee health safety wellbeing gri health humanity report johnson johnson take uncompromising approach safety everything also invest extensively health wellbeing employees believe advancing health humanity starts protecting enhancing total healthphysical mental emotional financialof workforce aim ensure employees around world well temporary contractors visitors reinforce best safety practices commenced yearlong global refresher program sites work safely workplace health safety programs include adherence robust six safety habits framework employees rd spaces supply chain facilitiesand global safety standards risk assessments extensive training communications continuously working construction projectsto reacquaint workplace habits ensure safety expand health wellbeing benefits throughout johnson johnson globally incorporating new continues essential part culture thinking technologies help employees achieve personal mind body health goals global employee safety employee health safety wellbeing six safety habits learning responsible learn successes everyone personally responsible failures safety safety others caring transparent demonstrate caring inspire everyone feels safe make suggestions andor strong value safety heart share complaints need know lost workday serious injury total recordable case rate illness case rate injury rate proactive inclusive everyone anticipates actively seek diverse perspectives share safety engages controlling safety hazards knowledge within beyond four walls see employee safety table esg performance data section report footnote considerations related global employee safety data constantly reinforce uncompromising approach safety ensuring people work safely foundational wellbeing fact nothing communications important however must continue remain vigilant many employees around facilities operations around world presenting potential safety risks every world minute every day rely approximately people well contractors visitors sites practice safe working every single one minutes johan geerinck worldwide vice president environmental health safety johnson johnson health advancing road safety road safety key element safe beyond safety aspire healthiest workforce inspiring enhanced employee assistance programs care humanity report working programs continuously seek improve us continually examine expand total health benefits confidential accessible responsible engaged services safety vehicles even importantly awareness programs offerings support total wellbeing select countries intent introduce additional vigilance safe practices drivers took several employees embed culture health throughout johnson countries enhanced services connect employees actions improve driver fleet safety globally johnson healthiest workforce ambition tracked health professional assistance broad range topics mental humanity goals annual healthiest workforce score health support professional life coaching worklife services expanded predictive analytics majority global ie elderadult care travel childcare education pet care fleet drivers household services parenting employees easily digitized global road safety data online ataglance health humanity goals navigate support need dashboards effective safety controls management also road safety assurance audit process introduced new virtual mental health resources us support employees families including behavioral standardized global road safety training internal support children teens families along leading online training platform accessible fleet drivers companies across industries joined thrive society distributed highly reflective inflatable airbag vest riders human resources management pledging continued employee health safety wellbeing twowheeled power vehicles india reduce risk potential injury commitment prioritizing employee wellbeing mental progress healthiest workforce score health johnson johnson leaders managers achieved healthiest expanded travel benefits us employees families workforce score providing reimbursement travel receive medical services inclusive limited reproductive healthcare available outofnetwork provider within miles patients home comprehensive wellbeing portfolio available johnson global activity challenge held seventh day johnson employees families reflected positive global activity challenge encouraging employees join employee perception organizational support total health teams boost health getting moving employees global employees believed senior leaders support able select walking running dancing cycling gardening health wellbeing exemplified credo practicing yoga preferred physical activity competing survey results global teams challenge engaged improved health benefits programs participants countries recording support employee health wellbeing rolled several billion steps throughout challenge end challenge new initiatives enhance robust portfolio wellbeing johnson johnson donated operation smile since johnson johnson donated offerings including unicef lifesaving helmets children vietnam potential injury mplemented expanded paid parental leave benefits employees energy management enterprisewide energy around world weeks paid leave covering maternal performance program helps employees manage energy paternal adoptive surrogacyassisted foster parents capacity best work life consistently expanded use program introduced virtual courses continue deliver important training pandemic employees completed energy performance courses health humanity report environmental health leed goldcertified janssen facility completed second phase photovoltaic pv panel installation climate action gri health humanity report johnson johnson understand human health environmental health health humanity goals fundamentally linkedhealthy people need healthy planet two decades set achieved carbon reduction goals taken sustained longterm action reduce greenhouse gas ghg emissions encouraging suppliers largest diversified healthcare products company johnson johnson set three public goals reduce ghg progress renewable electricity recognize opportunity drive positive change issues emissions across value chain nearterm goal reduce affect health people serve continually scope scope ghg emissions levels electricity produced procured renewable energy sources strive improve environmental footprint operations validated science based targets initiative sbti climate action products value chain also working others consistent reductions required keep global warming n johnson johnson signed additional renewable power purchase agreements ppas brazil india accelerate scale solutions together likeminded c previously signed renewable electricity agreements partners working tackle todays global challenges europe us went effect intersection human environmental health including climate change health equity johnson johnson recognized cdp list rating progress carbon neutrality according climate change single biggest health leadership climate action operations threat facing humanity climatesensitive health risks fifth consecutive year one disproportionately felt vulnerable disadvantaged companies named bb el lu int ee r e uc rt eio dn u c tn io nc inp ce lu g c ca ar rb bo n e cm reis ds itio sns vs climate list five johnson johnson sites newly certified carbonneutral external organization climate impact partners bringing total number certified carbonneutral sites six since absolute scope scope ghg emissions reduced absolute reduction mt coe take intentional approach climate action mt coe order benefit health planet health progress scope emissions company health people including reductions disproportionately impacted scope ghg emissions mt coe increase greenhouse gas ghg emissions scope effects rising temperatures extreme weather upstream vs baseline e tov e pn rots g ren sd c tl oim wa ss oe un rs cti lv ime ah te ea glt oh r li ss k ws e n ra ed wdi oti ro kn g pru imr ac rio lyp p e um rcis hs ai en ds gin oc ore da ss ae nd b sy e r v ic f ero u p trr eiv ae mn partners strengthen climate resilience transportation distribution calculation emissions categories based spend data category healthcare workforce healthcare systems specific economic inputoutput emission factors versus serve vulnerable health impacts activitybased emissions fuel price increases inflation changing climate exacerbated costs used calculation emissions progress includes becoming founding member pharmaceutical industrys program activate supporting api suppliers decarbonization efforts also piloted paulette frank joint climate action planning process high emitting chief sustainability officer suppliers identify areas opportunity collaboration johnson johnson see greenhouse gas ghg emissions table esg performance data reduce scope emissions section report footnote considerations related scope scope ghg emissions data climate change health httpswwwwhointnewsroomfactsheetsdetailclimatechangeandhealth accessed february health accelerating use renewable electricity minimizing ghg emissions humanity report operations products making meaningful progress deploying renewable renewable electricity across electricity across greater portion operations around operations end addition accelerating use renewable energy continue world global electricity use powered renewables invest energyefficient processes equipment green end construction lowercarbon renovations sites north america europe global operations since energy efficiency programs energyintensive data percentage electricity used manufacturing rd sites allocated million per year johnson johnson johnson johnson generated renewable capital relief co capital relief program energy maintains sources including onsite offsite renewable projects demonstrate potential co savings financial return onsite renewable energy systems like direct ppas virtual ppas utility green least systems countries tariffs europe three virtual ppas finalized climate action executed brought us equivalent renewable example janssens xian facility china completed second contracts electricity europe due renewable electricity phase photovoltaic pv panel installation part co capital offsite renewable certificates recs contracted relief program integrating existing system electricity procurement global expansion use renewable electricity execution virtual ppas green tariffs significant onsite cleanrenewable energy capacity type mw factor reducing scope scope emissions line goal achieve carbon neutrality operations completed several initiatives procure renewable electricity globally propelling johnson johnson toward solar pv renewable electricity goal global level cogeneration initiatives included wind brazil direct ppa signed renewable electricity geothermal wind farm northern brazil johnson johnson operations country starting largest deal weve made biomass south america date india direct ppa signed mulund india enable xian site team completing second phase photovoltaic pv mulund consumer health plant source electricity panel installation wind power see greenhouse gas ghg emissions table esg performance data section report footnote considerations related scope scope ghg australia china south america multiple utility green tariffs emissions data completed renewable electricity across several sites johnson johnson vision care achieved renewable mexico direct ppa wind farm mexico helps deliver part electricity across global manufacturing operations using utility ethicons juarez site renewable electricity september green tariffs onsite solar us onsite wind malaysia south africa spain expansion onsite solar power offsite wind power direct ppa ireland power generation completed three consumer health sites europe includes belgium france germany greece ireland italy netherlands poland spain sweden switzerland uk north america includes us canada health since total absolute energy consumption across green buildings continue pursue leadership energy humanity report johnson johnson sites reduced tj environmental design leed certification equivalents co capital relief program overview tj represents energy reduction building research establishment environmental assessment intensity basis per billion sales methodology breeam added one leed certification across facilities bringing total end million leedcertified breeamcertified johnson total energy use since tj annual energy projects tj annual johnson sites cost savings completed energy savings scroll chart information million mt co total spent annual ghg approximately million square feet completed projects emissions avoided johnson johnson workspace leedcertified climate action green labs jj medtech depuy synthes rd five johnson johnson sites france szanne germany lab leeds uk janssen immunology lab california wuppertal italy pomezia switzerland neuchtel achieved green lab certification implementing us lititz pennsylvania newly certified carbonneutral sustainability best practices green lab certification external organization climate impact partners bringing recognized un race zero campaign key measure total number certified carbonneutral sites six including nonrenewable sources renewable sources progress toward zerocarbon future considered helsingborg sweden originally certified carbon emissions gold standard laboratory sustainability best practices reductions achieved energy efficiency initiatives around world intend seek certification hvac optimization chiller system replacements wasteto energy intensity since tj billion johnson johnson labs coming year energy projects renewable electricity use carbon credits carbon offsets utilized remaining emissions reducing energy consumption overall base year health humanity environmental goals reduced total energy consumption business grew period words energy intensity expressed tj per billion sales customers reduced strongly demonstrating cumulative effect continuous improvement deliberate energy efficiency initiatives year year across global operations see greenhouse gas ghg emissions table esg performance data section report footnote considerations results completed projects based fuel electricity reduction calculations avoidance energy consumption ghg emissions calculated comparing energy consumption project implementation expected consumption implementation using engineering estimates time projects approved internal process health driving carbon reductions across value chain building capability helping educate suppliers continued engage partnerships coalitions help humanity report emissions measurement disclosure well renewable energy make positive impact health climate beyond engaging key suppliers across global supply base adoption also trained procurement teams support value chain critical reducing absolute upstream scope ghg highquality data submission suppliers cdp early national academy medicines nams emissions line health humanity goal driving reductions piloting joint climate action planning action collaborative decarbonizing us health sector reduction levels process highemitting suppliers across various industries publicprivate partnership leaders across health help us understand climate goals efforts needed achieve system began engagement forming climate upstream scope ghg emissions mt coe source joint climate action planning able identify collaborative forum align around collective goals scroll chart information biggest opportunities collaborate suppliers drive actions decarbonization based evidence shared solutions reductions scope emissions commitment improve health equity one current work streams group focuses developing sharing regarding logistics continued work suppliers reduce resources help healthcare supply chain companies start climate action shippingrelated emissions example europe johnson accelerate sustainability journeys johnson introduced rolling highway project transports fully loaded trucks rail italy belgium significantly reducing foundational funders beyond megawatt initiative clean energy buyers institute emissions road travel program expanded include ceba charged creating resilient equitable shipments environmentally sustainable energy system benefit leveraging energy customer demands clean energy partnering climate action also work partners advance environmental health equity includes supporting programs empower healthcare also engaged two initiatives support collective workers strengthen resilience healthcare facilities efforts driving ghg emissions pharmaceutical supply areas needed chains purchased goods capital goods energize program pharmaceutical industry collaboration services platform aim increase access renewable electricity upstream transportation fuel energyrelated within pharmaceutical supply chains educate suppliers distribution activities renewable energy adoption contracting business travel upstream leased assets johnson johnson suppliers registered platform energize program supported first renewable employee commuting waste generated operations electricity buyers cohorta group companies came together contract renewable electricity scale via ppa see greenhouse gas ghg emissions table esg performance data section report footnote considerations related scope ghg emissions data activate program pharmaceutical industry collaboration make progress area procurement logistics teams launched bringing together five pharmaceutical worked closely identify realize opportunities improve companies including johnson johnson founding members scope data drive emissions reductions introduced new support active api suppliers decarbonization efforts upstream scope strategy encompasses measurement ghg emissions provision practical decarbonization tools improving data quality piloting collection detailed sources emissions data supply base well using data science capabilities visualize cdp supply chain data shows maturity level largestemitting suppliers including goals emissions footprint reductions water waste management gri sasb cghpa cghpa health humanity report continue advance initiatives across facilities throughout supply chain minimize impacts planet responsible use water avoidance waste reduction waste sent landfill water stewardship part efforts continuously improve watersaving projects helsingborg sweden consumer track achieve goal certified true zero waste management water resources water stewardship health site helsingborg sweden three new watersaving projects facility green business certification incs true zero waste pursuing alliance water stewardship aws certifications completed newly installed chiller closedloop certification program rates well facilities perform across elected facilities network johnson johnson water cooling system reduced coolant water needs minimizing nonhazardous solid wastes maximizing consumer health thailand janssens xian china facility half requiring less energy operate old model efficiency use resources several new onsite waste achieved aws certification international aws certification production equipment cleaning processes also optimized management processes including waste inventory management addresses sustainable water management confirmation shortened save purified water annually finally adjustment system internal packaging reuse systems combined water waste management met global benchmark responsible water stewardship reverse osmosis processes equipment service methodology outreach suppliers takeback packaging items reuse pursuing additional site certifications coming years completed saving additional water onsite recycling contributed reduction nonhazardous waste sent landfill facility past five years water withdrawal million per waste management continually advance initiatives across billion sales across johnson johnson globally reduced facilities throughout supply chain systematically total waste generated mt demonstrating efficiencies water management alongside avoid waste reduce waste landfill increase sustainable scroll chart information business growth sales management waste waste streams generated directly operations include hazardous nonhazardous waste research laboratories manufacturing processes warehouses total water withdrawn million offices waste management initiatives progressed included reducing hazardous waste aim reduce hazardous waste materialintensive api processes implementing green chemistry engineering principles improve chemical conversion yields increasing reuse recycling raw materials example janssen continued program reduce hazardous waste small molecule api production four johnson johnson sites hazardous waste nonhazardous waste working toward zero waste brazil teams jos dos campos site houses manufacturing three business segments johnson johnson working johnson johnson recognized cdp rating toward improving waste management program since leadership water security several initiatives put place advance recycling across nonhazardous waste streams site achieved highest recycling level since start program product packaging sustainability gri jj sasb hcmsa sasb hcmsa sasb cghpa sasb cghpa health humanity report committed developing sustainable products support health people reducing medical ewaste jj medtechs biosense webster brazil implemented initiative help hospital staff understand planet focus product categories platforms lifecycle areas highest potential change practice discarding singleuse connector impact prioritize improvements implemented across multiple products cables used surgical ablation procedures safely preparing reuse biosense webster cables designed exclusive materials perform sterile conditions product endoflife circularity addressing digital health device waste janssen launched properly sterilized safely reused times investing coordinated new multiyear collaborative initiative co educating hospital staff sterilization procedures tons cables recognize products create may continue funding eu horizon europe program address discarded annually brazil avoided environmental impacts use working offer issue increasing digital health device waste initiative called reducing waste equipment expenses hospitals endoflife circular solutions selection initiatives include digital health circular economy dice brings together organizations fields manufacturing research refurbishing expanding surgical device recycling expanded hospital remanufacturing recycling social science policy nine surgical device recycling program piloted germany countries across europe aim examine lifecycle product packaging sustainability include eight countries europe program allows digital health devices design end life help extend hospitals recycle specific metal plastic components lifetime andor responsibly manage end ethicon biosense websters singleuse instruments useful life use digital health devices predicted increase digitally capturing communicating environmental impact rapidly collaborative solution timely salvaging materials steel titanium aluminum copper chrome steel well specific plastics reprocessing recycling medical devices reduce endoflife impact medical device parts environment components singleuse products jj medtech reprocessed singleuse devices manufactured recycled hospital johnson johnson company sterilmed also offers recycling program reprocessed products original manufacturers line local laws program also expanding recover ethicons absorbable suture aluminumbased packaging countries germany jj medtech us canada switzerland soundstar catheter shown reusable ecocable connection expanding pharmaceutical device takeback expanded collected reprocessed us safe returns program homeadministered janssen million million immunology products switzerland safe returns allows patients return selfinjectable devices using paper medical devices medical devices envelopes instead plastic containers used feature program removal hazardous material classification due needlesafe authorization thereby eliminating need additionally jj medtechs biosense webster collaboration patients prepare special paperwork handling mainstream sterilmed expanded onsite support collect postal services program expected expand several reprocessable ultrasound catheters diagnostic catheters additional european countries electrophysiology cables maximize reprocessing programs canada us help health systems support environmental sustainability objectives recycling varies country health sustainable packaging zero waste boxes distributed partnering opticians stores transformation engineering parameters upon scaleup humanity report provide nationwide access contact lens recycling consumers reduced manufacturing process mass intensity resulted across diverse portfolio products working multiple providing simple accessible solution storing shipping halving api manufacturing cycle time well lowering opportunities improve sustainability product packaging recycling contact lens waste including lenses along manufacturing costs without significant process yield selection initiatives include original foil covers blister packaging improvements patient access innovative medicine would restrictive terms affordability well annual investing new circular technologies johnson johnson johnson johnson visions acuvue manufacturing capacity aim work suppliers attempting find solutions help divert contact lens recycle scheme recycled million waste landfills develop technologies turn diverted pairs contact lenses blister packs foils u pstream downstream process improvements manufacturing remicade infliximab enabled significant increase batch waste new materials ethicon entered yield thereby improving products environmental profile new agreement eastman purchase eastmans eastar renew collaborations sustainable product packaging remicade manufacturing process enables significant reduction copolyester medical device trays eastman global members several organizations promote sustainable required batches deliver final product thereby lowering specialty materials company produces broad range advanced packaging circularity industry including healthcare quantities raw materials deliver output materials chemicals fibers found items people use every day plastics recycling council advancing plastics recyclability healthcare sustainable healthcare coalition healthcare purchasing eastmans eastar renew copolyester ethicon sectorled group inspires sustainable practices healthcare pharmaceuticals environment pie product packaging sustainability able attribute portion weight tray materials european federation pharmaceutical industries eastman collects recycling tray ethicon helps divert associations efpia advances transition circular play important role supporting initiatives reduce waste landfills advances new technology solutions economy across pharma value chain key pillar activity potential impact pharmaceuticals personal care products eastmans molecular recycling technology know collective environment mature robust program managing pie approach essential tackle todays greatest environmental learn sustainable packaging solutions position found challenges important first step toward advancing consumer health circularity healthcare packaging progress included using recycled packaging medical devices jj medtech green chemistry technology w e continued active participation industryled eco company depuy synthes launched product items pharmacostewardship program released responsible synfix evolution brand postconsumer recycled pcr rd teams continue integrate principles green chemistry manufacturing effluent technical guidance document used paperboard material pcr packaging replaced white engineering develop medicines progress included industry johnson johnson inform control boxes made virgin paperboard new packaging went janssen obtained fda approval inline conditioning process concentrations apis may enter environment extensive testing confirm stands stringent installed janssens ireland facility process already approved manufacturing plants suppliers standards sterility structural integrity ireland health products regulatory authority developed member antimicrobial resistance industry alliance janssen rd team part new manufacturing installation reducing recycling contact lens waste part amria contributed publication amria antibiotic support plant expansion inline conditioning applies unique commitment reduce environmental footprint johnson manufacturing standard minimizing risk developing antibiotic approach preparing supplying releasing solutions real time johnson vision removed plastic pouches outside resistance aquatic ecotoxicity environment resulting manufacturing process without need largescale storage delivery boxes acuvue contact lenses europe change manufacturing human antibiotics capacity traditional manual batch approach making buffers involving placing delivery notes inside orders without external involves dissolving buffer components large tanks filled water w e also joined innovative medicines initiatives prioritization packaging save tons plastic across europe every year cases transferring solution bags risk evaluation medicines environment premier transported point use inline conditioning saves time project consortium brings together public private sector uk johnson johnson visions acuvue contact lens reduces material waste energy use throughout process organizations proactively manage potential environmental recycle scheme launched collected million impact medicines initiative aims design novel information lenses recently expanded increase capacity lenses blister janssen improved efficiency manufacturing process assessment system identifying addressing environmental packs foils recycled year acuvue offers oligonucleotide api api manufacturing process highly risks medicines support new european standard contact lens recycling program uk expansion complex involve linear chemical steps environmental protection achieved agreement terracycle johnson consuming high quantities solvents reagents expanded johnson vision funding zero waste boxes alone process development deep understanding chemical health humanity report accountability innovation manufacturing operator isabelle v demonstrates manual intervention seidenader automatic inspection line syringes inspected photo dries luytensupply chain innovation health humanity report innovation critical engine longterm business success driver positive contribution sustainable development across johnson johnson deliver innovation multiple ways janssen latina italy deployed streamlined continuous pharmaceutical medtech consumer health business manufacturing line fully automated digitally segments combine innovative technologies leading connected similar mirror line located janssen rd johnson johnson lighthouse designations science generate transformational solutions across spectrum plant beerse belgium twin linesconnected sensors march healthcare see section healthcare innovation throughout big data digital analyticsenable quick seamless global operations supply chain deploy transfer products rd manufacturing greatly janssen vision advanced technologies including digital support diverse accelerating time market well improving product healthcare portfolio focusing quality reliability efficiency cork ireland jacksonville process time efficiency bringing products treatments patients enable better designations florida us supply chain innovation consumer health bangkok thailand adopted ai quality health outcomes equally advance sustainability latina italy london uk inspections listerine filling lines replacing manual many technologydriven innovations support environmental inspection process new ai modules filling lines learn efficiencies global supply chain examples include depuy synthes consumer health visual differences bottle quality enabling automatic identification defective bottles speed production embracing advanced technologies early adopters cork ireland helsingborg sweden process reduce waste site ship listerine fourth industrial revolution ir across organization suzhou china bangkok thailand directly packing line halving lead times ir means deploying digital technologies make bigger faster leaps forward productivity efficiency sustainability bridgewater mulund india customers enhanced customer service approach recognized new jersey us consumer health mulund india deployed ir solutions world economic forum wef global lighthouse network demand sensing smart logistics robotics printing identifies leadership ir technology deployment transform improve reliability accelerate new product introductions factories value chains business models global enhance costeffectiveness customers lighthouse designations granted wef johnson johnson improving customer service machine learning privileged lighthouse designationsmore janssens cork site ireland designated twice first incorporating established janssen track trace platform drive proactive company world ir technologies daily manufacturing supply chain operations using ir advance sustainability efforts advance case risk management enhance customer experience using management endtoend business model recognized johnson johnson partners internet things sensors machine learning developed customers manage inventory point consumption effort ensure right orthopaedic implants right patient right time industryleading estimated arrival time capability provides customers minute delivery window unprecedented ir represents new era innovation technology four recent johnson johnson sites receive wef level accuracy predicting informing customers building digital revolution preceded ir lighthouse designations adopting ir technologies follows shipments arrive new capability live marked shift innovation made possible johnson johnson customer connect website game janssen cork ireland received sustainability designation artificial intelligence robotics autonomous changer personalized medicine timesensitive products use adaptive process controls automatically adjust vehicles printing internet things chiller system faultless operation built digital twin chiller cart technologybased cell therapies see section breakthrough digital technologies innovation pharmaceutical rd hospital trauma kits gene therapies loop connects plant energy provider allowing based fusion technologies share monitor single source data dramatically reduce sites carbon footprint gary hartnett vice president partnership external supply janssen supply chain health revolutionizing transportation network using realtime optimizing surgical inventories using realtime data advance natural language processing used deconstruct documents humanity report tools implementation new johnson johnson global case management acm digitally enabled system increase structured data sets automatically populate new transportation control tower covering contracted interregional perioperative efficiencya priority surgery centers documents submission requiring minor manual additions air ocean transport selected road transportation hospitalswas scaled two years operation process increased efficiency resulted concise three business segments revolutionized transport planning acm digitally integrates electronic medical records surgical documentsan additional advantage reduces turnaround time efficiency shipment visibility transit customer confidence schedules patient health information inform proprietary multiple language translations required document shipment status realtime communications aidriven algorithm accurately predict patientspecific control tower supported logistics partner integrated implant surgical instrument needs based patient joint sizing hundreds shipping sites thousands transportation lanes biometrics surgeon preference using acm patient dozens erp systems form single transport planning procedurespecific equipment supplied surgery centers hub offers several benefits including endtoend visibility hospitals enabling reduce overall jj medtech inventory launch products across several supply chain movements standardized procedures shipment minimize operating room setup time achieve efficiencies jurisdictions everything isnt always called booking management nearreal time performance reporting leading higher equipment availability alongside cost savings acm thing order required regulatory spend visibility freight audit capabilities continuous doubled volume supporting surgeons documentation needed create solution improvements freight optimization improved lead times health systems around us improving overall patient care could use gain knowledge determine supply chain innovation improved response times data requested creating smart hot room china jj medtech ethicon suzhou plant china new smart hot room improves production efficiency optimizes production environment joshua samuels reduces safety risks ethicon employees operate hot room director clinical evaluations using intelligent automation ia complete hot degassing global transportation control tower jj medtech important process suture production employees need important step journey become agile enter room stage using radio frequency digital unified transportation team across identification rfid tagging track products end end globe accelerates reach key markets real time enabling touchless accurate supply chain meet reduces total spend helps us monitor chinas growing demand surgical sutures deliveries real time proactively resolve issues impact customers automating new product development launches jj medtech ia used create tailored robotic documentdrafting solution accelerates new product launch timelines previously nico sacco jj medtech teams submitted thousands pages documents worldwide vice president planning customer regulators detailing device data clinical study results management deliver janssen supply chain applying new product authorization many cases different regulatory bodies require different data meant jj medtech technical writers spent weeks reviewing extensive documentation identify collate relevant content regulatory submissions new tool machine learning responsible supply base gri sasb hcmsa health humanity report critically important link value chain johnson johnsons supplier network underpins business continuity enables us manufacture deliver essential products services billion patients consumers customers suppliers globally total supplier spend guided credo values aim maintain collaborative responsible supply base ambitions reflected three supplier relationships encourage broad diversity suppliers health humanity goals supplier spend contracted region work us responsibility standards suppliers supplier sustainability program ssp global supplier diversity inclusion program core frameworks underscore health humanity goals interactions suppliers expect support partnerships good encourage suppliers join us developing sustainable solutions social environmental challenges responsible supply base progress supplier sustainability program suppliers included one three tiers vital role strong supply network evident representing johnson johnsons supply base us johnson johnson saying takes asia pacific europe middle east africa village could written supply latin america north america chainalthough case tens thousands progress global supplier suppliers johnson johnson employees across diversity inclusion globe talking large village supplier spend contracted business segment point clear could achieve goals without chieved exceeded target two consecutive years dedication collaboration responsiveness responsible conduct engaged dayin dayout helping us meet commitments partnerships good patients supply products goods services technologies organization established six total partnerships including three partnerships focused womens empowerment packaging sustainability fair chance employment c odeveloped womens empowerment program kathryn e wengel focused ensuring women equal professional executive vice president chief technical access growth opportunities operations risk officer johnson johnson eployed recyclable ecommerceready pumps johnson johnson packaging portfolio mplemented hiring practices remove common barriers pharmaceutical medtech experienced justiceimpacted communities build equitable workforce consumer health corporate represents spend control overaddressable spend defined products services procurement teams negotiate suppliers meet business goals supplier engagement gri health humanity report supply base extension business important link customers around world large diverse organization johnson johnson setting clear expectations suppliers across aspects interactions us enables best outcomes company suppliers serve supplier diversity equity inclusion suppliers expected foster culture dei within organizations johnson johnson named cdp throughout supply bases supply chain leaderboard sixth consecutive suppliers critical mission changing year result strong participation information security suppliers expected rigorously trajectory health humanity recognize suppliers disclosure cdp programs manage business activities employ appropriate information broadbased impact external partners security practices safeguard data systems maintain communities committed business continuity working suppliers provide highestquality products services also environmental responsibility suppliers expected align expanded requirements covering ghg reductions share commitment diversity equity inclusion invited suppliers participated supplier engagement willingness measure publicly disclose data increased sustainability respecting human rights working cdp supply chain focus energy efficiencies integration biodiversity climate program suppliers embrace imperatives considerations recyclability recycled material use drive even greater benefits society communicated new standards suppliers supported training ongoing engagement shashi mandapaty invited suppliers participated chief procurement officer aim work respectfully collaboratively suppliers cdp supply chain johnson johnson engage johnson johnson supplier sustainability water program program ssp key tool engage selected suppliers requiring conform responsibility standards suppliers help us deliver high standards embodied credo regularly complete assessment ecovadis recognized assessing engaging suppliers social risks continued seek relationships suppliers uphold principles provider business sustainability ratings global supply chains strengthen processes tools assess verify address reflected responsibility standards suppliers also encourage transparency among largest suppliers risks supply base part compliance laws standards outline expectations number important encouraging publicly disclose environmental regulations check conformance human labor topics integral supplierselection process helping performance including ghg emissions water use cdp rights section responsibility standards suppliers us build supply base shares commitment strong ethics human rights supply base work included targeted due quality global citizenship standards periodically diligence existing potential suppliers including use updated align current best practices internal advances updated responsibility standards onsite smeta pillar audits fuller investigations potential suppliers including new sections covering highrisk commodities supply chains also deployed two techenabled risk assessment tools using ai gain upstream supply chain visibility potential highrisk commodities ii embedding thirdparty modern slavery metrics ssp assess potential supplier risks health held first dedicated human rights training session partnerships good executed three new partnerships particular maintain multiple multiyear forest partnerships humanity report part onward sustainability training programlaunched good advancing progress toward health enable protection tropical rainforests critical part sspfor suppliers providing guidance developing humanity goal collaborate suppliers create climate mitigation wildlife conservation longterm community human rights policy commitments see section human rights solutions drive environmental social economic wellbeing focus palm oil working earthworm improvements bringing total six partnerships good foundation bsrs action sustainable derivatives initiative building supplier capabilities part onward date three new initiatives woodfiber products working rainforest alliance johnson johnson procurement sustainability managers build transparency sourcing supply engage collaboration british standards institute introduced fair chance employment partnership kelly services suppliers responsible practices examples forest initiatives designed remove barriers employment contingent new content suppliers countries continue support include initiative world wildlife worker job candidates may previously overlooked sessions designed focus specific practical areas fund restore forests protect hectares program kelly services works johnson johnson development measuring reporting ghg emissions rainforest sumatra indonesia initiative forest evaluate existing policies jobcategory basis craft starting supplier diversity program establishing health conservation fund loreto peru prevent deforestation introduce new policies eliminate unnecessary barriers safety policies employees intention support hectares pristine amazon rainforest develop new contingent assignment postings inclusive suppliers help johnson johnson language achieve goals also help suppliers drive responsible conflict minerals members responsible minerals conduct supply chains resulting greater recyclable pumps partnership supplier aptar enabled initiative line regulatory requirements remain efficiency resilience sustainable practice wide supply johnson johnson consumer health launch recyclable committed taking steps determine use country origin supplier engagement network since launch onward sessions pump aveeno brand european markets potential source tin tungsten tantalum gold global product attendees global supply base expansion internationally million pumps portfolio used annually aveeno innovation potential engaging suppliers innovation johnson johnsons supplier prevent huge volumes plastic entering waste streams enabled innovation program allows us generate innovative solutions engagement supply base using womens empowerment initiative working supplier sodexo partnership focuses womens empowerment innovation technology platform johnson johnsons emea apac aiming promote equal access women procurement organization held second annual supplierenabled growth opportunities workplaces program innovation awards event recognizing top innovations initiatives delivered jointly sodexo johnson johnson programs among award winners includes mentoring coaching jobshadowing women facing manufacturing design improvement working supplier barriers work skilled volunteering opportunities jj medtech able improve performance ethicons flagship stapler creating new manufacturing process deliver enhanced design responsible sourcing enhancing precision marketing capabilities otc team throughout business source commodities raw china worked supplier generate unique data insights materials require heightened procurement focus consumer behavior data help engage consumers due critical environmental biodiversity concerns elevated meet needs effectively human rights risks supply chain work understand improving product sustainability johnson johnson consumer potential risks impacts procurement activities health brazil partnered several suppliers develop areas define appropriate standards controls responsible sanitary napkin sempre livre brand uses sourcing commodities raw materials concern less plastic includes pouch component made recyclable paper supplier diversity health humanity report global supplier diversity inclusion program provides platform proactive outreach diverse small suppliers collaboration partners advancing supplier diversity guidance suppliers engage johnson johnson third decade program continue realize value inclusive supply base brings business people communities expanded global footprint driving social economic impact markets including us key measure progress advance supplier diversity th consecutive year johnson johnson broadening diverse supplier capabilities compete global global impact spend representing addressable spend small maintained membership billion dollar roundtable market johnson johnson sponsored national minority diverse suppliers globally small businesses us global group companies advance best practices supplier supplier development councils nmsdc certificate excellence impact spend also one health humanity goals diversity spend least billion annually program designed broaden capabilities minorityowned exceeded goal concluded confirmed diverseowned suppliers businesses compete global environment exceeded ninemonth program launched select nmsdccertified women minority business enterprises global impact spend numbers benefited coaching relationships corporate leaders supplier diversity mentors well instructional seminars delivered rutgers business school subject matter experts johnson johnson billion million really proud partner johnson multiple industry partners johnson recognizing total global impact small businesses highest platinum level annual global spend increase us compared champions supplier diversity inclusion awards johnson johnson amongst best best globally regards inclusive spend partnership th year continues grow johnson johnsons substantial support diverse seek jointly drive action break suppliers important indicator values million billion barriers prevent women business owners sponsor cohort nmsdc center excellence tier diverse tier diverse spend accessing new market opportunities certificate program johnson johnson making suppliers international million difference investing growth minority markets tier diverse spend business enterprises women business enterprises impacts communities economy elizabeth vazquez proud partner company long history ceo cofounder weconnect international community engagement corporate citizenship increase increase spend us spend us tier global supplier diversity inclusion team put tier womenowned black hispanic additional focus partnering external advocacy partners businesses compared owned businesses expand capability capacity diverse businesses following jeffrey robinson phd compared highlights academic director center urban entrepreneurship economic development rutgers business school health expanded mentoring manufacturing logistics supporting development advocacy bodies around world humanity report johnson johnson also became founding sponsor support development advocacy bodies help us diverse manufacturing supply chain alliance dmsca discover certify diverse suppliers critical enablers foundation sponsorship enabled organization program also advance adoption supplier diversity expand training incorporate digitalization modules inclusion practices companies drive even greater impact assessments build capabilities suppliers developing minorityowned supplier advocacy europe corporate partner dmsca development program johnson johnson became founding member european diverse manufacturers logistics suppliers since supplier diversity project esdp initiative led minority building capacity women colorowned businesses supplier development uk support ethnic minority migrant johnson johnson sponsored two cohorts totaling close owned businesses esdp aims enable businesses certify women womens business enterprise council metro ny access opportunities corporate supply chains initiative greater dmv district columbia maryland virginia amplify supported research sponsored johnson johnson program amplify program uniquely designed engage documents increasingly diverse europe needs equality support women color maximizing opportunities scale procurement ethnic minority entrepreneurs frequently businesses suffer discrimination basis race ethnicity also sponsored buy social europe initiative support strategy procure social enterprises well supplier diversity new relationship britain support procurement businesses owned members lgbtq community entered program hoping build foundational understanding running business solopreneur europe increasingly diverse minority businesses help local received much able expand economies thrive create jobs wealth innovate export network grow business revenue mention paying taxes minority entrepreneurs often economic social disadvantage engaging customers suppliers extend endtoend bianca ellis impact expanded impact across value chain ceo projacct workflow reporting engagements customers us introduced customer engagement program partnership internal groups connecting major customers across healthcare systems share best practices support efforts address social determinants health addition grew supplier tier spend reporting engagements johnson johnson prime suppliers legrain p fitzgerald equip europe increasingly diverse europe needs equality procurement ethnic minority entrepreneurs msduk httpswww msdukorgukstaticequipeuropereportpdf accessed february corporate governance gri health humanity report board directors oversees company accordance credo values enabling us put patients serve first create value society maintaining thriving business governance structure policies processes designed board directors responsible overseeing execution serve needs business shareholders risk management duties assessing johnson johnsons board stakeholders promote culture accountability across approach risk management board reviews discusses directors enterprise details corporate governance principles strategic operational financial reporting risks well april independent approach enterprise risk management erm framework nonfinancial esg risks including compliance environmental governance structures board charters organizational documents social eg human capital management cybersecurity risks sec filings please see position corporate leveraging erm framework information see section governance corporate governance section esg governance johnson johnsons website women ethnicallyracially diverse changes governance structure included announced appointment joaquin duato th chairman johnson johnson board directors addition role chief executive officer effective january corporate governance decades johnson johnson also announced alex gorsky would stepping role executive chairman shown robust corporate practices disciplined leadership valuesdriven culture winning annual review board evaluates mix underpinning longterm value creation mitigates risk concluded regulatory compliance shareholders patients customers partners sustainability committee best positioned oversee employees around world move next certain esg matters alongside complementary compliance era companys history separation matters turn science technology committee consumer health business reliable legacy oversees medical safety devotes even greater attention right things right way positions us well companys product pipeline evaluation innovative continue deliver purpose profoundly technologies restructuring helps ensure governance changing future health humanity structure reflects important issues opportunities facing johnson johnson collaboration compensation benefits liz forminard committee audit committee board formalized executive vice president general counsel ensure incentives compensation appropriately johnson johnson aligned financial performance credo tax responsibility gri health humanity report first published credo stipulates paying taxes responsibility communities live work johnson johnson committed paying fair share taxes tax footprint evolves time reflects healthcare total taxes collected additionally johnson johnson taxes taxes tax contribution billions activities investments including research development borne collected collected billion related commerce company manufacturing changed wavered generates collections form payroll social commitment good corporate citizenship demonstrate corporate income tax insurance taxes approximately employees across sustainable values behaviors relating tax world sales use taxes valueadded taxes taxes governance compliance planning risk management relationship payroll social insurance taxes collected behalf governments employees customers governmental authorities transparency business partners taxes collected important part fully described johnson johnson tax policy tax policy measure contribution made johnson johnson salesuse taxes updated provide greater transparency regarding job creation business activities many countries tax governance compliance tax planning incentives operate total johnson johnson contributed approximately billion taxes fees governments economies around total tax contribution world total tax contribution made two components total taxes borne company total taxes collected tax responsibility see pwcs report independent accountants managements assertion taxes borne direct cost company whereas taxes collected collected customers employees behalf total taxes borne johnson johnson bore billion governments ultimately remitted taxes around world taxes include corporate income taxes companys share payroll social insurance taxes intent provide comprehensive view total taxes paid companys share sales taxes sales taxes include sales around world corporate income tax represents payments use nonrecoverable valueadded tax taxes primarily markets operate amount reported comprised customs duties local taxes income taxes paid annual report taxes special fees related pharmaceutical industry shown aggregate companys data major markets represent vast majority revenues aspire include markets future years tax information contained section intended provide reader overview taxes contributed johnson johnson income taxes read conjunction companys tax information filed us securities exchange commission sec including recently filed quarterly reports form q annual report tax information supplemental substitute information reported companys sec filings ethics compliance gri jj jj health humanity report values guide decisionmaking spelled credo guides us act ethically within laws govern businesses everywhere times supported corporate heroes interactive games strengthened culture accountability compliance week comprehensive policies procedures training programs everyone johnson johnson knows value right thing embed credo values throughout company ensure statistically reliable third year row indicates critical employees contingent workers know responsibilities thinking required answer enterprise hcc annual training act accordance applicable laws regulations industry assessment questions correctly passing assessment codes well companys internal standards expectations simply result guesswork ethical compliant conduct use biennial credo survey assess values come life across enterprise supplemented alternate years voice survey monitors employee sentiment related many topics including employees completed sales marketing ethical business conduct hcc training employees completed hcc training building credo values code business conduct cbc compliancerelated investigations responsible health care compliance hcc policies list comprehensive marketing indicators ethical standards decisions actions every market operate mandatory cbc training conducted every two years ethics compliance number compliancerelated johnson johnson hcc training conducted year new employees allegations investigated enterprise hcc annual training assigned required complete cbc hcc relevant measuring effectiveness percentage compliancerelated allegations required training methodology awarded investigated category prestigious brandon hall gold aspects ethics compliance advanced included award best advance healthcare compliance compliance training along updating compliance framework revised hcc silver award best advance framework provide updated practical guidance compliance financial learning measurement hcc guidelines based ten hallmarks effective compliance program us department justice highlight specific focus role business leaders setting strong message top continuing drive culture reinforcing culture accountability throughout number warning letters accountability throughout organization communication training efforts focused strengthening untitled letters issued opdp culture accountability several initiatives including aplb us annual compliance training enterprise hcc annual training communications leadership ethical leadership workshops using encompasses foundations compliance using rolebased situational cases training assist preventing detecting see pwcs report independent accountants managements assertion pwcs report independent accountants previous health humanity reports topics scenarios drive training effectiveness design correcting noncompliant behavior well compliance week opdp office prescription drug promotion aplb advertising promotional training objective ensuring learning achieved initiative containing interactive games contests appealing labeling branch fda center biologics evaluation research incorporating interactive challenges final assessment communication materials support culturebuilding initiatives evaluate learning transfer using proprietary methodology tagline people follow people evaluation showed learning transfer proved health johnson johnson named fifth consecutive data transparency conducted workshops bioethics humanity report inquiries complaints year cpazicklin index corporate political disclosure principles launched bioethicsrelated mentoring program recorded accountability trendsetter status employees jjbc members undertook professional ethics training credo integrity line category fellowships auschwitz study professional ethics independent assessment external research proposals faspe addition ocmo sponsored harvard multiregional human resourcesrelated since working yale university open clinical trials bioethics collaborative bioethics colloquium data access yoda project enable consistent approach convened nyu new york academy sciences business integrityrelated independent assessment external research proposals cofounded cochairs bioethics community within dia requesting use clinical trial data generated johnson global organization advancing life sciences networks privacy information johnson companies research proposals security general security reviewed articles published using data shared promoting animal welfare research involving animals led ehs etc yoda project enabling researchers create new insights major medical advances continue important general information advance science medicine lead improvements public part discoveries viable nonanimal alternatives questions health johnson johnson continues demonstrate support developed accepted year year utilize nonanimal expanding reach clinical trial data joined alternatives whenever possible work regulatory bodies financialrelated vivli antimicrobial resistance surveillance data register gain acceptance appropriate nonanimal alternatives johnson see section antimicrobial resistance johnson committed rs principles ethical treatment human rightsrelated animals involved biomedical researchreplacing reducing reported refining use whenever possible global animal product quality welfare officer responsible ensuring adherence collaborate nyu school medicine support patient safetyrelated monitoring animal welfare standards supported many rd janssen decision making investigational medicine professionals certified different aspects veterinary see pwcs report independent accountants managements assertion requests also known compassionate use pre ethics compliance pwcs report independent accountants previous health humanity reports medicine animal welfare johnson johnson triage committee case investigators ability approval access compassionate use advisory change issue type cases upon receipt credo integrity line committee compac comprising ethicists physicians occurred cases part commitment ethical humane treatment patient representatives independently selected laboratory animals care hold annual rs awards credo integrity line provides channel employees nyu provides recommendations janssen pre program recognize teams outstanding achievements contractors customers thirdparty agencies partners approval access plans individual requests received replacing reducing refining use animals fields report potential violations cbc company policies janssen compac affirms johnson johnsons biomedical research education training winning applicable laws regulations countries operation commitment ensuring transparent ethical innovation advanced use donated human cadavers avoid increase human resources inquiries complaints objective approach reviewing compassionate use animal use hcp training medical devices credo integrity line result period significant requests since janssen provided access organizational change almost patients globally preapproval transparent animal welfare practice engage access paa program advanced widely inform share work toward improving public policy continuous improvement anticorruption controls aim transparency providing first time list animal testing example janssens beerse site achieve continuous improvement vigilance governance controls potential treatment options available per country belgium welcomed animal welfare committee processes prevent corruption part business following territory janssencom flemish parliament number stakeholders completion transparency international uk tiuk corporate life sciences ecosystem visitors toured animal facilities anticorruption benchmark comprehensive selfassessment engaged discussions around janssens animal welfare policy tool measures compares performance anticorruption alternatives could reduce animal testing programs across companies continued engage quarterly keeping bioethics agenda office chief medical meetings tiuk companies participating officer ocmo sponsors johnson johnson bioethics facilities animals veterinary oversight benchmark share insights discuss best practices committee jjbc advises global teams ethical issues sites animals accredited aaalac international alignment ethical code conduct rd jjbc continued advise many johnson johnson teams ethical l earn anticorruption disclosures nbim questions related research access investigational medicines esg disclosure index human rights gri health humanity report guided credo values respect promote human rights across operations business relationships communities operate risk modern slavery supply chains critical companies consider approach focus areas line ungps focus efforts areas regulatory compliance sustainability committee rcsc respecting human rights working potential actual risk adverse human rights impacts board directors provides oversight managements approach collaboration johnson johnson linked business significant established respecting human rights rcsc received update due diligence approach identify respond fourpillar framework guide human rights priority focus areas outlining continued evolution companys approach potential modern slavery risks supply base related action plans human rights external regulatory stakeholder developments improving human rights due diligence continually evolve rosey hurst strengthen broadbased human rights due diligence process founder commercial director impactt worked erm independent sustainability fair working conditions consultancy develop risk identification tool better identify maintaining living wage line commitment fair ensuring fair working conditions johnson johnson geographies sites potentially higher risk adverse human working conditions continued implement annual employees engaging suppliers rights impacts within johnson johnsons operations living wage assessment collaboration business social across supply base facilities tool deployed prioritize targeted responsibility bsr ensure employees countries due diligence reviews supply base continued assess operate receive pay market competitive sufficient access healthcare human rights risks supply chain use tools attain sustainable standard living previous years advancing sustainable equitable access medicines ecovadis selfassessments suppliers ssp supplier made small number wage adjustments countries ensure medical solutions save improve lives cure patients prevent disease need audits also updated responsibility standards suppliers living wage standards met rss strengthened guidance suppliers human rights safe effective products capability building johnson johnson employees certain establish policies management systems identify address categories contingent workers assigned required providing patients consumers healthcare providers human rights impacts provided training suppliers products effective safe possible complete code business conduct training available rss updates see section supplier engagement every stage product development manufacturing languages every two years training includes guidance related supply chain commercialization prohibit use forced bonded labor manufacture human rights furthermore foundational human rights sustainable environment product component product outlined learning education course available employees globally antihuman trafficking policy employment young persons end employees contingent improving environmental footprint operations products value chain also integrating policy established antimodern slavery work stream workers key human rights program completed module human rights considerations environmental advance due diligence efforts area worked johnson johnson procurement employees policies programs impactta consulting firm specializing ethical trade human completed mandatory human rights training rightsto support us developing suite modern slavery due diligence materials training materials supplier assessment collaborating advance human rights continue questionnaire investigation guidelines also integrated verisk participate various external platforms share insights maplecroft risk indicators modern slavery supplier risk good practices across industry including shifts business governance johnson johnsons enterprise human rights management system identify potentially higherrisk suppliers learning program bsrs human rights working group governance council ehrgc established comprised work inform due diligence pharmaceutical supply chain initiative human rights labor crossfunctional group senior leaders representing key functions working group oversees companys approach human rights including setting priority focus areas implementing action plans annual basis ehrgc supported direction guidance learn approach frameworks respecting human rights position human rights responsibility standards chief sustainability officer worldwide vice suppliers related esg policies positions grievance mechanism see section ethics compliance president legal strategy operations risk management product quality gri jj sasb hcbpa hcbpa hcmsa hcmsa health humanity report johnson johnson reaches patients consumers across world medicines medical technologies consumer health products safety using products critical priority johnson johnson insist quality safety every stage product development manufacturing supply chain commercialization quality management product quality indicators commitment quality safety reliability basis bold ambition leading edge everything quality policies quality standards cover number fda warning industry quality compliance organization lifecycle products rd patient consumer letters issued enabled fully connected digital ecosystem experience provide framework common foundation product recall rate business segment highly competent people skilled managing quality expectations help ensure reliable supply highquality addressing aspects quality spectrum products across business segments markets serve pharmaceutical future healthcare increasingly rely upon digital quality compliance organization led several solutions continually evolving improvements quality compliance practices including systems teams embrace digital technology medtech support consistent quality compliance positive transforming quality processes digital solutions many tasks experiences products patients consumers quality compliance transactional date much employee consumer health self customers care otc time spent manual processes automating manual tasks applying intelligent analytical tools allows employees tackle see pwcs report independent accountants managements assertion highervalue tasks datadriven proactive decision making pwcs report independent accountants previous health humanity reports product quality product recall rate defined number lots removed market per total carol montandon assessing larger data sets advance preventive quality globally manufactured based field action removals determined global vice president chief quality officer management create valuable product patient insights internally quality review board aligned johnson johnson enterprise compliance reasonable probability product may cause johnson johnson continued progress digital transformation quality temporary medically reversible adverse health consequences certain cases cause serious adverse health consequences pharmaceutical medtech process management systems several ways including recall rates consider products business segment consumer health product quality recall rate inclusive consumer health products selfcare installed new data portal increase access quality overthecounter otc business segment compliance data sources improve agility quality reinforcing commitment quality employees insights analytical data tools dashboards across business required take interactive elearning quality segments management framework course course informs achieved considerable efficiencies automation employees quality management systems manual processes enabled ia applications combination provides examples roles responsibilities help data insights natural language processing solutions maintain quality across johnson johnson everyone every role play part developed new digital tools assist simplifying improving quality literature document report reviews capturing product insights complaints improving product release cycle time transparency planning managing sample process flows health refreshing quality compliance competency model introducing new quality model better customer experience employees around johnson johnson engaged quality humanity report model prioritizes upskilling people prepare customer experience engineering cxe new proactive month multiple inperson virtual events across proactive capable quality management digitally enabled quality model capability supports involvement communication channels future encourages employees actively participate quality compliance organization technical improvements individual career journey promotes culture continuous products services cxe focuses entirely experiences innovative learning customers led internal quality experts make practical contribution solving product challenges several projects pipeline cxe promises help transform experience patients physicians surgeons enhancing product delivery quality tangible customer outcomes johnson johnsons quality compliance example quality compliance cxe team engaged competency model two core categories jj medtech depuy synthes team solve challenge nine core competencies four proficiency levels relating purevue visualization system used per competency arthroscopic procedures systems camera lens began fog procedures temporarily clouding visualization operating area cxe team visited surgeons witness issue real time operating rooms contributed new design solution significantly improved temporary visualization issue employees janssen india engaged quality month left right mahadev desai shivani ganesh nalavade saurabh dole reimagining quality month theme quality month digitally enabled endtoend quality supported weekly topics encouraged global sites focus critical quality compliance initiatives product quality digital transformation using digital enable employees customers patients strategy leading way endtoend patient consumer customer experiences enabled fully integrated digital ecosystem innovation innovating use digital tools enhance customer success learning driving learning engagement beyond quality month build digitally enabled workforce future quality compliance capability framework including competency model developed wide collaboration across johnson johnson aligned enterprise approach judith boateng katherine buitrago participate learning development provides advanced platform quality month raritan new jersey site ensure employees developing within critical capabilities needed deliver quality compliance strategic goals including strengthening quality compliance talent pipeline medical safety gri health humanity report johnson johnson recognize fundamental responsibility provide patients consumers surgeons regulators studies important provide information safety effectiveness devices healthcare providers products effective safe possible take evidence provide lifechanging healthcare thousands patients sciencebased ethics valuesdriven approach medical safety putting patient different parts world consumer wellbeing first foremost decision making actions janssen participated along industry experts regulators international council harmonisation technical requirements pharmaceuticals human use office chief medical officer ocmo global ich expert working group development ich e functionally independent group medical scientific guideline aims support largescale efficacy safety professionals working across johnson johnson guide clinical trials excellence product safety development across three johnson johnson leading ocmo provides business segments apply expertise safety science entire team opportunity make advancing safety children safety children epidemiology bioethics inform evidence sciencebased farreaching lasting contribution improving always priority johnson johnson rd across product decisions put people first ocmo also chairs patients lives delivering advanced otc medicines achievements include pharmaceutical development committee reviews product methods assure product safety company development plans ensure products address unmet across industry treatment children suffering active psoriatic arthritis needs benefit people ultimately use psa ocmos child health innovation leadership department child supported janssens clinical development team healthcare women goal reflects growing design execution pediatric safety study evaluate william n hait md phd importance rwd improving health outcomes safety new treatment option pediatric patients active executive vice president chief external innovation medical officer johnson johnson psa generated data label supported much needed treatment option enable children suffering psa health humanity goals live fuller life ocmo collaboration many internal external groups medical safety advanced multiple initiatives improve medical safety including spearheading medication safety education health education programs help families protect small children innovative rwd methods generate reliable realworld evidence accidental unsupervised ingestion medicines frequent patient health outcomes across numerous initiatives occurrence often requires emergency treatment spanning pharmaceutical products vaccines medical devices ocmo collaborated young minds inspired develop consumer health products highlights work include progress healthcare women educational resources teach youth otc medicine safety achieved publication nine original publications insights improving access critical medical devices using rwd worked nonprofit safe kids worldwide implement based realworld data points representing conducted rwd studies inform clinical regulatory safety medication safety program tools tips parents million women research focus two main areas decision making two key areas evaluating safety safe storage dosing medicine continued aternal health racial equity tfnadvanced proximal femoral nailing system compared advance safe pill storage innovation collaboration sex biologic variable women traditionally nail implants treat hip fractures evaluating cdc protect initiative quickfire challenge awardee underrepresented medical research potential risk cancer reproductive issues associated gatekeeper innovation inc winning quickfire challenge primary contributing publications include following studies cobaltcontaining devices work areas generated concept reinvented traditional pill minder improved new jersey maternal mortality dashboard interactive social extensive evidence comparative safety tfnadvanced safety functionality patient adherence anticipated determinantsofhealth tool million data points representing cobaltcontaining products confirmed safe use commercialization female residents sex differences sequelae covid patients supported publication six papers infection long covid syndrome review peerreviewed journals drive transparency among patients female participants health promoting maternal health ocmo supported advancement improving maternal health outcomes black women talc safety continue address allegations johnsons humanity report maternal health maternal health equity us several activities included initiating effort design baby powder cause adverse health effects sympathize continued guidance clinical teams conducting evidence care model reimagines role front office staff deeply patients families appreciate generation activities include women well pregnant patient connectors advocates critical members care seeking answers however science facts show lactating women collective action close black maternal team initiating effort elevate representation black people illnesses caused use talcumbased health equity gap work accelerating sex medical illustrations continuing advance multiple products information please see factsabouttalccom disaggregated data uncovering insights improve care pilot projects investigate creation digital tools help talc transition johnson johnson consumer health outcomes women offering evidence pregnant advance maternal healthcare services black women made commercial decision transition cornstarch people providers make informed decisions birthing people based baby powder portfolio part larger portfolio safe use johnson johnson products recent examples include enhancing patient voice clinical studies coleading assessment result transition talcbased johnsons accelerating womencentric science shifting innovative medicines initiative prefer project fiveyear baby powder discontinued globally sexbiased sexinclusive science data provide project establish recommendations industry regulatory treatment innovation specifically tailored women authorities health technology assessment bodies ocmo collaborated different groups within johnson use patient preferences benefits risks medicinal johnson provide sexdifferentiated analyses immunologic products decision making johnson johnson serves neurologic conditions understand experiences prefer steering committee closely supported men women altering approach two achievements treatment might enhance health sexes healthcare women health humanity goal prefer released detailed framework recommendations industry regulators health technology assessment bodies delivered nine publications provide sexdifferentiated assessment use patient preferences medical product analyses long covid psoriasis conditions decision making advancing pregnancy lactation science johnson johnson pregnancy lactation advisory group prefer framework received formal qualification ema european network health technology jjpal composed experts across functions support assessment eunethta planning evidencegeneration activities pregnant medical safety lactating people jjpal progressed several areas ema qualification prefer framework significant including nine internal consultations product teams enable explicit pathway stakeholders help improve designing interpreting evidence related engage ema conducting patientfocused structured safe use medication pregnancy lactation benefitrisk assessments also help grow acceptability delivering searchable inventory global rwd sources studies part clinical regulatory decisions around studying medication use pregnancy lactation co world chairing national academy science engineering medicine workshop facilitate inclusion pregnant coauthored new report council lactating people clinical research initiating survey international organizations medical sciences cioms pregnant postpartum lactating persons us better recommendations involve patients throughout lifecycle understand opportunities increased inclusion pregnant medicines lactating people clinical trials counterfeiting illicit trade gri jj sasb hcbpa sasb hcmsa health humanity report johnson johnson trade counterfeit products enormously concerning counterfeit healthcare products place peoplethe people aim helpat risk adverse events serious health problems potentially death fake medical products undermine confidence product quality safety reliability johnson johnson center everything constantly strive adopt new ways monitoring detecting conducted training sessions led ongoing continue deploy holistic brand protection illicit trade enhanced product security analytics related seizures illicit trade shipments various regions programs enhance value chain integrity disrupt advanced technologies critical addressing growing illicit supply chain partner internally across functions continued reinforce programs engage sophistication illicit trade especially online marketplaces also engage widely array national international widely across markets including regulatory bodies online monitoring includes global marketplaces trade groups industry alliances organizations law enforcement protect patients combating fake products illicit trade dark web locations social media sites agencies educational coalitions groups share example throughout first half johnson johnson unique domains investigate bad actors seek determination eliminate counterfeiting globally actively involved investigation counterfeit hiv stop flow illicit trade sharing relevant information law medication ring filed suit number distributors enforcement assist tracking prosecuting pharmacies involved scheme june endangering patients illicit trading activities us department justice doj announced arrest fake medicines kill almost subsaharan africans year indictments two individuals allegedly distributing million adulterated hiv drugs unsuspecting patients across us continue engage doj law enforcement ongoing investigations guided credo aim safeguard patients jj medtechs ethicon created compelling educational brand reputation risks posed illicit campaign targeting healthcare facilities raise awareness trade includes product counterfeiting tampering risks counterfeit medical devices patients prevent counterfeiting illicit trade illegal diversion protecting patients consumers introduction supply chain informational materials counterfeit versions products essential distributed promoted ethicons sales force using promoting worldwide access beneficial healthcare various channels example ethicon presented information genuine johnson johnson products illegal gray market conduit counterfeit products attendees american society healthcare risk management ashrm annual conference taira bell first time topic ever presented ashrm vice president global brand protection influential audience healthcare risk professionals hope johnson johnson lead engagement collaboration combat illicit trade continue record trademarks customs border protection agencies help eliminate illicit versions products crossing borders around world conduct specialized training various national international law enforcement agencies across globe united nations news fake medicines kill almost subsaharan africans year unodc report httpsnewsunorgenstory accessed february information security data privacy gri health humanity report believe maintaining proactive information security strategy protect information assets laws multiple privacy data security legal regulations china also supported data science digital initiatives deliberate inadvertent threats safeguard business including defining standards anonymization pseudonymization deidentification increase ability compliantly leverage data insights promote digital health solutions sectors improved robustness information security made progress various key privacy processes designed privacy programs following ways consistently support rights consumers patients management personal data delivered privacy support enhancing protection cyber risk critical ensuring availability critical systems preventing pharmaceutical research improved cyber posture ensure successful completion major deals unintended unauthorized access business multiple pharmaceutical rd sites deploying additional cyber personal information foundational business reinforcing cybersecurity privacy frameworks ensure capabilities protect systems data actions continuity people rely johnson johnson continuous evaluation enhancement johnson johnson improved protection company ip resilience day cybersecurity program periodically undertake program rd environments meeting needs healthcare maturity assessments pursue security certifications way partners patients reduced potential rd example engaged independent third party negatively affected cyber event increased gary harbison conduct maturity assessment nist cybersecurity protection company ip new capabilities included technology chief information security officer ciso framework providing current view program maturity implementations research laboratory environments johnson johnson areas continued improvement also obtained iso provide increased visibility security posture rd systems certification environment supporting johnson detection potential cyber threats johnson cart immunotherapy offering emea extending similarly johnson johnson committed data privacy expanding cyber capabilities investments new number certifications hold range company products ensuring protecting personal information integral core capabilities strategic partnerships improved security parallel monitor introduction new standards way operating addition code business conduct company products data systems initiatives included iso covering privacy design released early compliance laws apply operating companies strategic investment technology industryleading evaluate requirements technical controls needed handling personal information maintain robust data privacy security provider enhance security medical device certification process controls protect personal information employees product suite deployment new capabilities supporting customers partners entrust information us enhancing cyber awareness offered continued adoption zero trust principles increased information security data privacy employees around globe various opportunities improve cyber protection company customers cyber awareness learn smart cyber practices deployment advanced aisupported tools better detect innovative ways one example cyberescape online escape block security threats rooms attracted hundreds employees worked teams complex patchwork compliance obligations protecting personal information continued commitment solve series basic cyber challenges puzzles different active regulatory enforcement many international protecting personal information consumers clinical escape room scenarios raising cybersecurity knowledge markets imposes greater demands data protection research participants employees expanding efforts additionally alongside ongoing information security privacy cyber professionals design right type governance ensure compliance growing legal regulatory data training employees expanded johnson models solutions ensure johnson johnson protection requirements broaden protection individual johnson phishsmarts phishing simulation program program compliantly pursue datarelated initiatives across data subject rights time continued participate provides quarterly simulated phishing emails followup help globe industry associations external forums help shape new employees better detect real phishing attempts defend regulations review crossborder data flows data phishing email threats pose potential risk organization localization healthcare initiatives privacy winston khoo cybersecurity space focus areas included establishing chief privacy officer johnson johnson compliance programs new expanded us state privacy health humanity report reporting hub reporting hub contains following information following downloads supplement health humanity report g lobal reporting initiative gri ustainability accounting standards board sasb ask force climaterelated financial disclosures tcfd n orges bank investment management nbim u n global compact ungc see annual communication progress three generations women stem share knowledge experiences inspire girls pursue careers science technology reduce existing barriers increase number female role models industries esg performance data health humanity report financial results financial results millions access medicine total sales number products list prequalified medicinal products part net earnings prequalification medicines programme market price per share yearend close number products list rd investment prequalified vaccines part sales business segment prequalification vaccine programme pharmaceutical medtech darunavir darunavir darunavir ethanolate tablet ethanolate tablet ethanolate tablet consumer health filmcoated mg filmcoated mg filmcoated mg darunavir darunavir darunavir number consecutive years dividend increases ethanolate tablet ethanolate tablet ethanolate tablet esg performance data filmcoated mg filmcoated mg filmcoated mg approximately billion fiscal certain international otc products primarily china financial results reclassified pharmaceutical segment consumer health segment based operational changes list products list darunavir darunavir darunavir global health equity includes dividend declared april prequalified medicinal products part fe lh n co ol aa tt ee ab l met g fe ilt mha cn oo ala tt ee b mlet g fe ilt mha cn oo ala tt ee b mlet g prequalification medicines programme etravirine tablet etravirine tablet etravirine tablet filmcoated mg filmcoated mg filmcoated mg etravirine tablet etravirine tablet etravirine tablet mg mg mg mebendazole mebendazole mebendazole tablets tablets chewable tablets chewable global health equity chewable mg mg mg vermox donations mvabea mvabea number vermox mebendazole doses donated mvabnfilo mvabnfilo list products list recombinant recombinant annual total millions prequalified vaccines part zabdeno zabdeno cumulative doses donated since start initiative prequalification vaccine programme adzebovgp adzebovgp private donations billions recombinant recombinant ebola vaccine ebola vaccine number countries vermox mebendazole doses donated change average net price across us product portfolio vs prior year access tuberculosis treatment annual number patients receiving access bedaquiline molecule branded generic health giving millions humanity report total products cash contributed products contributed cash contributed disaster relief millions total allocated support immediate mid longterm response well readiness natural disasters around world worth johnson johnson product provided communities impacted natural disasters around world global community impact number patients reached johnson johnson impact ventures jjiv portfolio companies funds since reported date investment global health equity number hcps supported jjiv portfolio companies since reported reported date investment metric assured erm cvs see health humanity goals assurance see pwcs report independent accountants management 's assertion pwc 's report independent accountants previous health humanity reports average people infected per one nontreated drugresistant tuberculosis drtb patient based tuberculosis fact sheet cure rate patients treated bedaquiline containing regimens based lancet respiratory medicine volume september pp upon review data reconciliation processes change needed correct number courses sirturo bedaquiline shipped resulted reduction cumulative number reflects update represents yearoveryear change average net price list price less rebates discounts fees product donations include confirmed johnson johnsons internal tracking system distributed within calendar year number always reflect donations regional johnson johnson operating companies local partners patients reached defined additional individual patients customers users healthcare products services provided companies funds jjivs investment portfolio employees health global employees humanity report total number employees women men declined answer region asia pacific europe middle east africa latin america north america gender representation declined declined declined women men women men women men answer answer answer employement type employees fulltime employees parttime employees fixedterm employees region asia pacific europe middle east africa latin america north america job category vice presidents directors managers professionals management executive positions women management positions women executive positions health diversity board composition ethnicracial diversity us job category humanity report women vice presidents ethnicracial diversity white asian blackafrican american global age diversity hispaniclatino declined answer directors managers declined answer white asian age diversity job category blackafrican american vice presidents hispaniclatino declined answer professionals employees directors managers white asian blackafrican american hispaniclatino professionals declined answer ethnicracial diversity us white asian blackafrican american hispaniclatino declined answer health new employee hires yearend performance reviews completed humanity report job category total number new hires vice presidents region directors managers asia pacific professionals europe middle east africa latin america overall employees north america gender representation women global employee activity men number global activity challenge participants reported declined answer number global activity challenge countries age reported number employees completed energy performance courses reported training development employees number leaders trained enterprise leader development employee retention turnover program cumulative bn ua sg ine ers sn ed g mab eo nv e li nm eo sved across functions country n thu em tub ie tir nf ru ei ms ba un rd ep mue er nt p r roic go r ae mmployees participated overall voluntary turnover voluntary turnover high performers spend employee learning development millions leadership training executive coaching parental leave compliance professional skills gender composition us employees took parental leave tuition external certifications women operations administration elearning men total gender composition us employees returned work parental leave ended women men health average employee training hours employee resource groups ergs humanity report overall average hours enterprise wide training per employee number employees engaged ergs average training hours enterprise wide training per employee gender number us erg chapters women number nonus erg chapters men number wesustain teams reported declined answer number countries wesustain teams reported average hours enterprisewide training per employee job category number actions taken via healthyplanet platform reported vice presidents number employees completing sustainability training reported directors managers professionals credo survey results number languages credo survey made available number countries credo survey administered response rate among active employees employees increase participation compared among eligible employees favorability rate increase favorability compared liketolike questions percentage agreed statement ensures first responsibility patients doctors nurses mothers fathers others use products services provides inclusive work environment employee considered individual acts responsibly communities live work world community well health see pwcs report independent accountants management 's assertion pwc 's report independent accountants employee safety previous health humanity reports humanity report employee defined individual working full time part time excluding fixedterm employees interns coop employees employee safety global employee data may include full population recently acquired companies individuals longterm disability excluded contingent workers contractors subcontractors also excluded abiomed headcount excluded global lost workday case rate employee data well employee deirelated disclosures fixedterm employees employee contract limited period ends specific time period expires lost workday workrelated injury case rate reported reported specific task event attached time estimate completed excluded employee deirelated disclosures fixedterm contracts make less total employees plus individuals fixedterm contracts lost workday workrelated illness case rate reported reported values rounded nearest tenth due rounding numbers presented add precisely totals provided percentages may precisely reflect absolute figures total recordable injury rate professional positions defined pay grades management positions defined pay grades executives defined employees reporting directly ceo recordable injury rate reported reported figures april figures december figures december october new categories added allow employees actively decline selfidentification remain unidentified recordable illness rate reported reported value declined answer rounded zero excluded reported table gender ethnicracial diversity reported accordance gender ethnicity race selfreported employee serious injury illness case rate recorded human resources information system hris december defined employees selfreported american indian alaskan native native hawaiian pacific islander two races serioussevere workrelated injury case rate reported reported career progression movement includes upward promotion lateral transfer excludes employees rd organizations category includes employees dont merit plan part compensation package serioussevere workrelated illness case rate reported reported numbers restated johnson johnson invested significantly internal jj learn platform identified areas efficiency number fatalities learning development vendors resulting decrease external spend due overlapping spend categories johnson johnson returned consolidated reporting approach learning development employee safety region average hours enterprisewide training data represents available data three johnson johnsons primary learning management systems working include training data additional sources available future training durations included applied estimates based training type lost workday case rate reported injuryillness rates excluding covid cases lwdc rate trir siic rate fatalities calculated johnson johnson employees contingent workers contingent asia pacific workers ie workers supplied thirdparty agencies workers employer record intended supplement temporarily replace existing workforce directly supervised johnson johnson employee employees europe middle east africa lost days calendar days counted beginning day incident taken place cpmm ipmm rates based safe fleet data rate calculation methodology uses actual estimated data miles latin america driven collect safe fleet data employees drive companyowned leased personally owned vehicles company business employees latter category drive company business regular part job duties north america receive car allowance purchase vehicle andor reimbursed vehicle expenses fuel maintenance insurance miscellaneous charges associated vehicle upkeep total recordable injury rate asia pacific europe middle east africa latin america north america serious injury illness case rate asia pacific europe middle east africa latin america north america road safety crashes per million miles cpmm rate injuries per million miles ipmm rate environmental health health energy use greenhouse gas ghg emissions humanity report total energy use tj scope ghg emissions total mt coe renewable sources scope ghg emissions source mt coe nonrenewable sources facilities energy intensity tjbillion sales fleet percentage change energy intensity compared baseline refrigerants tjbillion aviation percent renewable electricity region scope ghg emissions facilities mt coe north america locationbased europe marketbased global scope scope ghg emissions total mt coe purchased energy use type tj ghg emissions intensity scope scope revenue electricity mt coemillion natural gas percentage decrease ghg emissions intensity scope scope diesel revenue compared baseline mt coe million direct heatingcooling total offsets applied reporting year reported reported propane net scope scope marketbased emissions mt coe reported reported environmental health biogas scope ghg emissions source mt coe fuel oil total purchased energy purchased goods services upstream transportation distribution onsite generated energy use type tj business travel cogeneration employee commuting wind capital goods solar pv fuel energyrelated activities geothermal upstream leased assets fuel cell waste generated operations biomass available total onsite generated energy downstream transportation distribution onsite cleanrenewable energy capacity type use sold products solar pv direct cogeneration indirect wind endoflife treatment sold products geothermal biomass fuel cell onsite cleanrenewable energy technology capacity mw health co capital relief fund water use million cont humanity report number projects completed annual water withdrawn source cont cumulative projects completed since amount spent projects annual millions gray water cumulative spend completed projects since millions surface water total annual energy cost savings result completed projects water withdrawn category since millions freshwater mgl total dissolved solids reported reported total annual energy savings result completed projects since tj water mgl total dissolved solids reported reported total annual ghg emissions avoided result completed water withdrawn areas high extremely high baseline water stress source projects since mt coe municipal reported groundwater reported air emissions source mt rainwater reported reported hazardous air pollutants hap gray water reported mononitrogen oxides nox surface water reported ozonedepleting substances water withdrawn areas high extremely high water stress category ozonedepleting substances mt cfc equivalents freshwater mgl total dissolved solids reported reported particulate matter pm environmental health water mgl total dissolved solids reported reported refrigerants total water withdrawn areas high extremely high sulfur oxides sox reported water stress volatile organic compounds voc water discharge areas high extremely high water stress destination wastewater treatment plant reported reported water use million surface water reported reported total water withdrawn irrigation reported reported total water consumed reported reported total water recycled reused ocean reported reported total water discharge total water discharge areas high extremely high reported reported water stress percentage water withdrawn regions high extremely high baseline water stress water discharge destination percentage water consumed regions high extremely wastewater treatment plant high baseline water stress surface water water withdrawn source irrigation municipal ocean groundwater rainwater health operational waste mt ehs compliance certifications humanity report total waste generated number manufacturing rd sites certified iso hazardous waste percentage manufacturing rd sites certified iso nonhazardous waste number manufacturing rd sites certified iso percentage waste diverted disposal percentage manufacturing rd sites certified iso percentage waste directed disposal number environmental noncompliances waste diverted disposal fines paid environmental noncompliances thousands hazardous waste recycled leed buildings energy recovery number newly leedcertified johnson johnson reused buildings annual nonhazardous waste number johnson johnson buildings recycled leedcertified total energy recovery percentage johnson johnson built space leedcertified total reused total area office building space total waste diverted disposal leedcertified million square feet waste directed disposal environmental health hazardous waste product end life millions landfilled number medical devices collected us incinerated number medical devices reprocessed us biochemical treatment metric assured erm cvs see ghg air emissions electricity water data see pwcs report independent accountants management 's assertion pwc 's report independent accountants previous health humanity reports nonhazardous waste includes sitespecific data johnson johnson owned leased sites square feet johnson johnson operational control well manufacturing rd sites square feet unless otherwise noted landfilled energy intensity ratio includes electricity stationary fuels district heating cooling percentage electricity used johnson johnson generated renewable sources europe includes belgium france incinerated germany greece ireland italy netherlands poland spain sweden switzerland united kingdom north america includes united states canada biochemical treatment values rounded nearest whole number due rounding numbers presented add precisely totals provided percentages may precisely reflect absolute figures accordance guidance world resources institute wri corporate accounting reporting standard restated values reflect newly released electricity grid emission factors well addition removal acquisitions total waste directed disposal divestitures threshold restatement deviates one included report section currently use purchases sales transfers offsets ghg accounting gases covered calculations include co ch hfcs perfluorinated chemicals sulfur hexafluoride nitrogen trifluoride result operations biogenic co emissions mt co electricity emission factors obtained international energy agencys co emissions fuel combustion report us environmental protection agency 's epa 's egrid publication locationbased scope reporting supply contracts residual emission factors available marketbased scope reporting fuel emission factors obtained epa climate leadership publication global warming potentials obtained intergovernmental panel climate change fifth assessment report chosen consolidation approach emissions operational control health emissions calculated using company spend reporting year paired appropriate economic inputoutput io emission factors carnegie mellon data set specific primary data able obtained used place humanity report io calculation methodology business travel emissions personal vehicle travel reflect co data survey sample employees regions extrapolated employees globally used estimate average employee commuting remote working emissions intensity per employee value used calculate emissions employee commuting year year trend may due methodology adjustments emissions fuel energyrelated activities calculated emissions transmission distribution td losses purchased electricity welltotank wtt emissions purchased electricity wtt emissions td losses wtt emissions purchased fuels emissions calculated using international energy agency iea loss factors electricity department environment food rural affairs defra wtt emission factors fuels electricity emissions upstream leased assets calculated applying energy intensity office locations scope scope footprint building area leased assets less square feet greater square feet outside operational control excluded scope scope reporting emissions waste generated operations calculated nonhazardous hazardous waste manufacturing rd operations using department environment food rural affairs ' emissions factors waste emissions downstream transportation distribution calculated using us epas smartway program provided us shippers ghg covered calculations include co calendar year upto date available data available december reported future reports identified level uncertainty around reporting boundary reported value potentially overstated values restated due correction calculation methodology emissions use sold products endoflife treatment sold products calculated using sales volumes johnson johnson products combined lifecycle assessment lca models sales volumes could obtained could obtained sales revenues average unit prices used estimate volumes due size product portfolio lcas performed every johnson johnson product products placed lca categories representative product lca applied emissions processing sold products downstream leased assets franchises investments applicable johnson johnson operations ghgs covered calculations include co includes sitespecific data johnson johnson manufacturing rd sites results completed projects based fuel electricity reduction calculations avoidance energy consumption ghg emissions calculated comparing energy consumption project implementation expected consumption implementation using engineering estimates time projects approved internal process municipal water groundwater rainwater surface water sources considered freshwater category grey water water sources considered water category environmental health certified iso iso means site received external certification valid december decrease sites iso certifications driven part decrease overall johnson johnsonowned manufacturing rd sites denominator total manufacturing rd sites excludes small rd manufacturing sites defined less employees newly acquired sites ie owned less three years december environmental noncompliances represent instances noncompliance environmental regulatory requirements laws either selfreported authorities reporting year ii identified authorities noncompliance occurred reporting year authorities include regional national statecountryprovince localcity regulatory agencies environmental noncompliances fines paid exclude newly acquired sites ie owned less two years december fines paid environmental noncompliances include paid reporting year include fines assessed andor negotiation paid december number regulatory noncompliances increased root cause analysis performed needed corrective actions identified totals include breeam building research establishment environmental assessment methodology certified sites accountability innovation health supply base overview diverse supplier spend us millions humanity report number johnson johnson suppliers tier supplier spend total johnson johnson supplier spend billions diverseowned supplier spend contracted region disabledowned reported asia pacific minorityowned reported europe middle east africa lgbtowned reported latin america veteran disabled veteranowned reported north america womenowned reported supplier spend contracted business total small business spend pharmaceutical percentage total supplier spend attributable small suppliers medtech percentage total supplier spend attributable diverse suppliers consumer health percentage increase tier diverse spend us black reported hispanicowned corporate diverse supplier spend global millions supplier engagement total global impact spend billions reported number suppliers invited participate cdp supply chain climate program number countries outside us tracking diversity accountability innovation percentage participated inclusion indicators tier diverse supplier spend countries outside us number suppliers invited participate cdp supply chain water program global tier supplier spend percentage participated womenowned ecovadis assessments completed minorityowned supplier risk ranking based ecovadis assessments lgbtowned reported low risk veteran disabled veteranowned reported medium risk total veteran disabled veteranowned reported high risk total tier diverse billions reported tier diverse health supplier audits cybersecurity data privacy humanity report supplier environment health safety ehs audits percentage employees completed information reported reported security training ehs audits technical visits completed ehs audits technical visits region board directors composition asia pacific number directors europe middle east africa number independent directors latin america percentage independent directors north america number suppliers identified high risk nonconformance independent lead director yes yes yes johnson johnson responsibility standards suppliers independent audit committee yes yes yes number critical ehs findings identified result independent compensation benefits yes yes yes ehs audits independent nominating corporate governance committee yes yes yes safetyrelated findings independent regulatory compliance sustainability committee yes yes yes environmentalrelated findings independent science technology committee yes yes yes supplier social audits number regular special meetings held supplier social audits completed total board directors completed using smeta pillar protocol social audits completed region tax contribution billions accountability innovation asia pacific payroll social insurance taxes borne europe middle east africa payroll social insurance taxes collected latin america salesuse taxes borne north america salesuse taxes collected number critical findings identified result supplier social audits corporate income tax total taxes borne animal welfare total taxes collected total tax contribution number facilities animals veterinary oversight reported reported number sites animals accredited aaalac international reported reported percentage sites animals accredited code business conduct cbc compliance reported reported aaalac international percentage senior leaders certified compliance percentage research performed rodents fish reported reported organizations cbc nonanimal alternatives available number warning letters untitled letters issued opdp aplb us health health care compliance hcc training product quality indicators humanity report number relevant johnson johnson employees number regulatory inspections johnson johnson completed hcc training includes anticorruption section sites worldwide health authorities percentage sales marketing employees completed percentage regulatory inspections resulted hcc training zero observations number fda inspections johnson johnson sites percentage fda inspections resulted zero inquiries complaints recorded credo integrity line category observations human resourcesrelated average number observations per fda inspection number independent audits johnson johnson sites business integrityrelated ensure compliance johnson johnson quality policy privacy information security general security ehs etc standards general information questions number independent audits external manufacturing sites financialrelated ensure compliance johnson johnson quality policy standards human rightsrelated reported number fda warning letters issued product quality patient safetyrelated product recall rate business segment pharmaceutical compliancerelated allegations investigated medtech triage committee accountability innovation number compliancerelated allegations investigated consumer health selfcare otc percentage compliancerelated allegations investigated category anticounterfeiting healthcare compliance number anticounterfeiting best practices trainings delivered financial law enforcement agents customs border protection etc number external trade groups alliances organizations agencies johnson johnson engaged leadership positions industry working groups collective bargaining agreements percentage employees covered collective bargaining agreements health metric assured erm cvs see health humanity goals assurance see pwcs report independent accountants management 's assertion pwc 's report independent accountants humanity report previous health humanity reports represents spend control overaddressable spend defined products services procurement teams negotiate suppliers meet business goals values rounded due rounding numbers presented add precisely totals provided percentages may precisely reflect absolute figures supplier ecovadis assessments reported january may capture suppliers updated assessment january except tier diverse spend indicators represent spend johnson johnson control addressable spend defined products services procurement teams negotiate suppliers meet business goals total global impact spend consists tier diverse supplier spend us billions countries outside us plus small business spend us less overlap spend plus tier diverse supplier spend global millions us suppliers classified tier diverse small business tier diverse small business overlap removed avoid double counting spend suppliers designated multiple diverse categories counted category supplier qualifies total tier diverse supplier spend us billions counts spend supplier technical visit followup visit initial audit define critical finding evidence high risk human life potential catastrophic impact facility community environment expect suppliers potential suppliers address critical findings immediately social audits conducted using sedex members ethical trade audit smeta protocol figures march committee changed names tax information contained section intended provide reader overview taxes contributed johnson johnson income taxes read conjunction companys tax information filed us securities exchange commission sec including recently filed quarterly reports form q annual report tax information supplemental substitute information reported companys sec filings certifiers include senior leaders vp level selected managing directors general managers based country business segment risk profile executives recently acquired companies opdp office prescription drug promotion aplb advertising promotional labeling branch fda center biologics evaluation research johnson johnson triage committee case investigators ability change issue type cases upon receipt credo integrity line occurred product recall rate defined number lots removed market per total globally manufactured based field action removals determined internally quality review board aligned johnson johnson enterprise compliance reasonable probability product may cause temporary medically reversible adverse health consequences certain cases cause serious adverse health consequences pharmaceutical medtech recall rates consider products business segment consumer health product quality accountability innovation recall rate inclusive consumer health products selfcare overthecounter otc business segment result sporadic attendance logs kept law enforcement trainings stemming potential security concerns number training sessions captured vs number attendees employees johnson johnson trained code business conduct well become aware product complaint adverse event brand protection awareness included mandatory trainings raise understanding awareness illicit trade issues among employees supplemental brand protection training also available stakeholders reflected number independent assurance statements health humanity report independent limited assurance statement johnson johnson health humanity goals erm certification verification services inc erm cvs engaged johnson johnson inc jj provide limited assurance relation selected information reported johnson johnson health humanity report health humanity goals scorecard together report healthforhumanityreportjnjcom conclusion engagement summary based activities described nothing come attention indicate whether selected information detailed fairly presented report selected information disclosures listed scope fairly presented material respects accordance reporting criteria report material respects accordance reporting criteria reported progress health humanity goal cumulative scope vermox mebendazole doses donated millions assurance activities assurance patients reached jj impact ventures jjiv portfolio companies funds since date considering level assurance assessment risk material misstatement engagement investment number december selected information multidisciplinary team sustainability assurance specialists performed issued healthcare professionals hcps supported jjiv portfolio companies since date range procedures included restricted following investment number december assurance engagement extend information respect earlier periods assessing appropriateness reporting criteria selected information including review information included report healthforhumanityreportjnjcom reporting principles boundaries definitions internal guidelines health humanity goals reporting cumulative january december review external media reporting relating jj identify issues reporting period period january december may relevant assurance scope independent assurance statements interviews management representatives staff understand evaluate relevant reporting health humanity goals defined report management systems processes including internal review control processes used criteria jj basis reporting described applicable footnotes within report collecting reporting selected information performed limited assurance engagement accordance international review corporate level sample qualitative quantitative evidence supporting standard assurance engagements isae revised assurance engagements selected information audits reviews historical financial information issued international assurance review ghg renewable energy data confirm consistency findings auditing standards board standard separate ghg renewable energy verification engagement including completeness procedures performed limited assurance engagement vary nature timing level consistency assurance less extent reasonable assurance engagement consequently level assurance obtained limited assurance engagement substantially lower reviewing presentation information relevant scope work report assurance would obtained reasonable assurance engagement healthforhumanityreportjnjcom ensure consistency findings performed limitations engagement jj responsible preparing report collection presentation reliability assured information subject inherent uncertainties given nature information within designing implementing maintaining internal health humanity goals dependence partner organisations provide performance controls relevant preparation presentation selected information respective information well use estimates assumptions extrapolations determining selected erm cvs responsibility provide conclusions jj agreed scope based responsibilities information important understand assurance conclusions context engagement terms jj assurance activities performed exercising professional judgement accept responsibility deny liability party jj conclusions reached health independence integrity quality control humanity report erm cvs independent certification verification body accredited ukas iso accordingly maintain comprehensive system quality control including documented policies procedures regarding compliance ethical requirements professional standards applicable legal regulatory requirements quality management system least demanding relevant sections isqm isqm erm cvs applies code conduct related policies ensure employees maintain integrity objectivity professional competence high ethical standards work processes designed implemented ensure work undertake objective impartial free bias conflict interest certified management system covers independence ethical requirements least demanding relevant sections parts b iesba code relating assurance engagements team undertaken assurance engagement extensive experience conducting assurance environmental social ethical health safety information systems processes provides consultancy related services johnson johnson inc respect independent assurance statements matters provided jj separate management report detailed nonmaterial findings recommendations beth wyke partner corporate assurance malvern pa usa june erm certification verification services inc wwwermcvscom postermcvscom health independent limited assurance statement johnson johnson ghg air emissions electricity water data humanity report erm certification verification services incorporated erm cvs engaged johnson johnson jj provide limited assurance relation selected information set presented jjs health humanity report report healthforhumanityreportjnjcom set engagement summary engagement summary reporting whether corporate data following selected indicators fairly presented year ending december period report material respects accordance reporting criteria ghg emissions total absolute scope ghg emissions metric tonnes coe total absolute scope ghg emissions using locationbased marketbased wbcsdwri ghg protocol updated january scope reporting calculation methods metric tonnes coe ghg emissions criteria total offsets applied reporting year metric tonnes co e johnson johnsons internal reporting criteria definitions net scope scope marketbased ghg emissions metric tonnes coe absolute scope ghg emissions metric tonnes coe following categories category purchased goods services category capital goods performed limited assurance engagement accordance international category fuel energyrelated activities standard assurance engagements isae revised assurance engagements assurance category upstream transportation distribution audits reviews historical financial information procedures performed standard scope category waste generated operations limited assurance engagement vary nature timing less extent level assurance category business travel reasonable assurance engagement consequently level assurance obtained assurance engagement category employee commuting limited assurance engagement substantially lower assurance would independent assurance statements category upstream leased assets obtained reasonable assurance engagement performed energy electricity use generated renewable energy sources eu electricity use generated renewable energy sources north america electricity use generated renewable energy sources global water jj responsible preparing report collection presentation total water withdrawn million information within designing implementing maintaining internal total water consumed million controls relevant preparation presentation report total water recycled reused million respective erm cvs responsibility provide conclusions jj agreed scope based total water discharge million responsibilities engagement terms jj assurance activities performed exercising percentage water withdrawn regions high extremely high baseline professional judgement accept responsibility deny liability party water stress jj conclusions reached percentage water consumed regions high extremely high baseline water stress health conclusion percentage water withdrawn regions limitations engagement high extremely high baseline water stress humanity report based activities described nothing come reliability assured information subject inherent attention indicate data information percentage water consumed regions uncertainties given available methods determining disclosures listed scope fairly presented high extremely high baseline water stress calculating estimating underlying information important report material respects accordance understand assurance conclusions context assurance activities reporting criteria independence integrity quality control considering level assurance assessment risk scope ghg emissions mt coe material misstatement report multidisciplinary team erm cvs independent certification verification body scope ghg locationbased mt coe sustainability assurance specialists performed range accredited ukas iso accordingly maintain emissions procedures included restricted following comprehensive system quality control including documented scope ghg marketbased mt coe policies procedures regarding compliance ethical assessing appropriateness reporting criteria emissions requirements professional standards applicable legal selected information regulatory requirements quality management system total offsets applied mt coe virtual interviews relevant corporate staff understand least demanding relevant sections isqm reporting year internal reporting guidance processes including use isqm net scope scope marketbased mt coe internal ghg protocol internal spreadsheets various emissions internal data management reporting systems erm cvs applies code conduct related policies ensure metrics scope employees maintain integrity objectivity professional scope ghg emissions competence high ethical standards work following categories review reporting boundary compared jjs internal processes designed implemented ensure work reporting criteria purchased goods services mt co e undertake objective impartial free bias conflict capital goods mt coe analytical review yearend data submitted interest certified management system covers independence locations included consolidated group data ethical requirements least demanding fuel energy related activities mt co e selected disclosures included testing completeness relevant sections parts b iesba code relating independent assurance statements upstream transportation mt co e mathematical accuracy conversions calculations assurance engagements distribution consolidation line stated reporting boundary team undertaken assurance engagement waste generated operations mt coe review estimates extrapolations assumptions extensive experience conducting assurance environmental made relation data relevant ghg scope business travel mt coe social ethical health safety information systems emissions categories employee commuting mt coe processes provides consultancy related services jj inperson site visits four sites lititz us pomezia italy respect upstream leased assets mt coe schaffhausen switzerland springhouse us virtual visits four sites athens us norderstedt germany ringaskiddy percentage renewable electricity ireland xian china review local reporting processes region eu consistency reported annual data selected underlying percentage renewable electricity source data indicator interviewed relevant staff beth wyke region north america reviewed site data capture reporting methods checked partner corporate assurance calculations assessed local internal quality assurance percentage renewable electricity malvern pa usa processes region global june total water withdrawn million confirming conversion emission factors assumptions used erm certification verification services inc total water consumed million reviewing presentation information relevant scope wwwermcvscom postermcvscom work report ensure consistency findings total water recycled reused million total water discharge million health humanity report report independent accountants board directors johnson johnson preparation sustainability metrics requires management establish criteria make determinations relevancy information included make assumptions affect reviewed accompanying management assertion johnson johnson sustainability reported information selection management different acceptable measurement techniques metrics year ended december managements assertion presented could resulted materially different amounts metrics reported accordance assessment criteria set forth managements assertion johnson johnsons management responsible assertion selection criteria management based review aware material modifications made johnson believes provide objective basis measuring reporting sustainability metrics johnsons management assertion order fairly stated responsibility express conclusion managements assertion based review review conducted accordance attestation standards established american institute certified public accountants aicpa atc section concepts common attestation engagements atc section review engagements standards require plan perform review obtain limited assurance whether material modifications made florham park new jersey managements assertion order fairly stated procedures performed review vary june nature timing substantially less extent examination objective obtain reasonable assurance whether managements assertion fairly stated material respects order express opinion accordingly express opinion limited nature engagement level assurance obtained review substantially lower independent assurance statements assurance would obtained examination performed believe review evidence obtained sufficient appropriate provide reasonable basis conclusion required independent meet ethical responsibilities accordance relevant ethical requirements related engagement firm applies statements quality control standards established aicpa accordingly maintains comprehensive system quality control procedures performed based professional judgment performing review performed inquiries performed tests mathematical accuracy computations sample basis read relevant policies understand terms related relevant information sustainability metrics reviewed supporting documentation regard completeness accuracy data sustainability metrics sample basis performed analytical procedures health johnson johnson management assertion humanity report year ended december johnson johnson management assertion year ended december management johnson johnson responsible completeness accuracy validity sustainability diversity equity inclusion dei continued metrics included tables year ended december reporting year global operations unless otherwise noted metrics rounded nearest whole number unless otherwise metric description metric value indicated gender representationabci management asserts metrics reported tables also included health humanity report identified symbol presented accordance assessment criteria set forth regiondj asia pacific management responsible selection criteria management believes provide objective women basis measuring reporting sustainability metrics preparation sustainability metrics requires men management establish criteria make determinations relevancy information included declined answer make assumptions affect reported information selection management different acceptable europe middle east africa measurement techniques could resulted materially different amounts metrics reported women givinga men declined answer metric description metric value millions latin america women total productsb cash contributed men productsb contributed declined answer north america cash contributed women men contributions include products cash donations made qualified nonprofit entities ie c organizations us ngo declined answer source c equivalency determination organizations outside us johnson johnson reporting year administrative costs incurred johnson johnson contribution process also included cash contributions approximately cash employment type fulltime employees contributed women b products contributed measured fair market value price product determined internal price list usd december johnson johnson would sell consumers market men independent assurance statements declined answer diversity equity inclusion dei parttime employees women metric description metric value men global employeesac declined answer fixedterm employees total number employeesb women women men men declined answer declined answer job categorydgj vice presidents regiond asia pacific women europe middle east africa men latin america declined answer north america directors managers women men declined answer professionals women men declined answer management executive positionsg women management positions women executive positions diversity equity inclusion dei continued metric description metric value gender representationabci regiondj asia pacific women men declined answer europe middle east africa women men declined answer latin america women men declined answer north america women men declined answer employment type fulltime employees women men declined answer parttime employees women men declined answer fixedterm employees women men declined answer job categorydgj vice presidents women men declined answer directors managers women men declined answer professionals health diversity equity inclusion dei continued women diversity equity inclusion dei continued diversity equity inclusion dei continued humanity report men metric description dmeectrliince vda tolu aen swer mmeettrriicc ddeessccrriippttiioonn mmeettrriicc vvaalluuee mgeanndaegre rmeepnrte asnedn teaxtieocnuativbec pio sitionsg women management positions egtehnndicerr raceiparle dsievnetrastiitoynba inb tchei us job categoryacdg diversity equity inclusion dei continued regiondj asia pacific regiondj asia pacific women executive positions professionals white women women metric description metric value asian men men diversity board composition declined answer b dl ea cc lk ina edfr tc oa n na sm er ri c n hispaniclatino diversity board compositionf weuormopeen middle east africa europe middle east africa ewthonmicenr acial iversity women declined answer men men global age diversity u dn ed cle inr e n sw er new employee hiresh declined answer latin america latin america total number new hires wom en women dmeecnl ined answer regiondij amseian pacific age diversitye job categoryacdg declined answer eduercolipneed toid adnles weears frica north america lnaotrinth ammeerricicaa vice presidents uwnodmeer n nwoormthe anm erica men men dec lined answer declined answer demirepclotoyrms eanntd ympaen agers ufunldletirm e emplo yees g emen pd loe yr mre ep nr te ts ye pn et ationbi w fuo llm tie mn e e p lo yees wome n e n men ec nl e nswer declined answer declined answer professionals agee parttime employees parttime employees women women men men ethnicracial diversity us declined answer declined answer independent assurance statements ethnicracial diversity usj wfixheitde term em ployees global employees global employee headcount december johnson johf ni sx oe nd hte ur mm ne rm ep solo ury ce e e ins fo r mation system awsoiamne n hris employee defined individual working fulltime parttime excluding fixedterm ewmpolomyeeens interns coop employees fixed bmleanck africa n american term employees defined employees contract limited period ends spemcieficn ime peri od expires specific task event attached time estimate completed fixedterm contracts make less total employees plus individuals hdiescplainneicd ltoa tainnos wer fixedterm contracts employee data may include data recently acquired companies dwheoc alirnee ndot tyoe ta renfslewcteedr hris exceed two years date acquisition individuals longterm disability excluded contingent workers ie workers supplied job categorydgj ovitchee rp resid ents jobby c thaitredgpoarrtyy adgegnjc ies workers employer record contractors subcontractors arve iacleso p erxeclsuiddeedn atsbio med headcount dweocmlineend ans wer excluded global employee data well employee deirelated disclosures women b gender ethnicracial diversity reported accordance gender ethnicity race selfreported employee recorded ethnicracial diversityb us job categoryacdg men hris november defined employees selfreported american indmiane onr alaskan native native hawaiian declined answer pacific islander two races declined answer vice presidents wdihreitcet ors managers c individual working fulltime defined employee working hours week indidvidirueacl twoorrsk inagn pda rmttaimnea igs edersfin e employee working less hours week awsoiamne n women bmleanck africa n american region job category obtained hris december men hdiescplainneicd ltoa tainnos wer e age diversity reported accordance age selfreported employee recorded e ch lr inis e das ah ne sd wat ee ro f h ire f gender ethnicracial diversity board composition reported accordance gender ethnicity confirmed board oprtohfeers siona ls members april professionals dweocmlineend ans wer g professional positions defined paygrades management positions defined paygwradoem e na nd executives defined employees reporting directly chairman chief executive officer based organization chart including names positions directors managersj wmehnit e december men adseicalnin ed nswer h new employee hires external hires start date january december eclin eobdt atione ad nfrsowm ehrr management executive positionsg bwlaocmkeanf rinic amna anamgeermicaenn posit ions aw nh ae gre e mthe e v na tl u ae n fo dr ed xe ec clin ue td iv eo pn os sw ie tir nis ro gu nded zero zero prior year e wxc olu mde ed n fr inm mthe nre ap gor ete md eta nb tle p ositions j values rounded nearest tenth due rounding numbers presented add precisely hispan iclatino owtohmere n e xecutive positions women executive positions decline answer health employee retention turnover employee safety continued humanity report f siic rate calculated follows data used calculation obtained internal johnson johnson curve system number metric description metric value siic work hourstotal work hours managers moved across functions country business segment ethics compliance inquiries complaints recorded credo integrity line category lines abc overall voluntary turnover metric description metric value inquiries complaints recorded credo integrity line human resourcesrelated voluntary turnover high performers e categoryab business integrityrelated privacy information security represents percentage employees manager job categories defined paygrade hris december general security ehs etc career progression moved upward promotion lateral transfer reporting year b employee count excludes fixedterm intern coop employees employees longterm disability employees recently acquired general information questions companies yet reflected hris exceed years date acquisition employees research development rd organizations pharmaceutical medtech consumer health business segments c employee movement tracked monthly hris consolidated year end employee moves example across function financialrelated country month counted one move human rightsrelated employee count excludes fixedterm intern coop employees employees longterm disability employees recently acquired companies yet reflected hris exceed years date acquisition voluntary turnover numerator product quality patient safety excludes employees leaving company due retirement death related e high performer defined individual two consecutive annual performance ratings exceptionalexceptional exceptionalstrong strongexceptional note exceptional strong two four possible dimension ratings employees part performance management process excluded voluntary turnover high performers metric four possible dimension ratings johnson johnsons anonymous grievance mechanism includes inquiry complaint categories person reporting select employees part performance management process excluded voluntary turnover high performers metric reporting inquiries complaints field reports summarized seven reported categories johnson johnson consists following categories privacy information security global security environment health safety ehs legalregulatory report follow employee safetyab b johnson johnsons triage committee case investigators ability change category inquiry complaint upon receipt using set established criteria credo integrity line occurred total recorded inquiries complaints metric description metric value lost workday case ratecd global compliancerelated allegations investigated triage committeea asia pacific metric description metric value europe middle east africa number compliancerelated allegations investigated latin america independent assurance statements north america percentage compliancerelated allegations investigated category healthcare complianceb financialc total recordable injury ratee global otherd asia pacific europe middle east africa latin america compliancerelated allegations filed internal external parties allegations meet internal escalation criteria logged categorized johnson johnson management within johnson johnsons sensitive issue case management system north america presented investigated johnson johnson triage committee internal escalation criteria includes actual alleged non compliance internal johnson johnson policies could result termination employee ii expense violations exceeding serious injury illness case ratef global iii theft fraud misuse funds exceeding iv noncompliance laws regulations anticorruption laws human asia pacific trafficking rules v governmental noncompliance failure abide relevant terms us government invoice contract pricing program financial conflicts interest false incomplete statements made us government vi data breach privacy incidents europe middle east africa vii misconduct members senior leadership team latin america b healthcare compliance allegations consist violations health care compliance guidelines including us foreign corrupt practices act fcpa violations north america c financial allegations consist asset misappropriation conflicts interest financial statementrelated allegations consist legal quality antitrust product registration privacy number fatalities global includes data december hours worked reporting year recently acquired sites ie owned less two years ehs compliance certifications december excluded employee safety metrics b lost workday case lwdc rate total recordable injury rate trir serious injury illness case siic rate fatalities calculated metric description metric value johnson johnson employees contingent workers contingent workers ie workers supplied thirdparty agencies workers employer record intended supplement temporarily replace existing workforce directly supervised johnson johnson number environmental noncompliancesab employee cases contractorsubcontractors contingent workers excluded reported illnessinjury rates exclude covid illness cases fines paid environmental noncompliancesabc thousands c lost days calendar days employee unable work due illness injury beginning day incident taken place last day leave excluding holidays vacations number manufacturing rd sites certified iso lwdc rate calculated follows data used calculation obtained internal johnson johnson curve system number lwdc work hourstotal work hours number manufacturing rd sites certified iso e trir calculated follows data used calculation obtained internal johnson johnson curve system number recordable cases work hourstotal work hours health ehs compliance certifications continued credo survey results humanity report metric description metric value metric description metric value percentage manufacturing rd sites certified iso de number languages credo survey made available percentage manufacturing rd sites certified iso de number countries credo survey administered response rate among active employeesb environmental noncompliances represent instances noncompliance environmental regulatory requirements laws either selfreported authorities reporting year ii identified authorities noncompliance occurred reporting year favorability ratebc authorities include regional national statecountryprovince localcity regulatory agencies b environmental noncompliances fines paid exclude newly acquired sites ie owned less two years december percentage agreed statement ensures first responsibility c fines paid environmental noncompliances include paid reporting year include fines assessed andor patients doctors nurses mothers fathers others negotiation paid december certified iso iso means site received external certification valid december use products servicesb e denominator total manufacturing research development rd sites excludes small rd manufacturing sites defined percentage agreed statement provides inclusive work less employees newly acquired sites ie owned less three years december environment employee considered individualbc product quality indicators percentage agreed statement acts responsibly communities live work world community wellbc metric description metric value number regulatory inspectionsa johnson johnson sites johnson johnson conducts credo survey biannually track employee sentiment globally credo survey metric data collected worldwide health authoritiesb b cd tiv et er med p li e eth si r id n cp lua drt ey jp ola ht nfo sr om n johnson employees december completed credo survey excludes percentage regulatory inspectionsa resulted zero f fi ox ld e st se r tm ha nin tt rr en e mn od n c hso p employees employees longterm disability contractors employees johnson johnson observationsb c favorability rate calculated determining percentage agree strongly agree responses responses credo survey questions response types include strongly disagree disagree neither agree disagree agree strongly agree know questions number fda inspections johnson johnson sitesc without responses removed numerator denominator percentage fda inspections resulted zero observationsc average number observations per fda inspectionc tax contribution billions number independent audits johnson johnson sites ensure metric description taxes borne metric value taxes collected metric value compliance johnson johnson quality policy standardsd independent assurance statements corporate income taxb number independent audits external manufacturing sitese ensure compliance johnson johnson quality policy payroll social insurance taxescd standardsd salesuse taxesce number fda warning letters issued product recall ratef business segmentg pharmaceutical total medtech consumer health selfcare otc total tax contributionf regulatory inspection defined inspection conducted health authority determine compliance applicable laws regulations taxes borne direct cost johnson johnson taxes collected direct cost johnson johnson represent taxes b health authorities organizations authority development manufacture distribution placing market post market collected customers employees behalf governments ultimately remitted governments surveillance products example us food drug administration fda korean food drug administration kfda british b corporate income tax represents income withholding taxes paid markets johnson johnson operates standards institution bsi health canada observations identified inspection listed form provided thirdparty c payroll social insurance taxes salesuse taxes based data collected major markets represent approximately health authority conducted inspection total rd party intercompany sales recorded market taxes reported remaining markets represent c fda inspection defined regulatory inspection performed fda observation defined observed condition approximately total rd party intercompany sales recorded market practice indicating fdaregulated product may violation fda requirements observations listed fda form payroll social insurance taxes borne represent taxes paid directly johnson johnson payroll social insurance taxes collected represent inspections conducted fda provided manufacturer following fda inspection amounts withheld employees federal local country government state social contribution taxes well contingent labor taxes independent audits conducted internal johnson johnson regulatory compliance auditors johnson johnson sites external collected manufacturing sites e salesuse taxes borne represent salesuse tax property tax nonrecoverable valueadded tax well taxes comprised e external manufacturing site defined owned operated johnson johnson customs duties pharmaceutical fees imposed government legal entities within pharmaceutical industry f product recall rate defined number lots removed market percentage total lots globally manufactured based field prescription drugs salesuse taxes collected represent net valueadded tax vat vat output less vat input sales tax action removals determined internally quality review board aligned johnson johnson enterprise compliance collected reasonable probability product may cause temporary medically reversible adverse health consequences certain f total tax contribution made two components total taxes borne johnson johnson total taxes collected cases cause serious adverse health consequences lot defined specific quantity material uniform character quality released market calendar year g pharmaceutical medtech recall rates consider products business segment consumer health product quality recall rate inclusive consumer health products selfcare overthecounter otc business segment glossary health humanity report acronym definition acronym definition global nonprofit promotes humane treatment animals science formerly jjdc johnson johnson innovationjjdc inc aaalac association assessment accreditation laboratory animal care international jj medtech johnson johnson medtech aapi asian american pacific islander jlabs johnson johnson innovationjlabs afib atrial fibrillation lai longacting injectable ai artificial intelligence lgbtqia lesbian gay bisexual transgender queer questioning intersex asexual others amr antimicrobial resistance lmics low middleincome countries apac asia pacific mdrtb multidrugresistant tuberculosis api active pharmaceutical ingredient ml machine learning arv antiretroviral norges bank investment management nbim basel institute governance 's measuring bipoc black indigenous people color nbim effectiveness anticorruption programmes reporting framework adding disclosures car cart chimeric antigen receptor chimeric antigen receptor tcell set indicators cdc centers disease control prevention ngo nongovernmental organizations cdp global nonprofit environmental impact disclosures formerly carbon disclosure project nih national institutes health dei diversity equity inclusion nist national institute standards technology drtb drugresistant tuberculosis ntds neglected tropical diseases ema european medicines agency otc overthecounter emea europe middle east africa orthe race health equity glossary erg employee resource groups ppa power purchase agreements erp enterprise resource planning ppe personal protective equipment esg environmental social governance pta priority topics assessment expec extraintestinal pathogenic escherichia coli rls resourcelimited settings fda us food drug administration rna ribonucleic acid gci global community impact rwd realworld data ghg greenhouse gas gases sdg sustainable development goal united nations gph global public health sec us securities exchange commission hcp healthcare professionals ssp supplier sustainability program hiv human immunodeficiency virus stemd science technology engineering mathematics manufacturing design hvac heating ventilation air conditioning tb tuberculosis ia intelligent automation ungps united nations guiding principles business human rights ip intellectual property world health organization health humanity report contact us johnson johnson enterprise esg program office wwcorporategovernanceitsjnjcom one johnson johnson plaza new brunswick new jersey healthforhumanityreportjnjcom